data_1ccf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ccf _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.458 ' N ' ' CD ' ' A' ' 49' ' ' GLN . 2.8 mp0 -98.01 -10.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 116.09 -2.244 . . . . 0.0 109.516 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.473 ' C ' ' H ' ' A' ' 52' ' ' GLY . 45.6 t -113.06 10.93 18.82 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 114.92 -2.712 . . . . 0.0 109.611 -175.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -75.24 19.18 0.17 Allowed 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 115.107 -2.637 . . . . 0.0 111.418 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -131.68 27.8 3.65 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 114.67 -3.633 . . . . 0.0 111.337 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 48.86 73.94 0.91 Allowed Pre-proline 0 N--CA 1.498 1.943 0 C-N-CA 117.256 -1.778 . . . . 0.0 111.043 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.53 -35.35 1.16 Allowed 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 121.108 1.206 . . . . 0.0 110.686 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.2 m -89.11 148.72 23.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.735 -2.386 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.504 ' O ' ' C ' ' A' ' 57' ' ' ASN . 79.4 mt -100.91 174.5 5.99 Favored 'General case' 0 C--O 1.268 2.049 0 C-N-CA 116.191 -2.203 . . . . 0.0 108.814 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 56' ' ' LEU . 7.0 m-80 34.27 68.57 0.18 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 118.167 -1.413 . . . . 0.0 111.477 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 1.39 HE21 ' NE2' ' A' ' 58' ' ' GLN . 11.3 pt20 36.51 54.09 1.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.669 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.21 178.09 41.68 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 115.623 -3.18 . . . . 0.0 109.573 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.483 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 45.4 t60 -89.8 136.96 32.73 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 115.436 -2.505 . . . . 0.0 108.437 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.68 129.02 30.02 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 115.287 -2.565 . . . . 0.0 109.237 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 115.661 -2.416 . . . . 0.0 108.121 174.678 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.396 0 CA-C-O 121.918 0.732 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 65' ' ' ILE . 28.2 mt -114.3 55.65 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 114.612 -2.835 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.7 -61.34 2.04 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 114.177 -3.868 . . . . 0.0 111.225 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' O ' ' O ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -78.92 3.74 16.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 115.721 -2.392 . . . . 0.0 110.07 -174.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.571 ' O ' ' O ' ' A' ' 67' ' ' ASP . 53.1 p90 39.68 179.04 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.191 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 p -139.74 145.8 38.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 115.946 -2.302 . . . . 0.0 107.694 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 25.2 m -131.56 119.12 21.04 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 114.955 -2.698 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -108.23 153.31 23.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 116.199 -2.2 . . . . 0.0 108.876 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.117 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 85.8 m -98.02 148.51 23.43 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 115.943 -2.303 . . . . 0.0 109.846 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.61 27.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 115.26 -2.576 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.64 102.28 0.71 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 114.902 -2.719 . . . . 0.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.22 -43.91 0.65 Allowed Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 115.411 -3.28 . . . . 0.0 108.902 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.91 155.96 18.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 116.308 -2.157 . . . . 0.0 109.502 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -146.74 142.82 28.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.855 -2.338 . . . . 0.0 108.936 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 140.68 166.82 10.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 114.174 -3.869 . . . . 0.0 109.605 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 78' ' ' GLY . 53.0 tptt -42.4 -54.36 3.85 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.664 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 21.7 m-20 -109.26 14.34 23.84 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.942 -1.903 . . . . 0.0 109.492 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.117 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 4.0 m 72.24 25.17 2.93 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 115.262 -2.575 . . . . 0.0 108.839 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -71.64 -30.38 65.69 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.928 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 . . . . . 0 CA--C 1.506 -0.714 0 C-N-CA 115.918 -2.313 . . . . 0.0 109.021 -177.3 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.928 0.871 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.443 ' N ' ' CD ' ' A' ' 49' ' ' GLN . 15.7 mp0 -94.67 -23.84 17.42 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 116.634 -2.026 . . . . 0.0 108.466 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.094 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 41.9 t -90.62 20.98 4.24 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 115.702 -2.399 . . . . 0.0 110.422 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.97 26.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.758 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -139.27 19.9 3.02 Favored Glycine 0 C--N 1.319 -0.375 0 C-N-CA 114.782 -3.58 . . . . 0.0 110.289 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.496 ' C ' ' O ' ' A' ' 52' ' ' GLY . 51.5 t60 40.66 72.97 0.93 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 116.797 -1.961 . . . . 0.0 109.809 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 5.1 Cg_exo -81.21 -37.02 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.607 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.9 m -77.68 143.92 37.75 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 114.797 -2.761 . . . . 0.0 111.499 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.653 ' O ' ' C ' ' A' ' 57' ' ' ASN . 83.9 mt -103.43 178.15 4.64 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 116.296 -2.161 . . . . 0.0 110.426 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 56' ' ' LEU . 37.1 m-80 27.81 60.73 0.11 Allowed 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 118.188 -1.405 . . . . 0.0 111.539 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 48.3 tt0 66.87 73.05 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 116.681 -2.007 . . . . 0.0 111.771 168.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.03 160.16 17.57 Favored Glycine 0 C--N 1.363 2.031 1 C-N-CA 112.592 -4.623 . . . . 0.0 110.377 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -88.51 108.94 19.66 Favored 'General case' 0 C--O 1.254 1.29 0 C-N-CA 114.497 -2.881 . . . . 0.0 108.121 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.094 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 23.6 p -88.79 112.14 22.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.08 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.8 tptt . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 115.26 -2.576 . . . . 0.0 107.963 177.61 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.205 0 CA-C-O 123.347 1.526 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.416 ' O ' ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -92.39 87.22 2.4 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.882 0 C-N-CA 117.036 -1.866 . . . . 0.0 108.568 178.502 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.37 -67.18 3.12 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 114.285 -3.817 . . . . 0.0 111.062 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -74.72 164.5 26.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 116.04 -2.264 . . . . 0.0 110.096 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -129.37 162.14 28.7 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 116.367 -2.133 . . . . 0.0 108.87 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.3 p -132.79 142.52 49.04 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.199 -2.6 . . . . 0.0 109.636 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.0 m -106.1 119.73 39.97 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 115.134 -2.626 . . . . 0.0 109.201 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.29 126.09 41.25 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 115.832 -2.347 . . . . 0.0 109.233 173.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 35.7 m -82.27 158.39 23.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 114.529 -2.868 . . . . 0.0 110.208 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.33 166.9 22.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 115.181 -2.607 . . . . 0.0 108.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.13 112.24 1.83 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 114.585 -2.846 . . . . 0.0 109.202 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.96 -47.49 0.8 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 114.431 -3.747 . . . . 0.0 110.452 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.95 167.5 9.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 115.805 -2.358 . . . . 0.0 109.903 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -158.18 -0.69 0.1 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 115.398 -2.521 . . . . 0.0 111.865 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . -63.8 168.51 23.1 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 115.696 -3.145 . . . . 0.0 110.649 175.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -47.71 -52.61 17.78 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.721 -1.992 . . . . 0.0 108.667 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.73 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 50.5 m-20 -93.7 16.84 12.98 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 115.017 -2.673 . . . . 0.0 107.39 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 14.6 m 76.21 23.57 1.21 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 116.079 -2.248 . . . . 0.0 108.443 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.12 -32.51 67.02 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 115.025 -2.67 . . . . 0.0 110.411 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 . . . . . 0 N--CA 1.473 0.716 0 C-N-CA 115.836 -2.345 . . . . 0.0 109.041 -178.525 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 . . . . . 0 C--O 1.203 -1.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 91.3 mm-40 -79.17 -15.82 57.53 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 116.563 -2.055 . . . . 0.0 109.025 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.223 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 30.5 p -98.78 18.25 17.45 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 115.539 -2.464 . . . . 0.0 109.25 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -74.25 30.37 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 116.661 -2.016 . . . . 0.0 111.121 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -141.66 28.1 2.31 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 114.478 -3.725 . . . . 0.0 110.462 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' GLY . 72.5 m80 43.62 76.37 0.54 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 115.263 -2.575 . . . . 0.0 110.643 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -89.14 -32.99 0.11 Allowed 'Trans proline' 0 N--CA 1.427 -2.414 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 3.7 m -83.2 156.32 23.26 Favored 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 115.088 -2.645 . . . . 0.0 110.894 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.546 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.3 mt -98.6 173.16 7.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 117.009 -1.877 . . . . 0.0 108.703 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.546 ' C ' ' O ' ' A' ' 56' ' ' LEU . 21.1 m-80 36.99 60.04 1.02 Allowed 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 116.148 -2.221 . . . . 0.0 112.66 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 55.55 31.37 17.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 117.469 -1.693 . . . . 0.0 113.296 166.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.92 158.31 53.11 Favored Glycine 0 N--CA 1.504 3.185 1 C-N-CA 113.353 -4.261 . . . . 0.0 110.405 172.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.444 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 7.6 t-160 -88.38 172.01 9.71 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 115.204 -2.599 . . . . 0.0 109.48 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.223 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 30.9 p -139.95 122.76 16.49 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 114.592 -2.843 . . . . 0.0 109.31 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 115.171 -2.611 . . . . 0.0 108.972 176.419 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 CA-C-O 122.799 1.221 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.17 93.28 2.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 C-N-CA 114.86 -2.736 . . . . 0.0 107.741 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 89.36 -69.16 2.59 Favored Glycine 0 CA--C 1.548 2.133 0 C-N-CA 114.437 -3.744 . . . . 0.0 110.076 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -77.76 170.02 17.29 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 115.433 -2.507 . . . . 0.0 109.527 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -132.11 158.24 42.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.166 -2.214 . . . . 0.0 109.572 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -127.36 133.84 50.01 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 116.39 -2.124 . . . . 0.0 108.364 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.3 m -104.97 132.7 50.88 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.742 -2.783 . . . . 0.0 109.909 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -104.72 148.72 26.28 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 115.83 -2.348 . . . . 0.0 109.701 175.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.191 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 64.7 m -110.91 143.41 41.59 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 116.298 -2.161 . . . . 0.0 108.8 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -76.34 170.27 16.67 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 115.392 -2.523 . . . . 0.0 110.173 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.82 140.04 58.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 116.163 -2.215 . . . . 0.0 108.987 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.71 -21.19 43.27 Favored Glycine 0 N--CA 1.427 -1.957 1 C-N-CA 113.474 -4.203 . . . . 0.0 109.904 -174.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 65.7 m-85 -133.22 143.32 49.06 Favored 'General case' 0 CA--C 1.471 -2.065 0 C-N-CA 114.725 -2.79 . . . . 0.0 110.051 -170.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.597 ' C ' ' HA ' ' A' ' 81' ' ' CYS . 2.0 pt-20 -164.99 173.36 11.66 Favored 'General case' 1 N--CA 1.367 -4.619 0 C-N-CA 113.843 -3.143 . . . . 0.0 112.775 165.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 139.33 178.2 16.29 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 114.698 -3.62 . . . . 0.0 110.158 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 78' ' ' GLY . 29.1 ttpp -41.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 116.433 -2.107 . . . . 0.0 108.871 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.648 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 57.2 m-20 -118.28 24.49 10.92 Favored 'General case' 0 C--O 1.207 -1.167 0 C-N-CA 115.556 -2.458 . . . . 0.0 109.466 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.191 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.7 m 76.87 39.25 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 115.299 -2.56 . . . . 0.0 106.99 -170.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -88.25 -28.96 20.78 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 116.358 -2.137 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 77' ' ' GLU . 65.4 m-85 . . . . . 0 N--CA 1.483 1.214 0 C-N-CA 114.984 -2.687 . . . . 0.0 108.994 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 49' ' ' GLN . 31.2 t70 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.498 ' N ' ' CD ' ' A' ' 49' ' ' GLN . 2.9 mp0 31.79 33.92 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 117.499 -1.681 . . . . 0.0 113.493 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.2 t -166.87 27.0 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 115.94 -2.304 . . . . 0.0 108.715 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -76.18 24.23 0.14 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 115.682 -2.407 . . . . 0.0 111.24 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -146.06 24.31 1.75 Allowed Glycine 0 N--CA 1.484 1.897 0 C-N-CA 114.062 -3.923 . . . . 0.0 110.56 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 22.2 t-160 42.79 78.37 0.39 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.299 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 5.0 Cg_exo -82.12 -33.83 0.53 Allowed 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 121.035 1.157 . . . . 0.0 110.961 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.091 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.6 m -75.85 149.27 37.87 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 115.39 -2.524 . . . . 0.0 110.464 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' O ' ' C ' ' A' ' 57' ' ' ASN . 70.7 mt -97.91 174.03 6.78 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 116.114 -2.234 . . . . 0.0 109.746 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.59 ' C ' ' O ' ' A' ' 56' ' ' LEU . 21.5 m-80 33.76 57.29 0.57 Allowed 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 115.845 -2.342 . . . . 0.0 114.118 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 56.62 41.99 27.69 Favored 'General case' 0 N--CA 1.515 2.811 0 C-N-CA 116.047 -2.261 . . . . 0.0 111.749 168.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.47 54.87 Favored Glycine 0 N--CA 1.444 -0.771 1 C-N-CA 113.653 -4.118 . . . . 0.0 110.125 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -93.36 133.12 36.94 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 114.65 -2.82 . . . . 0.0 109.438 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 88.4 m -98.43 105.49 17.64 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 114.742 -2.783 . . . . 0.0 107.338 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 N--CA 1.48 1.058 0 C-N-CA 115.513 -2.475 . . . . 0.0 107.696 176.425 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.605 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.74 85.02 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 C-N-CA 114.767 -2.773 . . . . 0.0 109.034 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.1 -60.56 4.58 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 115.803 -3.094 . . . . 0.0 110.932 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.98 167.52 21.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.554 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.53 159.1 44.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 114.748 -2.781 . . . . 0.0 108.923 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -137.04 132.25 33.94 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 115.146 -2.622 . . . . 0.0 108.395 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.091 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.8 m -91.46 129.09 37.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 116.059 -2.256 . . . . 0.0 109.761 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.3 m -107.46 106.07 16.29 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 114.827 -2.749 . . . . 0.0 109.677 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 77' ' ' GLU . 34.3 m -68.81 142.45 54.87 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 115.473 -2.491 . . . . 0.0 109.95 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.54 169.2 18.7 Favored 'General case' 0 C--O 1.26 1.649 0 C-N-CA 115.503 -2.479 . . . . 0.0 111.69 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.71 143.25 31.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 115.691 -2.404 . . . . 0.0 109.783 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.16 -23.73 34.84 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 115.11 -3.424 . . . . 0.0 110.292 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -131.48 143.87 50.73 Favored 'General case' 0 N--CA 1.407 -2.578 0 C-N-CA 114.484 -2.887 . . . . 0.0 110.243 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.621 ' C ' ' HA ' ' A' ' 81' ' ' CYS . 2.0 pt-20 -164.85 178.07 7.45 Favored 'General case' 1 N--CA 1.37 -4.461 0 C-N-CA 112.766 -3.574 . . . . 0.0 112.747 164.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 133.25 175.51 13.99 Favored Glycine 0 N--CA 1.484 1.864 0 C-N-CA 115.308 -3.33 . . . . 0.0 109.745 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.8 tttp -38.66 -52.21 1.66 Allowed 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 116.147 -2.221 . . . . 0.0 110.622 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 61.9 m-20 -119.55 20.39 12.41 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 116.412 -2.115 . . . . 0.0 108.471 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 4.5 m 79.57 43.66 0.06 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 115.884 -2.326 . . . . 0.0 107.816 -171.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -92.0 -30.5 16.03 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.549 -2.06 . . . . 0.0 109.468 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 77' ' ' GLU . 59.1 m-85 . . . . . 0 CA--C 1.465 -2.299 0 C-N-CA 115.55 -2.46 . . . . 0.0 107.179 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 94.6 mm-40 -83.0 13.83 3.74 Favored 'General case' 0 C--O 1.257 1.47 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.775 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 25.6 t -140.37 22.8 2.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 115.407 -2.517 . . . . 0.0 109.892 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.79 30.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 115.318 -2.553 . . . . 0.0 112.071 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -155.97 27.84 0.58 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 114.037 -3.935 . . . . 0.0 110.218 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.1 m80 48.44 71.39 1.61 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 115.6 -2.44 . . . . 0.0 112.086 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -76.97 -31.15 3.98 Favored 'Trans proline' 0 N--CA 1.413 -3.258 0 C-N-CA 122.224 1.949 . . . . 0.0 109.091 -177.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 14.5 m -83.92 158.65 21.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.998 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 57' ' ' ASN . 62.9 mt -104.43 165.48 11.03 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 117.773 -1.571 . . . . 0.0 108.896 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.524 ' C ' ' O ' ' A' ' 56' ' ' LEU . 15.9 m-80 34.28 63.73 0.41 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 118.181 -1.407 . . . . 0.0 111.552 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 53.88 59.03 4.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 115.4 -2.52 . . . . 0.0 111.553 169.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.23 170.69 52.81 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 114.223 -3.846 . . . . 0.0 110.91 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -97.09 104.96 17.03 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 115.383 -2.527 . . . . 0.0 108.124 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 53.5 t -95.25 118.57 32.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 114.372 -2.931 . . . . 0.0 109.676 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? . . . . . 0 C--O 1.215 -0.732 0 C-N-CA 116.356 -2.137 . . . . 0.0 108.032 174.559 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.71 100.1 9.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 115.305 -2.558 . . . . 0.0 108.762 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 86.07 -72.81 2.63 Favored Glycine 0 N--CA 1.477 1.386 0 C-N-CA 114.04 -3.933 . . . . 0.0 110.187 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.72 166.52 22.87 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.436 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -128.82 159.63 35.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 115.929 -2.308 . . . . 0.0 108.724 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.3 p -130.54 130.43 44.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 116.068 -2.253 . . . . 0.0 109.394 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 69.3 m -107.35 139.27 42.1 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 115.475 -2.49 . . . . 0.0 109.961 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.08 121.96 36.58 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 116.293 -2.163 . . . . 0.0 109.072 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.154 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 33.7 m -73.79 148.05 42.85 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 115.659 -2.416 . . . . 0.0 110.881 -176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.9 166.24 11.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 115.873 -2.331 . . . . 0.0 109.146 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -53.78 115.42 1.98 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.513 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.45 ' O ' ' CE1' ' A' ' 76' ' ' PHE . . . 136.27 -34.67 2.22 Favored Glycine 0 C--O 1.262 1.862 0 C-N-CA 115.007 -3.473 . . . . 0.0 110.363 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.45 ' CE1' ' O ' ' A' ' 75' ' ' GLY 0.266 28.9 m-85 -133.84 162.84 30.92 Favored 'General case' 0 CA--C 1.568 1.669 0 C-N-CA 118.145 -1.422 . . . . 0.0 107.686 -172.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.063 ' N ' ' O ' ' A' ' 83' ' ' PHE . 3.7 tm-20 -161.25 136.86 7.86 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 113.726 -3.19 . . . . 0.0 112.126 175.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 142.16 178.39 18.17 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 114.52 -3.705 . . . . 0.0 110.604 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' GLY . 62.9 tttm -46.84 -61.33 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 115.339 -2.544 . . . . 0.0 111.342 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.701 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 68.7 m-20 -93.09 5.35 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.154 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.1 m 79.91 72.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 115.927 -2.309 . . . . 0.0 106.972 -164.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.434 ' H ' ' HA3' ' A' ' 78' ' ' GLY . 40.1 tt0 -107.25 -29.82 9.1 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.002 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 1.063 ' O ' ' N ' ' A' ' 77' ' ' GLU . 80.8 m-85 . . . . . 0 C--O 1.19 -2.063 0 C-N-CA 116.904 -1.919 . . . . 0.0 108.049 164.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 . . . . . 0 CA--C 1.552 1.023 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -96.09 -8.56 33.03 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 116.207 -2.197 . . . . 0.0 108.49 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.242 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 18.3 t -102.25 -19.73 14.93 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.212 -2.595 . . . . 0.0 110.97 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -74.77 13.99 0.56 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 114.633 -2.827 . . . . 0.0 109.458 178.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -97.58 12.58 64.62 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 114.503 -3.713 . . . . 0.0 110.095 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.417 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 89.4 m-70 45.43 71.06 1.66 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 115.468 -2.493 . . . . 0.0 110.551 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.0 OUTLIER -84.47 -34.72 0.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.36 0 O-C-N 122.401 0.685 . . . . 0.0 110.674 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.106 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 m -92.63 156.26 17.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 116.219 -2.192 . . . . 0.0 109.945 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 57' ' ' ASN . 89.5 mt -103.04 176.29 5.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 116.645 -2.022 . . . . 0.0 109.308 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 56' ' ' LEU . 16.4 m-80 29.81 63.42 0.15 Allowed 'General case' 0 N--CA 1.4 -2.968 0 C-N-CA 116.801 -1.96 . . . . 0.0 113.11 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 51.51 55.75 8.93 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 115.734 -2.387 . . . . 0.0 110.721 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.93 172.24 55.17 Favored Glycine 0 CA--C 1.536 1.349 1 C-N-CA 113.463 -4.208 . . . . 0.0 109.346 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -90.83 87.7 6.76 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 115.276 -2.569 . . . . 0.0 108.795 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.242 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.6 t -89.0 125.12 34.85 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 115.852 -2.339 . . . . 0.0 109.558 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.9 tptt . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 115.863 -2.335 . . . . 0.0 107.985 176.366 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 123.11 1.395 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 67.2 mt -88.63 76.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 116.315 -2.154 . . . . 0.0 108.075 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.27 -68.74 3.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 115.16 -3.4 . . . . 0.0 109.982 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.59 165.5 24.98 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 115.914 -2.315 . . . . 0.0 110.407 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.85 157.42 23.32 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 115.312 -2.555 . . . . 0.0 109.186 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.4 p -124.88 134.27 52.76 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.099 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.106 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 90.6 m -108.56 132.33 53.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.728 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 123.41 40.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 115.887 -2.325 . . . . 0.0 109.226 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.16 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.8 m -75.08 143.99 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 115.373 -2.531 . . . . 0.0 109.724 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 170.06 15.36 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.612 -2.435 . . . . 0.0 110.292 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -59.12 132.38 53.86 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 115.931 -2.307 . . . . 0.0 109.075 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.41 -20.62 36.97 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 115.453 -3.26 . . . . 0.0 110.007 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.36 152.41 39.02 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 115.742 -2.383 . . . . 0.0 109.067 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -161.68 121.15 2.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.368 -2.533 . . . . 0.0 110.331 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 163.51 173.96 32.81 Favored Glycine 0 CA--C 1.55 2.259 1 C-N-CA 113.278 -4.296 . . . . 0.0 110.293 176.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 78' ' ' GLY . 14.6 tppt? -41.92 -55.69 3.02 Favored 'General case' 0 N--CA 1.417 -2.107 0 C-N-CA 115.881 -2.327 . . . . 0.0 110.896 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.714 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 47.8 m-20 -113.59 17.07 18.53 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.699 -2.401 . . . . 0.0 109.321 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.16 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.9 m 76.73 32.51 0.52 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 114.699 -2.8 . . . . 0.0 109.446 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.98 -30.15 62.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 115.165 -2.614 . . . . 0.0 109.735 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 . . . . . 0 N--CA 1.478 0.972 0 C-N-CA 116.022 -2.271 . . . . 0.0 110.387 -175.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 CA--C 1.571 1.768 0 CA-C-O 121.252 0.549 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 12.2 mp0 -94.11 -7.51 42.27 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 114.95 -2.7 . . . . 0.0 111.124 -171.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.7 t -125.08 12.25 8.31 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 115.31 -2.556 . . . . 0.0 110.452 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -75.41 17.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 113.909 -3.116 . . . . 0.0 110.444 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -117.38 17.82 12.29 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 115.554 -3.213 . . . . 0.0 109.537 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 44.07 74.7 0.74 Allowed Pre-proline 0 CA--C 1.568 1.66 0 C-N-CA 115.297 -2.561 . . . . 0.0 111.136 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.06 -40.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.974 0 C-N-CA 121.595 1.53 . . . . 0.0 110.051 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.175 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 m -74.97 152.96 38.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 115.175 -2.61 . . . . 0.0 108.842 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' ASN . 75.1 mt -103.9 170.8 7.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 116.464 -2.094 . . . . 0.0 108.877 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LEU . 8.8 m-80 33.81 62.41 0.43 Allowed 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.748 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 1.385 HE21 ' NE2' ' A' ' 58' ' ' GLN . 89.7 mt-30 49.93 62.35 2.7 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.689 173.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.97 168.66 32.87 Favored Glycine 0 C--O 1.251 1.158 1 C-N-CA 113.511 -4.185 . . . . 0.0 110.088 172.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -89.31 164.39 14.94 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.028 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 91.0 m -131.44 119.24 21.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 114.96 -2.696 . . . . 0.0 110.031 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.8 tptt . . . . . 0 C--O 1.25 1.09 0 C-N-CA 115.992 -2.283 . . . . 0.0 107.015 175.625 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.33 81.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 115.788 -2.365 . . . . 0.0 108.162 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.63 -59.19 3.7 Favored Glycine 0 C--N 1.343 0.944 1 C-N-CA 113.53 -4.176 . . . . 0.0 110.838 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.98 168.16 20.57 Favored 'General case' 0 C--O 1.259 1.597 0 C-N-CA 116.587 -2.045 . . . . 0.0 108.744 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.77 161.97 41.79 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 115.942 -2.303 . . . . 0.0 108.591 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 p -139.71 129.41 24.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 116.121 -2.232 . . . . 0.0 109.617 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.175 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 65.5 m -88.92 136.41 33.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 114.947 -2.701 . . . . 0.0 109.778 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.33 124.38 50.86 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 115.924 -2.31 . . . . 0.0 108.982 175.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 66.2 m -77.04 152.95 34.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.994 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.15 171.61 13.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 115.521 -2.471 . . . . 0.0 110.848 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.48 94.19 0.54 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 116.612 -2.035 . . . . 0.0 108.471 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.68 -30.06 0.93 Allowed Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 114.98 -3.486 . . . . 0.0 109.204 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -116.6 163.5 16.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 115.493 -2.483 . . . . 0.0 108.825 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -156.11 139.79 16.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 144.75 168.22 12.58 Favored Glycine 0 C--N 1.294 -1.766 1 C-N-CA 113.807 -4.044 . . . . 0.0 111.434 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 78' ' ' GLY . 39.1 ttpt -50.92 -54.71 21.78 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 115.556 -2.457 . . . . 0.0 109.957 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.724 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 70.7 m-20 -104.17 8.68 36.34 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.085 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.4 m 81.47 43.04 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 115.185 -2.606 . . . . 0.0 108.497 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.34 -18.23 42.88 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 115.455 -2.498 . . . . 0.0 109.854 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.5 2.066 0 C-N-CA 114.95 -2.7 . . . . 0.0 110.072 -178.124 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 . . . . . 0 N--CA 1.514 2.765 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.654 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 10.2 mp0 -97.99 -8.16 28.51 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.38 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.217 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.4 t -115.01 -10.76 12.21 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 115.238 -2.585 . . . . 0.0 111.288 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.99 20.17 0.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 116.003 -2.279 . . . . 0.0 111.26 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -132.31 24.9 3.91 Favored Glycine 0 C--N 1.311 -0.837 0 C-N-CA 114.344 -3.788 . . . . 0.0 111.294 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 49.62 84.13 0.21 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.96 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -95.47 -32.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.932 0 O-C-N 123.67 1.352 . . . . 0.0 109.115 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.189 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 34.1 m -81.56 163.01 22.94 Favored 'General case' 0 C--O 1.255 1.342 0 C-N-CA 114.007 -3.077 . . . . 0.0 110.937 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.523 ' O ' ' C ' ' A' ' 57' ' ' ASN . 94.5 mt -113.93 172.91 6.71 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 115.717 -2.393 . . . . 0.0 109.481 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER 43.05 49.58 5.38 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 116.881 -1.928 . . . . 0.0 110.334 172.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.462 ' N ' ' NE2' ' A' ' 58' ' ' GLN . 9.6 mp0 57.62 48.22 14.57 Favored 'General case' 0 C--O 1.272 2.284 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.2 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.78 160.56 34.15 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 114.917 -3.516 . . . . 0.0 111.01 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -87.5 158.29 18.97 Favored 'General case' 0 C--N 1.275 -2.647 0 C-N-CA 115.219 -2.592 . . . . 0.0 109.02 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.217 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 38.9 t -144.84 128.33 17.0 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 114.14 -3.024 . . . . 0.0 111.305 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.7 tptp . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 115.666 -2.414 . . . . 0.0 108.149 175.169 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.311 0 CA-C-O 123.837 1.798 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.39 89.51 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 114.643 -2.823 . . . . 0.0 109.829 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 80.79 -68.68 3.35 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 115.232 -3.366 . . . . 0.0 110.156 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.83 -174.47 3.06 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 114.243 -2.983 . . . . 0.0 109.569 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -139.19 166.87 23.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 116.184 -2.206 . . . . 0.0 110.737 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 p -133.18 143.52 49.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.5 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.189 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.9 m -117.53 141.49 48.3 Favored 'General case' 0 C--O 1.213 -0.843 0 C-N-CA 113.595 -3.242 . . . . 0.0 110.143 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.59 162.27 13.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 115.525 -2.47 . . . . 0.0 108.139 172.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.118 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 74.0 m -111.08 154.81 23.73 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 114.293 -2.963 . . . . 0.0 108.366 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.13 165.45 20.34 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 113.783 -3.167 . . . . 0.0 110.704 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.22 97.64 0.19 Allowed 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.31 -2.556 . . . . 0.0 109.604 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.68 -42.98 0.59 Allowed Glycine 0 N--CA 1.428 -1.858 0 C-N-CA 114.667 -3.635 . . . . 0.0 109.435 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -105.09 166.6 10.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.181 -2.608 . . . . 0.0 108.7 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -159.04 123.24 3.95 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 114.941 -2.703 . . . . 0.0 109.46 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 162.68 167.21 22.77 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 116.345 -2.836 . . . . 0.0 111.338 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 78' ' ' GLY . 10.8 tmtt? -44.27 -55.53 4.82 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 116.3 -2.16 . . . . 0.0 110.125 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.756 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 26.3 m-20 -102.13 5.36 40.31 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 115.095 -2.642 . . . . 0.0 109.428 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.118 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 25.0 m 79.21 14.82 1.05 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 115.46 -2.496 . . . . 0.0 109.569 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.68 -27.01 47.79 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 115.434 -2.506 . . . . 0.0 111.693 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 C--N 1.315 -0.916 0 C-N-CA 115.404 -2.518 . . . . 0.0 110.3 -172.87 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--O 1.214 -0.781 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -98.68 -17.81 18.38 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 114.514 -2.875 . . . . 0.0 109.751 -174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.516 ' C ' ' H ' ' A' ' 52' ' ' GLY . 36.8 t -82.65 -15.67 51.15 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 115.363 -2.535 . . . . 0.0 109.247 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.94 20.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 115.748 -2.381 . . . . 0.0 110.745 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -111.55 9.85 28.23 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 114.362 -3.78 . . . . 0.0 110.715 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.471 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 13.4 t-160 50.98 67.3 4.43 Favored Pre-proline 0 C--N 1.366 1.287 0 C-N-CA 116.41 -2.116 . . . . 0.0 109.067 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.2 Cg_endo -83.77 -30.46 0.77 Allowed 'Trans proline' 0 N--CA 1.419 -2.871 0 C-N-CA 121.071 1.181 . . . . 0.0 110.431 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.094 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.3 m -87.66 147.86 25.06 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 116.314 -2.154 . . . . 0.0 110.727 -175.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 57' ' ' ASN . 76.9 mt -94.85 172.7 8.0 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.472 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.557 ' C ' ' O ' ' A' ' 56' ' ' LEU . 16.8 m-80 32.68 61.83 0.36 Allowed 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 117.337 -1.745 . . . . 0.0 114.245 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 52.55 41.9 31.23 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.956 -1.498 . . . . 0.0 110.786 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.59 174.03 52.81 Favored Glycine 0 C--N 1.373 2.638 0 C-N-CA 113.946 -3.978 . . . . 0.0 109.008 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -88.76 147.95 24.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 115.123 -2.631 . . . . 0.0 108.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.9 t -140.18 123.99 17.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 115.699 -2.401 . . . . 0.0 110.599 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm . . . . . 0 CA--C 1.541 0.607 0 C-N-CA 115.374 -2.53 . . . . 0.0 108.791 176.244 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.463 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.5 mm -80.88 86.28 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 116.358 -2.137 . . . . 0.0 108.684 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.63 -72.32 2.0 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 114.323 -3.799 . . . . 0.0 110.158 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.25 167.89 19.45 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 115.214 -2.594 . . . . 0.0 109.493 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -113.3 152.72 29.52 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 115.757 -2.377 . . . . 0.0 109.075 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 114.897 -2.721 . . . . 0.0 109.469 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.094 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 63.0 m -105.14 137.22 43.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 115.933 -2.307 . . . . 0.0 109.854 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.96 114.01 20.38 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 116.89 -1.924 . . . . 0.0 108.532 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 32.4 m -71.97 145.15 48.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 116.505 -2.078 . . . . 0.0 108.996 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 169.04 14.05 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 116.264 -2.174 . . . . 0.0 110.063 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.73 145.81 6.49 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 115.92 -2.312 . . . . 0.0 110.214 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.72 -22.56 39.71 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 114.795 -3.574 . . . . 0.0 109.751 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.53 145.24 51.64 Favored 'General case' 0 CA--C 1.476 -1.899 0 C-N-CA 115.916 -2.314 . . . . 0.0 112.055 -173.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.599 ' C ' ' HA ' ' A' ' 81' ' ' CYS . 0.8 OUTLIER -165.56 174.53 9.8 Favored 'General case' 0 N--CA 1.399 -2.996 0 C-N-CA 114.066 -3.054 . . . . 0.0 112.632 164.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 137.76 171.74 12.29 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 116.507 -2.759 . . . . 0.0 110.642 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 78' ' ' GLY . 63.9 tttm -39.39 -52.81 2.05 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 116.976 -1.89 . . . . 0.0 110.179 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 67.6 m-20 -115.16 20.95 14.6 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 116.376 -2.129 . . . . 0.0 108.746 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.0 m 76.53 40.8 0.21 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 115.309 -2.556 . . . . 0.0 108.825 -171.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -88.87 -28.85 20.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 116.213 -2.195 . . . . 0.0 109.003 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 77' ' ' GLU . 62.9 m-85 . . . . . 0 CA--C 1.498 -1.04 0 C-N-CA 116.432 -2.107 . . . . 0.0 107.324 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' N ' ' CD ' ' A' ' 49' ' ' GLN . 7.4 mp0 -96.14 -15.24 22.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 114.481 -2.887 . . . . 0.0 110.862 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.15 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.4 t -121.79 20.3 10.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 115.581 -2.447 . . . . 0.0 110.264 -175.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -74.98 33.21 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 116.567 -2.053 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -153.91 23.6 0.71 Allowed Glycine 0 N--CA 1.47 0.961 0 C-N-CA 114.411 -3.757 . . . . 0.0 110.997 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.8 t-160 47.15 75.17 0.69 Allowed Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 115.931 -2.308 . . . . 0.0 109.123 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.49 -34.11 0.44 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 120.566 0.844 . . . . 0.0 111.123 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 10.6 m -71.57 164.1 26.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 115.636 -2.425 . . . . 0.0 109.403 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.7 mt -114.8 170.81 8.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 116.473 -2.091 . . . . 0.0 110.094 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.492 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 35.32 57.28 0.84 Allowed 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 115.811 -2.355 . . . . 0.0 114.732 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 56.7 mt-30 60.5 39.6 18.01 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.113 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 161.52 50.32 Favored Glycine 1 N--CA 1.521 4.352 1 C-N-CA 113.739 -4.077 . . . . 0.0 110.847 175.905 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -89.34 167.05 13.35 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 114.987 -2.685 . . . . 0.0 107.75 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.15 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 48.5 t -136.45 133.28 36.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 113.249 -3.38 . . . . 0.0 110.126 -172.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 115.702 -2.399 . . . . 0.0 107.635 175.645 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.01 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.16 88.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 115.544 -2.462 . . . . 0.0 107.234 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.75 -64.02 4.0 Favored Glycine 0 CA--C 1.545 1.966 0 C-N-CA 115.222 -3.37 . . . . 0.0 110.252 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -76.58 164.72 25.66 Favored 'General case' 0 C--O 1.26 1.629 0 C-N-CA 115.542 -2.463 . . . . 0.0 110.096 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -134.76 163.0 30.78 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 115.65 -2.42 . . . . 0.0 108.624 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 p -137.18 132.28 33.69 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.372 -2.531 . . . . 0.0 108.293 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 41.4 m -97.53 141.29 30.76 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 114.851 -2.74 . . . . 0.0 110.149 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 111.71 24.31 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 115.764 -2.375 . . . . 0.0 109.057 173.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.18 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.1 m -71.49 148.75 46.48 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 115.979 -2.288 . . . . 0.0 111.232 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.11 168.79 19.48 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 115.114 -2.635 . . . . 0.0 110.248 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.12 140.06 56.24 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 115.216 -2.594 . . . . 0.0 108.888 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.48 -14.91 61.75 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 116.317 -2.849 . . . . 0.0 110.425 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.17 150.18 49.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 116.268 -2.173 . . . . 0.0 110.334 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.73 130.87 11.11 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 115.72 -2.392 . . . . 0.0 108.755 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 154.15 163.36 11.84 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 114.314 -3.803 . . . . 0.0 110.993 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.9 tttm -43.83 -50.26 7.93 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.57 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 42.1 m-20 -110.62 10.98 22.9 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 116.001 -2.28 . . . . 0.0 110.33 175.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.18 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 21.9 m 78.01 30.58 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 116.067 -2.253 . . . . 0.0 108.237 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.44 -32.21 68.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.518 -2.073 . . . . 0.0 109.449 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--N 1.319 -0.728 0 C-N-CA 114.926 -2.71 . . . . 0.0 109.525 -176.498 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.475 0.775 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 7.7 mp0 -89.83 -9.61 48.45 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 116.656 -2.018 . . . . 0.0 109.539 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.533 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.3 t -116.37 1.82 13.09 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 114.425 -2.91 . . . . 0.0 109.979 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -74.99 20.33 0.13 Allowed 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 115.471 -2.492 . . . . 0.0 110.484 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -119.88 13.69 10.6 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 114.004 -3.951 . . . . 0.0 110.137 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 50.09 73.55 0.97 Allowed Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 116.878 -1.929 . . . . 0.0 111.237 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -83.48 -43.6 0.07 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.128 0 N-CA-C 110.082 -0.776 . . . . 0.0 110.082 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.129 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 2.8 m -85.41 147.41 26.51 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 115.387 -2.525 . . . . 0.0 110.05 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.58 ' O ' ' C ' ' A' ' 57' ' ' ASN . 61.2 mt -95.21 179.41 5.2 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 116.839 -1.944 . . . . 0.0 109.365 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.58 ' C ' ' O ' ' A' ' 56' ' ' LEU . 12.5 m-80 28.62 60.92 0.13 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.204 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 55.06 58.3 4.85 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 115.051 -2.66 . . . . 0.0 108.682 165.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.07 171.13 51.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 113.921 -3.99 . . . . 0.0 109.812 171.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -89.15 93.5 9.6 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 115.449 -2.5 . . . . 0.0 108.798 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.6 p -95.55 109.0 21.29 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 115.436 -2.506 . . . . 0.0 108.644 -171.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 tttp . . . . . 0 C--O 1.242 0.689 0 C-N-CA 115.917 -2.313 . . . . 0.0 107.879 176.756 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.475 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.6 mt -92.71 79.33 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 114.922 -2.711 . . . . 0.0 108.915 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 114.807 -3.568 . . . . 0.0 109.713 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.54 164.37 26.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 114.598 -2.841 . . . . 0.0 110.539 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -137.48 161.38 36.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.196 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -120.43 136.17 54.82 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 115.665 -2.414 . . . . 0.0 110.274 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.129 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 52.4 m -104.85 124.11 48.87 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 115.394 -2.523 . . . . 0.0 109.003 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 119.64 35.62 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 115.886 -2.326 . . . . 0.0 108.754 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.104 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 9.9 m -71.74 149.9 44.96 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 116.265 -2.174 . . . . 0.0 109.584 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.14 164.17 26.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 116.017 -2.273 . . . . 0.0 109.172 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.64 97.84 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 114.466 -2.893 . . . . 0.0 108.602 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.25 -33.32 0.65 Allowed Glycine 0 C--O 1.247 0.917 0 C-N-CA 115.357 -3.306 . . . . 0.0 110.227 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 96.2 m-85 -116.94 159.99 21.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 117.053 -1.859 . . . . 0.0 109.114 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.674 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 0.7 OUTLIER -159.7 -126.73 0.02 OUTLIER 'General case' 0 C--N 1.363 1.176 0 C-N-CA 114.212 -2.995 . . . . 0.0 109.653 166.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.411 ' N ' ' CZ ' ' A' ' 83' ' ' PHE . . . 68.58 -176.44 28.18 Favored Glycine 0 CA--C 1.554 2.509 1 C-N-CA 113.073 -4.394 . . . . 0.0 110.143 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -48.3 -61.17 2.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.901 -1.92 . . . . 0.0 113.616 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.605 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 81.8 m-20 -106.29 19.57 20.3 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 115.913 -2.315 . . . . 0.0 108.74 -171.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.104 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 10.3 m 73.1 46.6 0.23 Allowed 'General case' 0 C--O 1.252 1.195 0 C-N-CA 116.438 -2.105 . . . . 0.0 107.956 -167.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 77' ' ' GLU . 42.6 tt0 -90.24 -30.14 17.73 Favored 'General case' 0 C--O 1.261 1.672 0 C-N-CA 116.818 -1.953 . . . . 0.0 109.155 -170.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.688 ' HD1' ' O ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.379 -3.988 0 C-N-CA 112.298 -3.761 . . . . 0.0 108.758 -162.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.415 -2.202 0 CA-C-O 121.643 0.735 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 86.7 mm-40 -89.02 -19.35 25.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.294 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.542 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.4 t -95.53 11.9 31.43 Favored 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 115.302 -2.559 . . . . 0.0 108.652 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.98 26.61 0.07 Allowed 'General case' 0 C--O 1.258 1.533 0 C-N-CA 115.876 -2.33 . . . . 0.0 109.87 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -150.15 30.02 1.09 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 114.016 -3.945 . . . . 0.0 110.136 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 52' ' ' GLY . 21.8 t-160 40.31 83.87 0.19 Allowed Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 115.977 -2.289 . . . . 0.0 110.424 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -89.34 -27.12 0.38 Allowed 'Trans proline' 0 N--CA 1.426 -2.484 0 O-C-N 123.182 1.096 . . . . 0.0 111.547 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 m -94.16 166.64 12.02 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 114.314 -2.955 . . . . 0.0 110.415 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.1 mt -113.6 175.02 5.63 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 115.898 -2.321 . . . . 0.0 109.56 -177.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 56' ' ' LEU . 42.7 m-80 27.47 62.4 0.1 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.055 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 45.5 mt-30 58.9 47.33 12.56 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 125.248 1.593 . . . . 0.0 109.034 171.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.98 157.08 35.01 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 113.939 -3.981 . . . . 0.0 109.534 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -86.04 155.13 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 114.351 -2.94 . . . . 0.0 107.765 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.0 p -135.38 105.14 6.12 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.456 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp . . . . . 0 N--CA 1.486 1.37 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.338 177.739 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.363 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.26 94.0 2.07 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.477 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 80.11 -71.68 2.73 Favored Glycine 0 C--O 1.259 1.666 0 C-N-CA 115.889 -3.053 . . . . 0.0 112.297 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -77.83 174.53 10.92 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 114.288 -2.965 . . . . 0.0 109.697 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.95 160.96 37.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 116.383 -2.127 . . . . 0.0 108.718 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.1 p -131.3 140.82 49.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 114.479 -2.888 . . . . 0.0 108.592 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 55.8 m -100.44 128.91 46.37 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.463 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.32 119.71 40.3 Favored 'General case' 0 C--O 1.255 1.387 0 C-N-CA 116.018 -2.273 . . . . 0.0 108.481 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.2 m -72.46 155.93 39.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 114.854 -2.738 . . . . 0.0 109.169 -174.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 163.65 26.36 Favored 'General case' 0 C--O 1.25 1.104 0 C-N-CA 114.683 -2.807 . . . . 0.0 108.947 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.54 100.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 114.782 -2.767 . . . . 0.0 108.99 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.27 -42.27 0.65 Allowed Glycine 0 CA--C 1.546 2.031 0 C-N-CA 115.414 -3.279 . . . . 0.0 108.309 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.22 161.33 16.7 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 115.49 -2.484 . . . . 0.0 110.154 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -147.75 142.49 26.71 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 115.477 -2.489 . . . . 0.0 108.639 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.555 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 142.87 158.63 7.61 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 115.914 -3.041 . . . . 0.0 110.478 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 78' ' ' GLY . 38.7 ttmt -39.27 -50.55 1.99 Allowed 'General case' 0 C--O 1.187 -2.232 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.183 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.715 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 59.5 m-20 -107.83 -3.1 19.31 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 116.842 -1.943 . . . . 0.0 109.146 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.5 m 83.27 31.81 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 114.874 -2.73 . . . . 0.0 109.154 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.78 -30.29 63.99 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 116.511 -2.076 . . . . 0.0 109.896 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 115.079 -2.649 . . . . 0.0 108.87 -173.145 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.9 0.381 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -96.37 -34.17 11.65 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 116.393 -2.123 . . . . 0.0 110.219 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.092 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.8 t -93.78 20.59 7.4 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 116.43 -2.108 . . . . 0.0 109.516 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.18 23.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 114.879 -2.728 . . . . 0.0 110.969 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -147.2 23.38 1.57 Allowed Glycine 0 N--CA 1.472 1.079 0 C-N-CA 114.412 -3.756 . . . . 0.0 111.328 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 43.77 80.42 0.29 Allowed Pre-proline 0 CA--C 1.581 2.146 0 C-N-CA 116.84 -1.944 . . . . 0.0 111.123 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.19 -32.42 0.3 Allowed 'Trans proline' 0 N--CA 1.412 -3.272 0 C-N-CA 121.707 1.604 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 13.3 m -85.48 140.44 30.68 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 115.796 -2.362 . . . . 0.0 109.264 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.7 mt -101.63 168.7 9.31 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.777 -1.569 . . . . 0.0 110.719 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER 43.55 60.72 2.51 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 116.559 -2.056 . . . . 0.0 110.26 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 46.85 45.56 15.1 Favored 'General case' 1 C--N 1.441 4.571 0 C-N-CA 113.397 -3.321 . . . . 0.0 115.592 174.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.401 ' HA3' ' CD2' ' A' ' 60' ' ' HIS . . . -77.46 -156.62 8.12 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 114.655 -3.641 . . . . 0.0 111.231 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 1.389 ' CB ' ' N ' ' A' ' 71' ' ' THR 0.428 0.0 OUTLIER -79.61 155.32 28.17 Favored 'General case' 1 N--CA 1.367 -4.62 0 CA-C-N 109.742 -3.229 . . . . 0.0 114.009 176.685 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.092 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.2 t -147.26 120.08 8.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 114.632 -2.827 . . . . 0.0 109.151 158.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 115.623 -2.431 . . . . 0.0 106.768 174.629 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.559 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 mt -104.49 98.14 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 114.781 -2.768 . . . . 0.0 109.812 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.27 -69.15 3.05 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 114.843 -3.551 . . . . 0.0 111.298 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.48 166.41 20.36 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 115.316 -2.553 . . . . 0.0 108.882 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -123.46 150.18 44.18 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 115.351 -2.54 . . . . 0.0 109.503 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -120.93 124.27 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 115.158 -2.617 . . . . 0.0 108.888 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.8 m -109.69 146.56 34.65 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 116.337 -2.145 . . . . 0.0 108.02 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 1.389 ' N ' ' CB ' ' A' ' 60' ' ' HIS . 4.3 m -109.52 103.22 12.07 Favored 'General case' 1 N--CA 1.558 4.963 0 C-N-CA 116.788 -1.965 . . . . 0.0 112.071 175.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.106 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 90.2 m -60.83 143.38 54.84 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 115.913 -2.315 . . . . 0.0 107.86 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.2 166.95 15.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.548 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.45 96.57 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 115.711 -2.396 . . . . 0.0 108.822 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.38 -39.71 0.61 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 114.898 -3.525 . . . . 0.0 108.384 -168.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.22 166.81 11.27 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 115.441 -2.503 . . . . 0.0 108.305 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -157.64 112.78 2.73 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 115.091 -2.644 . . . . 0.0 109.229 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.58 174.78 35.5 Favored Glycine 0 C--O 1.212 -1.276 0 C-N-CA 114.472 -3.728 . . . . 0.0 111.223 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -45.32 -58.02 3.6 Favored 'General case' 0 N--CA 1.398 -3.027 0 C-N-CA 115.994 -2.282 . . . . 0.0 111.458 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.697 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 39.2 m-20 -106.28 18.09 22.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 114.924 -2.71 . . . . 0.0 109.121 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.106 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.9 m 76.34 18.56 1.82 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 115.662 -2.415 . . . . 0.0 108.708 -174.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.93 -32.59 73.91 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 116.865 -1.934 . . . . 0.0 110.273 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 115.216 -2.594 . . . . 0.0 110.387 -176.431 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 119.575 -0.25 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 49' ' ' GLN . 3.3 mp0 -96.51 0.06 49.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 114.709 -2.796 . . . . 0.0 110.073 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.9 t -126.8 18.15 7.32 Favored 'General case' 0 N--CA 1.508 2.437 0 C-N-CA 115.629 -2.429 . . . . 0.0 108.943 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -74.99 33.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 116.318 -2.153 . . . . 0.0 111.068 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -151.42 29.26 0.96 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 114.098 -3.906 . . . . 0.0 110.347 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 49.72 80.81 0.28 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.144 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.92 -35.53 0.14 Allowed 'Trans proline' 0 N--CA 1.404 -3.778 0 C-N-CA 121.334 1.356 . . . . 0.0 110.994 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.163 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.1 m -79.52 143.48 34.82 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 115.115 -2.634 . . . . 0.0 111.213 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.599 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.3 mt -102.44 175.02 5.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.512 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 30.02 62.95 0.17 Allowed 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 116.859 -1.936 . . . . 0.0 111.979 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 56.92 83.37 0.1 Allowed 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 117.089 -1.844 . . . . 0.0 109.272 170.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.72 161.44 20.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 115.75 -3.119 . . . . 0.0 109.536 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.529 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 43.4 t-80 -91.01 155.41 18.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 116.395 -2.122 . . . . 0.0 108.317 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 50.7 t -131.6 126.73 35.48 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 114.77 -2.772 . . . . 0.0 110.927 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 114.578 -2.849 . . . . 0.0 108.196 176.319 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.107 0 CA-C-O 122.107 0.837 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.2 mt -109.26 58.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 114.658 -2.817 . . . . 0.0 108.524 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.64 -55.02 3.81 Favored Glycine 0 N--CA 1.478 1.469 0 C-N-CA 114.673 -3.632 . . . . 0.0 112.269 173.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.711 ' C ' ' CD1' ' A' ' 68' ' ' TYR . 5.9 p-10 -80.55 -19.46 45.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 115.845 -2.342 . . . . 0.0 112.059 -174.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.711 ' CD1' ' C ' ' A' ' 67' ' ' ASP . 38.7 p90 51.36 166.5 0.01 OUTLIER 'General case' 1 C--N 1.218 -5.113 0 CA-C-N 111.478 -2.601 . . . . 0.0 112.727 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -141.43 129.33 21.84 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 116.13 -2.228 . . . . 0.0 108.905 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.163 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -100.74 127.25 47.23 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.569 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.529 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -94.97 149.95 20.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.91 -2.316 . . . . 0.0 109.49 176.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.102 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 84.4 m -99.27 156.35 17.03 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 115.132 -2.627 . . . . 0.0 109.299 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.47 164.57 26.48 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 115.371 -2.532 . . . . 0.0 109.455 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.82 102.98 0.39 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 115.014 -2.675 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.0 -33.3 1.38 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 114.502 -3.713 . . . . 0.0 110.201 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.69 164.41 12.77 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 116.082 -2.247 . . . . 0.0 109.162 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -159.38 118.49 2.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 115.618 -2.433 . . . . 0.0 109.225 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 169.79 170.11 33.84 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 114.29 -3.814 . . . . 0.0 110.288 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 85.1 tttt -41.0 -54.67 2.72 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 115.648 -2.421 . . . . 0.0 110.711 176.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.642 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 61.4 m-20 -110.83 15.81 21.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 115.731 -2.388 . . . . 0.0 109.862 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.102 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.1 m 74.01 28.34 1.5 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 115.092 -2.643 . . . . 0.0 109.338 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -70.08 -31.51 69.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 116.245 -2.182 . . . . 0.0 110.523 -177.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 114.708 -2.797 . . . . 0.0 109.954 -175.616 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 CA--C 1.574 1.903 0 CA-C-O 117.483 -1.246 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 3.4 mp0 -104.53 7.13 35.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 115.985 -2.286 . . . . 0.0 111.173 -177.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.6 t -128.33 8.48 6.01 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 116.201 -2.2 . . . . 0.0 110.226 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.76 24.32 0.06 Allowed 'General case' 0 C--O 1.249 1.075 0 C-N-CA 115.49 -2.484 . . . . 0.0 112.044 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -144.72 23.74 1.98 Allowed Glycine 0 C--N 1.341 0.836 0 C-N-CA 114.559 -3.686 . . . . 0.0 111.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 45.78 78.63 0.38 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 115.98 -2.288 . . . . 0.0 110.223 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.68 -33.77 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 N-CA-C 110.071 -0.781 . . . . 0.0 110.071 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.112 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.2 m -76.35 152.52 36.32 Favored 'General case' 0 C--O 1.261 1.667 0 C-N-CA 116.159 -2.216 . . . . 0.0 109.568 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.2 mt -105.3 171.6 7.24 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 116.782 -1.967 . . . . 0.0 109.958 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 56' ' ' LEU . 27.8 m-80 36.17 61.45 0.77 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 117.566 -1.653 . . . . 0.0 111.734 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.434 ' NE2' ' H ' ' A' ' 58' ' ' GLN . 2.8 mp0 48.68 51.21 16.03 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 115.664 -2.414 . . . . 0.0 110.109 172.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.6 171.6 45.57 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 114.702 -3.618 . . . . 0.0 109.737 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -88.67 145.95 25.36 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.212 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 51.9 t -134.03 124.64 26.57 Favored 'General case' 0 N--CA 1.417 -2.081 0 C-N-CA 115.449 -2.5 . . . . 0.0 109.126 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.1 tptt . . . . . 0 C--O 1.252 1.205 0 C-N-CA 115.578 -2.449 . . . . 0.0 109.454 -179.881 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.631 0 CA-C-O 122.544 1.08 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 57.2 mt -87.86 90.48 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 113.724 -3.19 . . . . 0.0 108.038 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 78.77 -72.31 2.44 Favored Glycine 0 N--CA 1.496 2.679 1 C-N-CA 113.859 -4.019 . . . . 0.0 109.257 -178.044 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -72.23 166.25 22.79 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 115.746 -2.382 . . . . 0.0 109.706 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -115.91 163.72 15.47 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 116.303 -2.159 . . . . 0.0 109.568 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 p -128.99 135.25 48.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 115.108 -2.637 . . . . 0.0 109.333 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.112 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 94.9 m -113.43 124.24 51.95 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.382 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.75 122.2 46.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 116.163 -2.215 . . . . 0.0 110.072 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.164 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.3 m -72.91 150.2 42.78 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 114.904 -2.718 . . . . 0.0 110.178 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 169.18 15.55 Favored 'General case' 0 C--O 1.254 1.338 0 C-N-CA 115.622 -2.431 . . . . 0.0 109.984 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.07 105.89 0.76 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 114.859 -2.736 . . . . 0.0 109.952 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.78 -40.56 1.08 Allowed Glycine 0 C--O 1.213 -1.194 0 C-N-CA 115.32 -3.324 . . . . 0.0 110.325 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.19 163.07 15.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 115.475 -2.49 . . . . 0.0 110.099 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -155.49 125.37 6.53 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 115.234 -2.586 . . . . 0.0 109.374 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 160.74 166.86 20.34 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.372 -4.251 . . . . 0.0 111.164 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 22.8 tptm -39.59 -53.72 2.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 116.403 -2.119 . . . . 0.0 109.449 175.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.662 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 41.8 m-20 -113.44 11.91 18.58 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 116.355 -2.138 . . . . 0.0 109.649 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.164 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.4 m 74.39 31.75 1.01 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.094 -2.642 . . . . 0.0 109.571 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.92 -36.25 79.84 Favored 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 116.474 -2.09 . . . . 0.0 110.243 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 C--N 1.305 -1.352 0 C-N-CA 114.941 -2.704 . . . . 0.0 109.53 -171.983 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.525 ' CA ' ' HA ' ' A' ' 45' ' ' LYS . 44.1 mmtm . . . . . 0 C--O 1.173 -2.939 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -106.47 72.05 0.9 Allowed 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 115.81 -2.356 . . . . 0.0 108.875 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.36 -82.31 0.26 Allowed Glycine 0 C--N 1.385 3.285 1 C-N-CA 113.731 -4.08 . . . . 0.0 109.217 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -107.85 129.2 55.09 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 115.797 -2.361 . . . . 0.0 110.237 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.458 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 2.8 mp0 -98.01 -10.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 116.09 -2.244 . . . . 0.0 109.516 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.473 ' C ' ' H ' ' A' ' 52' ' ' GLY . 45.6 t -113.06 10.93 18.82 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 114.92 -2.712 . . . . 0.0 109.611 -175.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -75.24 19.18 0.17 Allowed 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 115.107 -2.637 . . . . 0.0 111.418 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -131.68 27.8 3.65 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 114.67 -3.633 . . . . 0.0 111.337 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 48.86 73.94 0.91 Allowed Pre-proline 0 N--CA 1.498 1.943 0 C-N-CA 117.256 -1.778 . . . . 0.0 111.043 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.53 -35.35 1.16 Allowed 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 121.108 1.206 . . . . 0.0 110.686 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.2 m -89.11 148.72 23.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.735 -2.386 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.504 ' O ' ' C ' ' A' ' 57' ' ' ASN . 79.4 mt -100.91 174.5 5.99 Favored 'General case' 0 C--O 1.268 2.049 0 C-N-CA 116.191 -2.203 . . . . 0.0 108.814 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 56' ' ' LEU . 7.0 m-80 34.27 68.57 0.18 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 118.167 -1.413 . . . . 0.0 111.477 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 1.39 HE21 ' NE2' ' A' ' 58' ' ' GLN . 11.3 pt20 36.51 54.09 1.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.669 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.21 178.09 41.68 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 115.623 -3.18 . . . . 0.0 109.573 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.483 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 45.4 t60 -89.8 136.96 32.73 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 115.436 -2.505 . . . . 0.0 108.437 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.68 129.02 30.02 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 115.287 -2.565 . . . . 0.0 109.237 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 115.661 -2.416 . . . . 0.0 108.121 174.678 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.31 -92.12 0.09 OUTLIER Glycine 0 N--CA 1.477 1.396 0 C-N-CA 113.936 -3.983 . . . . 0.0 111.964 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 65' ' ' ILE . 28.2 mt -114.3 55.65 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 114.612 -2.835 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.7 -61.34 2.04 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 114.177 -3.868 . . . . 0.0 111.225 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' O ' ' O ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -78.92 3.74 16.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 115.721 -2.392 . . . . 0.0 110.07 -174.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.571 ' O ' ' O ' ' A' ' 67' ' ' ASP . 53.1 p90 39.68 179.04 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.191 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 p -139.74 145.8 38.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 115.946 -2.302 . . . . 0.0 107.694 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 25.2 m -131.56 119.12 21.04 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 114.955 -2.698 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -108.23 153.31 23.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 116.199 -2.2 . . . . 0.0 108.876 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.117 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 85.8 m -98.02 148.51 23.43 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 115.943 -2.303 . . . . 0.0 109.846 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.61 27.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 115.26 -2.576 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.64 102.28 0.71 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 114.902 -2.719 . . . . 0.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.22 -43.91 0.65 Allowed Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 115.411 -3.28 . . . . 0.0 108.902 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.91 155.96 18.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 116.308 -2.157 . . . . 0.0 109.502 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -146.74 142.82 28.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.855 -2.338 . . . . 0.0 108.936 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 140.68 166.82 10.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 114.174 -3.869 . . . . 0.0 109.605 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 78' ' ' GLY . 53.0 tptt -42.4 -54.36 3.85 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.664 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 21.7 m-20 -109.26 14.34 23.84 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.942 -1.903 . . . . 0.0 109.492 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.117 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 4.0 m 72.24 25.17 2.93 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 115.262 -2.575 . . . . 0.0 108.839 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -71.64 -30.38 65.69 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.928 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -88.44 144.23 26.5 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 115.918 -2.313 . . . . 0.0 109.021 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.9 p -111.32 150.05 30.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 115.683 -2.407 . . . . 0.0 108.094 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.6 p -86.9 38.23 0.79 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 114.462 -2.895 . . . . 0.0 110.946 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.454 ' NH2' HH21 ' A' ' 86' ' ' ARG . 45.8 ttp180 . . . . . 0 C--O 1.19 -2.064 0 C-N-CA 117.037 -1.865 . . . . 0.0 109.846 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 89.2 mttt . . . . . 0 C--O 1.161 -3.571 0 CA-C-O 125.067 2.365 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.71 142.18 27.64 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 115.057 -2.657 . . . . 0.0 107.882 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.61 -157.48 7.77 Favored Glycine 0 CA--C 1.555 2.58 1 C-N-CA 112.625 -4.607 . . . . 0.0 114.037 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -110.04 121.0 44.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 115.674 -2.41 . . . . 0.0 109.58 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.443 ' N ' ' CD ' ' A' ' 49' ' ' GLN . 15.7 mp0 -94.67 -23.84 17.42 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 116.634 -2.026 . . . . 0.0 108.466 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.094 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 41.9 t -90.62 20.98 4.24 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 115.702 -2.399 . . . . 0.0 110.422 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.97 26.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.758 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -139.27 19.9 3.02 Favored Glycine 0 C--N 1.319 -0.375 0 C-N-CA 114.782 -3.58 . . . . 0.0 110.289 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.496 ' C ' ' O ' ' A' ' 52' ' ' GLY . 51.5 t60 40.66 72.97 0.93 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 116.797 -1.961 . . . . 0.0 109.809 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.46 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 5.1 Cg_exo -81.21 -37.02 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.607 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.9 m -77.68 143.92 37.75 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 114.797 -2.761 . . . . 0.0 111.499 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.653 ' O ' ' C ' ' A' ' 57' ' ' ASN . 83.9 mt -103.43 178.15 4.64 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 116.296 -2.161 . . . . 0.0 110.426 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 56' ' ' LEU . 37.1 m-80 27.81 60.73 0.11 Allowed 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 118.188 -1.405 . . . . 0.0 111.539 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 48.3 tt0 66.87 73.05 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 116.681 -2.007 . . . . 0.0 111.771 168.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.03 160.16 17.57 Favored Glycine 0 C--N 1.363 2.031 1 C-N-CA 112.592 -4.623 . . . . 0.0 110.377 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -88.51 108.94 19.66 Favored 'General case' 0 C--O 1.254 1.29 0 C-N-CA 114.497 -2.881 . . . . 0.0 108.121 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.094 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 23.6 p -88.79 112.14 22.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.08 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.8 tptt . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 115.26 -2.576 . . . . 0.0 107.963 177.61 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.28 -135.93 3.33 Favored Glycine 0 CA--C 1.549 2.205 0 C-N-CA 114.133 -3.889 . . . . 0.0 110.127 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.416 ' O ' ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -92.39 87.22 2.4 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.882 0 C-N-CA 117.036 -1.866 . . . . 0.0 108.568 178.502 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.37 -67.18 3.12 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 114.285 -3.817 . . . . 0.0 111.062 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -74.72 164.5 26.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 116.04 -2.264 . . . . 0.0 110.096 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -129.37 162.14 28.7 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 116.367 -2.133 . . . . 0.0 108.87 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.3 p -132.79 142.52 49.04 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.199 -2.6 . . . . 0.0 109.636 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.0 m -106.1 119.73 39.97 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 115.134 -2.626 . . . . 0.0 109.201 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.29 126.09 41.25 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 115.832 -2.347 . . . . 0.0 109.233 173.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 35.7 m -82.27 158.39 23.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 114.529 -2.868 . . . . 0.0 110.208 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.33 166.9 22.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 115.181 -2.607 . . . . 0.0 108.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.13 112.24 1.83 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 114.585 -2.846 . . . . 0.0 109.202 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.96 -47.49 0.8 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 114.431 -3.747 . . . . 0.0 110.452 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.95 167.5 9.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 115.805 -2.358 . . . . 0.0 109.903 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -158.18 -0.69 0.1 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 115.398 -2.521 . . . . 0.0 111.865 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . -63.8 168.51 23.1 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 115.696 -3.145 . . . . 0.0 110.649 175.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -47.71 -52.61 17.78 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.721 -1.992 . . . . 0.0 108.667 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.73 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 50.5 m-20 -93.7 16.84 12.98 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 115.017 -2.673 . . . . 0.0 107.39 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 14.6 m 76.21 23.57 1.21 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 116.079 -2.248 . . . . 0.0 108.443 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.12 -32.51 67.02 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 115.025 -2.67 . . . . 0.0 110.411 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -87.98 151.62 22.65 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 115.836 -2.345 . . . . 0.0 109.041 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -111.11 141.6 44.4 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 115.145 -2.622 . . . . 0.0 109.013 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.0 p -92.71 35.93 1.03 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 115.767 -2.373 . . . . 0.0 109.836 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 . . . . . 0 N--CA 1.509 2.525 0 C-N-CA 115.026 -2.67 . . . . 0.0 109.436 -178.574 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 122.623 1.201 . . . . 0.0 108.739 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -82.2 162.91 22.23 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.218 -2.176 . . . . 0.0 110.68 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.72 -125.87 1.27 Allowed Glycine 0 N--CA 1.507 3.395 1 C-N-CA 112.498 -4.668 . . . . 0.0 109.785 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -89.49 103.12 15.78 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 115.87 -2.332 . . . . 0.0 110.678 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 91.3 mm-40 -79.17 -15.82 57.53 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 116.563 -2.055 . . . . 0.0 109.025 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.223 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 30.5 p -98.78 18.25 17.45 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 115.539 -2.464 . . . . 0.0 109.25 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -74.25 30.37 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 116.661 -2.016 . . . . 0.0 111.121 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -141.66 28.1 2.31 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 114.478 -3.725 . . . . 0.0 110.462 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' GLY . 72.5 m80 43.62 76.37 0.54 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 115.263 -2.575 . . . . 0.0 110.643 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -89.14 -32.99 0.11 Allowed 'Trans proline' 0 N--CA 1.427 -2.414 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 3.7 m -83.2 156.32 23.26 Favored 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 115.088 -2.645 . . . . 0.0 110.894 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.546 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.3 mt -98.6 173.16 7.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 117.009 -1.877 . . . . 0.0 108.703 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.669 ' ND2' HG22 ' A' ' 85' ' ' THR . 21.1 m-80 36.99 60.04 1.02 Allowed 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 116.148 -2.221 . . . . 0.0 112.66 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 55.55 31.37 17.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 117.469 -1.693 . . . . 0.0 113.296 166.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.92 158.31 53.11 Favored Glycine 0 N--CA 1.504 3.185 1 C-N-CA 113.353 -4.261 . . . . 0.0 110.405 172.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.444 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 7.6 t-160 -88.38 172.01 9.71 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 115.204 -2.599 . . . . 0.0 109.48 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.223 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 30.9 p -139.95 122.76 16.49 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 114.592 -2.843 . . . . 0.0 109.31 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 63' ' ' LAA . 5.3 tmtt? . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 115.171 -2.611 . . . . 0.0 108.972 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . 0.696 ' O ' ' O ' ' A' ' 62' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.3 -153.04 7.56 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 114.038 -3.934 . . . . 0.0 111.025 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.17 93.28 2.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 C-N-CA 114.86 -2.736 . . . . 0.0 107.741 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 89.36 -69.16 2.59 Favored Glycine 0 CA--C 1.548 2.133 0 C-N-CA 114.437 -3.744 . . . . 0.0 110.076 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -77.76 170.02 17.29 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 115.433 -2.507 . . . . 0.0 109.527 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -132.11 158.24 42.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.166 -2.214 . . . . 0.0 109.572 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -127.36 133.84 50.01 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 116.39 -2.124 . . . . 0.0 108.364 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.3 m -104.97 132.7 50.88 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.742 -2.783 . . . . 0.0 109.909 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -104.72 148.72 26.28 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 115.83 -2.348 . . . . 0.0 109.701 175.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.191 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 64.7 m -110.91 143.41 41.59 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 116.298 -2.161 . . . . 0.0 108.8 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HB2' ' CD2' ' A' ' 76' ' ' PHE . . . -76.34 170.27 16.67 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 115.392 -2.523 . . . . 0.0 110.173 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.82 140.04 58.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 116.163 -2.215 . . . . 0.0 108.987 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.71 -21.19 43.27 Favored Glycine 0 N--CA 1.427 -1.957 1 C-N-CA 113.474 -4.203 . . . . 0.0 109.904 -174.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.729 ' HE1' ' HA ' ' A' ' 85' ' ' THR . 65.7 m-85 -133.22 143.32 49.06 Favored 'General case' 0 CA--C 1.471 -2.065 0 C-N-CA 114.725 -2.79 . . . . 0.0 110.051 -170.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.736 ' N ' ' OG ' ' A' ' 84' ' ' SER . 2.0 pt-20 -164.99 173.36 11.66 Favored 'General case' 1 N--CA 1.367 -4.619 0 C-N-CA 113.843 -3.143 . . . . 0.0 112.775 165.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 139.33 178.2 16.29 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 114.698 -3.62 . . . . 0.0 110.158 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 78' ' ' GLY . 29.1 ttpp -41.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 116.433 -2.107 . . . . 0.0 108.871 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.648 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 57.2 m-20 -118.28 24.49 10.92 Favored 'General case' 0 C--O 1.207 -1.167 0 C-N-CA 115.556 -2.458 . . . . 0.0 109.466 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.191 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.7 m 76.87 39.25 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 115.299 -2.56 . . . . 0.0 106.99 -170.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -88.25 -28.96 20.78 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 116.358 -2.137 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.64 ' C ' ' OG ' ' A' ' 84' ' ' SER . 65.4 m-85 -89.53 101.62 14.3 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 114.984 -2.687 . . . . 0.0 108.994 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 1.32 ' CB ' HG21 ' A' ' 85' ' ' THR 0.292 24.6 m 164.36 174.33 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 113.01 -3.476 . . . . 0.0 109.972 -143.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 1.32 HG21 ' CB ' ' A' ' 84' ' ' SER . 2.5 p 54.55 45.73 26.33 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 114.362 -2.935 . . . . 0.0 111.905 148.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 . . . . . 0 C--O 1.188 -2.133 0 C-N-CA 116.887 -1.925 . . . . 0.0 109.568 -175.584 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.404 ' H2 ' ' N ' ' A' ' 45' ' ' LYS . 20.2 pttp . . . . . 0 N--CA 1.431 -1.406 0 CA-C-O 121.886 0.851 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -142.02 125.15 16.32 Favored 'General case' 0 C--O 1.261 1.68 0 C-N-CA 117.316 -1.754 . . . . 0.0 106.278 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.26 -53.0 0.01 OUTLIER Glycine 0 N--CA 1.502 3.081 1 C-N-CA 113.62 -4.133 . . . . 0.0 111.613 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 49' ' ' GLN . 31.2 t70 -136.67 10.64 3.15 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 116.43 -2.108 . . . . 0.0 108.97 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 2.9 mp0 31.79 33.92 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 117.499 -1.681 . . . . 0.0 113.493 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.2 t -166.87 27.0 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 115.94 -2.304 . . . . 0.0 108.715 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -76.18 24.23 0.14 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 115.682 -2.407 . . . . 0.0 111.24 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -146.06 24.31 1.75 Allowed Glycine 0 N--CA 1.484 1.897 0 C-N-CA 114.062 -3.923 . . . . 0.0 110.56 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 22.2 t-160 42.79 78.37 0.39 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.299 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 5.0 Cg_exo -82.12 -33.83 0.53 Allowed 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 121.035 1.157 . . . . 0.0 110.961 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.091 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.6 m -75.85 149.27 37.87 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 115.39 -2.524 . . . . 0.0 110.464 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' O ' ' C ' ' A' ' 57' ' ' ASN . 70.7 mt -97.91 174.03 6.78 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 116.114 -2.234 . . . . 0.0 109.746 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.59 ' C ' ' O ' ' A' ' 56' ' ' LEU . 21.5 m-80 33.76 57.29 0.57 Allowed 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 115.845 -2.342 . . . . 0.0 114.118 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 56.62 41.99 27.69 Favored 'General case' 0 N--CA 1.515 2.811 0 C-N-CA 116.047 -2.261 . . . . 0.0 111.749 168.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.47 54.87 Favored Glycine 0 N--CA 1.444 -0.771 1 C-N-CA 113.653 -4.118 . . . . 0.0 110.125 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -93.36 133.12 36.94 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 114.65 -2.82 . . . . 0.0 109.438 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 88.4 m -98.43 105.49 17.64 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 114.742 -2.783 . . . . 0.0 107.338 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 N--CA 1.48 1.058 0 C-N-CA 115.513 -2.475 . . . . 0.0 107.696 176.425 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.67 -131.8 2.07 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 114.9 -3.524 . . . . 0.0 110.26 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.74 85.02 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 C-N-CA 114.767 -2.773 . . . . 0.0 109.034 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.1 -60.56 4.58 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 115.803 -3.094 . . . . 0.0 110.932 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.98 167.52 21.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.554 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.53 159.1 44.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 114.748 -2.781 . . . . 0.0 108.923 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -137.04 132.25 33.94 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 115.146 -2.622 . . . . 0.0 108.395 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.091 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.8 m -91.46 129.09 37.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 116.059 -2.256 . . . . 0.0 109.761 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.3 m -107.46 106.07 16.29 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 114.827 -2.749 . . . . 0.0 109.677 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 77' ' ' GLU . 34.3 m -68.81 142.45 54.87 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 115.473 -2.491 . . . . 0.0 109.95 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.54 169.2 18.7 Favored 'General case' 0 C--O 1.26 1.649 0 C-N-CA 115.503 -2.479 . . . . 0.0 111.69 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.71 143.25 31.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 115.691 -2.404 . . . . 0.0 109.783 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.16 -23.73 34.84 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 115.11 -3.424 . . . . 0.0 110.292 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.806 ' HE1' ' HA ' ' A' ' 85' ' ' THR . 73.7 m-85 -131.48 143.87 50.73 Favored 'General case' 0 N--CA 1.407 -2.578 0 C-N-CA 114.484 -2.887 . . . . 0.0 110.243 -169.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' ' OG ' ' A' ' 84' ' ' SER . 2.0 pt-20 -164.85 178.07 7.45 Favored 'General case' 1 N--CA 1.37 -4.461 0 C-N-CA 112.766 -3.574 . . . . 0.0 112.747 164.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 133.25 175.51 13.99 Favored Glycine 0 N--CA 1.484 1.864 0 C-N-CA 115.308 -3.33 . . . . 0.0 109.745 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.8 tttp -38.66 -52.21 1.66 Allowed 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 116.147 -2.221 . . . . 0.0 110.622 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 61.9 m-20 -119.55 20.39 12.41 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 116.412 -2.115 . . . . 0.0 108.471 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 4.5 m 79.57 43.66 0.06 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 115.884 -2.326 . . . . 0.0 107.816 -171.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -92.0 -30.5 16.03 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.549 -2.06 . . . . 0.0 109.468 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.547 ' C ' ' OG ' ' A' ' 84' ' ' SER . 59.1 m-85 -88.82 99.51 12.43 Favored 'General case' 0 CA--C 1.465 -2.299 0 C-N-CA 115.55 -2.46 . . . . 0.0 107.179 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 1.324 ' CB ' HG21 ' A' ' 85' ' ' THR 0.263 20.6 m 166.47 175.82 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 113.959 -3.096 . . . . 0.0 109.118 -146.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 1.324 HG21 ' CB ' ' A' ' 84' ' ' SER . 1.5 p 51.48 44.39 29.05 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 116.064 -2.255 . . . . 0.0 111.276 148.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 . . . . . 0 C--N 1.372 1.553 0 CA-C-O 115.228 -2.32 . . . . 0.0 107.702 -179.382 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.541 ' CB ' ' HB2' ' A' ' 45' ' ' LYS 0.265 17.6 ptpt . . . . . 0 C--O 1.203 -1.378 0 CA-C-O 122.937 1.351 . . . . 0.0 107.965 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -102.67 151.07 22.8 Favored 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 113.866 -3.134 . . . . 0.0 110.066 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.95 -173.57 38.56 Favored Glycine 0 C--N 1.289 -2.079 0 C-N-CA 114.575 -3.679 . . . . 0.0 112.356 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -88.04 134.84 33.65 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 115.518 -2.473 . . . . 0.0 108.079 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 94.6 mm-40 -83.0 13.83 3.74 Favored 'General case' 0 C--O 1.257 1.47 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.775 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 25.6 t -140.37 22.8 2.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 115.407 -2.517 . . . . 0.0 109.892 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.79 30.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 115.318 -2.553 . . . . 0.0 112.071 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -155.97 27.84 0.58 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 114.037 -3.935 . . . . 0.0 110.218 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.1 m80 48.44 71.39 1.61 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 115.6 -2.44 . . . . 0.0 112.086 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -76.97 -31.15 3.98 Favored 'Trans proline' 0 N--CA 1.413 -3.258 0 C-N-CA 122.224 1.949 . . . . 0.0 109.091 -177.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 14.5 m -83.92 158.65 21.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.998 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 57' ' ' ASN . 62.9 mt -104.43 165.48 11.03 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 117.773 -1.571 . . . . 0.0 108.896 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.781 ' CB ' ' HA ' ' A' ' 85' ' ' THR . 15.9 m-80 34.28 63.73 0.41 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 118.181 -1.407 . . . . 0.0 111.552 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 53.88 59.03 4.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 115.4 -2.52 . . . . 0.0 111.553 169.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.23 170.69 52.81 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 114.223 -3.846 . . . . 0.0 110.91 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -97.09 104.96 17.03 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 115.383 -2.527 . . . . 0.0 108.124 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 53.5 t -95.25 118.57 32.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 114.372 -2.931 . . . . 0.0 109.676 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? . . . . . 0 C--O 1.215 -0.732 0 C-N-CA 116.356 -2.137 . . . . 0.0 108.032 174.559 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.7 -133.76 6.49 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 114.531 -3.7 . . . . 0.0 110.984 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.71 100.1 9.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 115.305 -2.558 . . . . 0.0 108.762 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 86.07 -72.81 2.63 Favored Glycine 0 N--CA 1.477 1.386 0 C-N-CA 114.04 -3.933 . . . . 0.0 110.187 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.72 166.52 22.87 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.436 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -128.82 159.63 35.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 115.929 -2.308 . . . . 0.0 108.724 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.3 p -130.54 130.43 44.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 116.068 -2.253 . . . . 0.0 109.394 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 69.3 m -107.35 139.27 42.1 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 115.475 -2.49 . . . . 0.0 109.961 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.08 121.96 36.58 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 116.293 -2.163 . . . . 0.0 109.072 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.154 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 33.7 m -73.79 148.05 42.85 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 115.659 -2.416 . . . . 0.0 110.881 -176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.9 166.24 11.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 115.873 -2.331 . . . . 0.0 109.146 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -53.78 115.42 1.98 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.513 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 1.05 ' C ' ' HB2' ' A' ' 84' ' ' SER . . . 136.27 -34.67 2.22 Favored Glycine 0 C--O 1.262 1.862 0 C-N-CA 115.007 -3.473 . . . . 0.0 110.363 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 1.158 ' HA ' ' C ' ' A' ' 84' ' ' SER 0.266 28.9 m-85 -133.84 162.84 30.92 Favored 'General case' 0 CA--C 1.568 1.669 0 C-N-CA 118.145 -1.422 . . . . 0.0 107.686 -172.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.063 ' N ' ' O ' ' A' ' 83' ' ' PHE . 3.7 tm-20 -161.25 136.86 7.86 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 113.726 -3.19 . . . . 0.0 112.126 175.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 142.16 178.39 18.17 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 114.52 -3.705 . . . . 0.0 110.604 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' GLY . 62.9 tttm -46.84 -61.33 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 115.339 -2.544 . . . . 0.0 111.342 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.701 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 68.7 m-20 -93.09 5.35 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.154 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.1 m 79.91 72.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 115.927 -2.309 . . . . 0.0 106.972 -164.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.706 ' C ' HG21 ' A' ' 85' ' ' THR . 40.1 tt0 -107.25 -29.82 9.1 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.002 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 1.063 ' O ' ' N ' ' A' ' 77' ' ' GLU . 80.8 m-85 -90.52 151.33 21.4 Favored 'General case' 0 C--O 1.19 -2.063 0 C-N-CA 116.904 -1.919 . . . . 0.0 108.049 164.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 1.158 ' C ' ' HA ' ' A' ' 76' ' ' PHE 0.3 2.2 p 41.38 116.23 0.0 OUTLIER 'General case' 1 CA--C 1.421 -4.015 0 C-N-CA 113.724 -3.19 . . . . 0.0 108.963 -160.192 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 1.128 ' N ' ' HD1' ' A' ' 76' ' ' PHE . 2.7 p 163.82 39.74 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 1 CA-C-N 108.002 -4.181 . . . . 0.0 108.764 -148.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.608 ' H ' ' HE1' ' A' ' 76' ' ' PHE . 1.7 mpp_? . . . . . 0 CA--C 1.561 1.367 0 C-N-CA 114.509 -2.877 . . . . 0.0 109.133 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -128.2 137.73 52.17 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 116.651 -2.02 . . . . 0.0 111.429 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.46 -169.76 30.03 Favored Glycine 0 N--CA 1.481 1.684 1 C-N-CA 112.23 -4.795 . . . . 0.0 109.754 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -100.3 118.5 36.69 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 116.34 -2.144 . . . . 0.0 108.539 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -96.09 -8.56 33.03 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 116.207 -2.197 . . . . 0.0 108.49 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.242 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 18.3 t -102.25 -19.73 14.93 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.212 -2.595 . . . . 0.0 110.97 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -74.77 13.99 0.56 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 114.633 -2.827 . . . . 0.0 109.458 178.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -97.58 12.58 64.62 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 114.503 -3.713 . . . . 0.0 110.095 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.417 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 89.4 m-70 45.43 71.06 1.66 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 115.468 -2.493 . . . . 0.0 110.551 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.0 OUTLIER -84.47 -34.72 0.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.36 0 O-C-N 122.401 0.685 . . . . 0.0 110.674 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.106 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 m -92.63 156.26 17.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 116.219 -2.192 . . . . 0.0 109.945 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 57' ' ' ASN . 89.5 mt -103.04 176.29 5.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 116.645 -2.022 . . . . 0.0 109.308 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 56' ' ' LEU . 16.4 m-80 29.81 63.42 0.15 Allowed 'General case' 0 N--CA 1.4 -2.968 0 C-N-CA 116.801 -1.96 . . . . 0.0 113.11 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 51.51 55.75 8.93 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 115.734 -2.387 . . . . 0.0 110.721 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.93 172.24 55.17 Favored Glycine 0 CA--C 1.536 1.349 1 C-N-CA 113.463 -4.208 . . . . 0.0 109.346 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -90.83 87.7 6.76 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 115.276 -2.569 . . . . 0.0 108.795 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.242 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.6 t -89.0 125.12 34.85 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 115.852 -2.339 . . . . 0.0 109.558 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.9 tptt . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 115.863 -2.335 . . . . 0.0 107.985 176.366 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.6 -123.19 1.64 Allowed Glycine 0 N--CA 1.478 1.459 0 C-N-CA 114.348 -3.787 . . . . 0.0 110.495 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 67.2 mt -88.63 76.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 116.315 -2.154 . . . . 0.0 108.075 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.27 -68.74 3.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 115.16 -3.4 . . . . 0.0 109.982 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.59 165.5 24.98 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 115.914 -2.315 . . . . 0.0 110.407 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.85 157.42 23.32 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 115.312 -2.555 . . . . 0.0 109.186 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.4 p -124.88 134.27 52.76 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.099 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.106 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 90.6 m -108.56 132.33 53.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.728 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 123.41 40.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 115.887 -2.325 . . . . 0.0 109.226 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.16 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.8 m -75.08 143.99 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 115.373 -2.531 . . . . 0.0 109.724 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 170.06 15.36 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.612 -2.435 . . . . 0.0 110.292 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -59.12 132.38 53.86 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 115.931 -2.307 . . . . 0.0 109.075 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.41 -20.62 36.97 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 115.453 -3.26 . . . . 0.0 110.007 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.36 152.41 39.02 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 115.742 -2.383 . . . . 0.0 109.067 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -161.68 121.15 2.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.368 -2.533 . . . . 0.0 110.331 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 163.51 173.96 32.81 Favored Glycine 0 CA--C 1.55 2.259 1 C-N-CA 113.278 -4.296 . . . . 0.0 110.293 176.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 78' ' ' GLY . 14.6 tppt? -41.92 -55.69 3.02 Favored 'General case' 0 N--CA 1.417 -2.107 0 C-N-CA 115.881 -2.327 . . . . 0.0 110.896 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.714 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 47.8 m-20 -113.59 17.07 18.53 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.699 -2.401 . . . . 0.0 109.321 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.16 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.9 m 76.73 32.51 0.52 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 114.699 -2.8 . . . . 0.0 109.446 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.98 -30.15 62.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 115.165 -2.614 . . . . 0.0 109.735 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -90.0 160.38 16.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 116.022 -2.271 . . . . 0.0 110.387 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' ' C ' ' A' ' 85' ' ' THR . 11.0 p -120.89 70.57 0.91 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 115.899 -2.32 . . . . 0.0 109.368 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.596 ' C ' ' O ' ' A' ' 84' ' ' SER . 27.5 p 32.58 53.9 0.34 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 115.782 -2.367 . . . . 0.0 110.083 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.499 ' NH1' HH11 ' A' ' 86' ' ' ARG . 76.5 mtp180 . . . . . 0 N--CA 1.5 2.029 0 C-N-CA 113.977 -3.089 . . . . 0.0 108.553 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.7 mttm . . . . . 1 N--CA 1.541 4.123 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -90.62 132.45 35.74 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-N 110.121 -3.218 . . . . 0.0 107.711 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.73 -87.17 0.43 Allowed Glycine 1 CA--C 1.596 5.121 0 C-N-CA 116.707 -2.663 . . . . 0.0 109.599 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -128.16 124.98 38.18 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 116.129 -2.228 . . . . 0.0 109.593 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 12.2 mp0 -94.11 -7.51 42.27 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 114.95 -2.7 . . . . 0.0 111.124 -171.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.7 t -125.08 12.25 8.31 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 115.31 -2.556 . . . . 0.0 110.452 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -75.41 17.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 113.909 -3.116 . . . . 0.0 110.444 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -117.38 17.82 12.29 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 115.554 -3.213 . . . . 0.0 109.537 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 44.07 74.7 0.74 Allowed Pre-proline 0 CA--C 1.568 1.66 0 C-N-CA 115.297 -2.561 . . . . 0.0 111.136 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.06 -40.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.974 0 C-N-CA 121.595 1.53 . . . . 0.0 110.051 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.175 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 m -74.97 152.96 38.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 115.175 -2.61 . . . . 0.0 108.842 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' ASN . 75.1 mt -103.9 170.8 7.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 116.464 -2.094 . . . . 0.0 108.877 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LEU . 8.8 m-80 33.81 62.41 0.43 Allowed 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.748 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 1.385 HE21 ' NE2' ' A' ' 58' ' ' GLN . 89.7 mt-30 49.93 62.35 2.7 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.689 173.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.97 168.66 32.87 Favored Glycine 0 C--O 1.251 1.158 1 C-N-CA 113.511 -4.185 . . . . 0.0 110.088 172.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -89.31 164.39 14.94 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.028 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 91.0 m -131.44 119.24 21.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 114.96 -2.696 . . . . 0.0 110.031 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.8 tptt . . . . . 0 C--O 1.25 1.09 0 C-N-CA 115.992 -2.283 . . . . 0.0 107.015 175.625 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.45 -145.48 4.19 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 115.517 -3.23 . . . . 0.0 110.041 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.33 81.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 115.788 -2.365 . . . . 0.0 108.162 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.63 -59.19 3.7 Favored Glycine 0 C--N 1.343 0.944 1 C-N-CA 113.53 -4.176 . . . . 0.0 110.838 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.98 168.16 20.57 Favored 'General case' 0 C--O 1.259 1.597 0 C-N-CA 116.587 -2.045 . . . . 0.0 108.744 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.77 161.97 41.79 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 115.942 -2.303 . . . . 0.0 108.591 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 p -139.71 129.41 24.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 116.121 -2.232 . . . . 0.0 109.617 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.175 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 65.5 m -88.92 136.41 33.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 114.947 -2.701 . . . . 0.0 109.778 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.33 124.38 50.86 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 115.924 -2.31 . . . . 0.0 108.982 175.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 66.2 m -77.04 152.95 34.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.994 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.15 171.61 13.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 115.521 -2.471 . . . . 0.0 110.848 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.48 94.19 0.54 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 116.612 -2.035 . . . . 0.0 108.471 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.68 -30.06 0.93 Allowed Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 114.98 -3.486 . . . . 0.0 109.204 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -116.6 163.5 16.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 115.493 -2.483 . . . . 0.0 108.825 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -156.11 139.79 16.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 144.75 168.22 12.58 Favored Glycine 0 C--N 1.294 -1.766 1 C-N-CA 113.807 -4.044 . . . . 0.0 111.434 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 78' ' ' GLY . 39.1 ttpt -50.92 -54.71 21.78 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 115.556 -2.457 . . . . 0.0 109.957 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.724 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 70.7 m-20 -104.17 8.68 36.34 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.085 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.4 m 81.47 43.04 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 115.185 -2.606 . . . . 0.0 108.497 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.34 -18.23 42.88 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 115.455 -2.498 . . . . 0.0 109.854 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -104.28 170.84 7.67 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 114.95 -2.7 . . . . 0.0 110.072 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.498 ' O ' ' C ' ' A' ' 85' ' ' THR . 41.1 p -121.05 82.69 1.96 Allowed 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 114.92 -2.712 . . . . 0.0 109.725 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.498 ' C ' ' O ' ' A' ' 84' ' ' SER . 24.7 p 27.78 51.9 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 117.133 -1.827 . . . . 0.0 111.002 -175.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 115.25 -2.58 . . . . 0.0 109.31 -178.721 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . 0.262 59.5 tttp . . . . . 0 CA--C 1.604 3.024 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -100.36 159.79 14.85 Favored 'General case' 0 CA--C 1.586 2.342 0 C-N-CA 113.826 -3.15 . . . . 0.0 108.432 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.77 175.39 3.77 Favored Glycine 0 C--O 1.197 -2.186 0 C-N-CA 115.363 -3.303 . . . . 0.0 111.071 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -90.44 133.53 34.96 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 115.876 -2.329 . . . . 0.0 109.831 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.654 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 10.2 mp0 -97.99 -8.16 28.51 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.38 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.217 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.4 t -115.01 -10.76 12.21 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 115.238 -2.585 . . . . 0.0 111.288 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.99 20.17 0.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 116.003 -2.279 . . . . 0.0 111.26 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -132.31 24.9 3.91 Favored Glycine 0 C--N 1.311 -0.837 0 C-N-CA 114.344 -3.788 . . . . 0.0 111.294 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 49.62 84.13 0.21 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.96 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -95.47 -32.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.932 0 O-C-N 123.67 1.352 . . . . 0.0 109.115 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.189 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 34.1 m -81.56 163.01 22.94 Favored 'General case' 0 C--O 1.255 1.342 0 C-N-CA 114.007 -3.077 . . . . 0.0 110.937 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.523 ' O ' ' C ' ' A' ' 57' ' ' ASN . 94.5 mt -113.93 172.91 6.71 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 115.717 -2.393 . . . . 0.0 109.481 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER 43.05 49.58 5.38 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 116.881 -1.928 . . . . 0.0 110.334 172.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.462 ' N ' ' NE2' ' A' ' 58' ' ' GLN . 9.6 mp0 57.62 48.22 14.57 Favored 'General case' 0 C--O 1.272 2.284 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.2 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.78 160.56 34.15 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 114.917 -3.516 . . . . 0.0 111.01 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -87.5 158.29 18.97 Favored 'General case' 0 C--N 1.275 -2.647 0 C-N-CA 115.219 -2.592 . . . . 0.0 109.02 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.217 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 38.9 t -144.84 128.33 17.0 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 114.14 -3.024 . . . . 0.0 111.305 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.7 tptp . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 115.666 -2.414 . . . . 0.0 108.149 175.169 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.46 -124.23 1.98 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 114.385 -3.769 . . . . 0.0 110.536 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.39 89.51 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 114.643 -2.823 . . . . 0.0 109.829 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 80.79 -68.68 3.35 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 115.232 -3.366 . . . . 0.0 110.156 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.83 -174.47 3.06 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 114.243 -2.983 . . . . 0.0 109.569 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -139.19 166.87 23.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 116.184 -2.206 . . . . 0.0 110.737 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 p -133.18 143.52 49.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.5 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.189 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.9 m -117.53 141.49 48.3 Favored 'General case' 0 C--O 1.213 -0.843 0 C-N-CA 113.595 -3.242 . . . . 0.0 110.143 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.59 162.27 13.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 115.525 -2.47 . . . . 0.0 108.139 172.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.118 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 74.0 m -111.08 154.81 23.73 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 114.293 -2.963 . . . . 0.0 108.366 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.13 165.45 20.34 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 113.783 -3.167 . . . . 0.0 110.704 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.22 97.64 0.19 Allowed 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.31 -2.556 . . . . 0.0 109.604 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.68 -42.98 0.59 Allowed Glycine 0 N--CA 1.428 -1.858 0 C-N-CA 114.667 -3.635 . . . . 0.0 109.435 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -105.09 166.6 10.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.181 -2.608 . . . . 0.0 108.7 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -159.04 123.24 3.95 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 114.941 -2.703 . . . . 0.0 109.46 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 162.68 167.21 22.77 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 116.345 -2.836 . . . . 0.0 111.338 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 78' ' ' GLY . 10.8 tmtt? -44.27 -55.53 4.82 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 116.3 -2.16 . . . . 0.0 110.125 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.756 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 26.3 m-20 -102.13 5.36 40.31 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 115.095 -2.642 . . . . 0.0 109.428 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.118 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 25.0 m 79.21 14.82 1.05 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 115.46 -2.496 . . . . 0.0 109.569 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.68 -27.01 47.79 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 115.434 -2.506 . . . . 0.0 111.693 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.42 151.89 19.03 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 115.404 -2.518 . . . . 0.0 110.3 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.4 p -114.99 148.75 38.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 114.787 -2.765 . . . . 0.0 109.126 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.8 p -102.05 35.8 2.28 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 115.505 -2.478 . . . . 0.0 108.934 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 . . . . . 0 CA--C 1.578 2.031 0 C-N-CA 115.697 -2.401 . . . . 0.0 109.529 176.112 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 pttt . . . . . 0 N--CA 1.42 -1.948 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -137.55 29.88 2.64 Favored 'General case' 0 N--CA 1.527 3.409 0 C-N-CA 116.659 -2.016 . . . . 0.0 108.921 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.02 -173.22 54.98 Favored Glycine 0 C--N 1.351 1.385 0 C-N-CA 114.2 -3.857 . . . . 0.0 110.582 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.39 117.84 26.11 Favored 'General case' 0 C--O 1.214 -0.781 0 C-N-CA 115.209 -2.596 . . . . 0.0 109.654 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -98.68 -17.81 18.38 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 114.514 -2.875 . . . . 0.0 109.751 -174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.516 ' C ' ' H ' ' A' ' 52' ' ' GLY . 36.8 t -82.65 -15.67 51.15 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 115.363 -2.535 . . . . 0.0 109.247 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.94 20.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 115.748 -2.381 . . . . 0.0 110.745 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -111.55 9.85 28.23 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 114.362 -3.78 . . . . 0.0 110.715 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.471 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 13.4 t-160 50.98 67.3 4.43 Favored Pre-proline 0 C--N 1.366 1.287 0 C-N-CA 116.41 -2.116 . . . . 0.0 109.067 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.2 Cg_endo -83.77 -30.46 0.77 Allowed 'Trans proline' 0 N--CA 1.419 -2.871 0 C-N-CA 121.071 1.181 . . . . 0.0 110.431 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.094 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.3 m -87.66 147.86 25.06 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 116.314 -2.154 . . . . 0.0 110.727 -175.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 57' ' ' ASN . 76.9 mt -94.85 172.7 8.0 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.472 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.557 ' C ' ' O ' ' A' ' 56' ' ' LEU . 16.8 m-80 32.68 61.83 0.36 Allowed 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 117.337 -1.745 . . . . 0.0 114.245 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 52.55 41.9 31.23 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.956 -1.498 . . . . 0.0 110.786 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.59 174.03 52.81 Favored Glycine 0 C--N 1.373 2.638 0 C-N-CA 113.946 -3.978 . . . . 0.0 109.008 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -88.76 147.95 24.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 115.123 -2.631 . . . . 0.0 108.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.9 t -140.18 123.99 17.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 115.699 -2.401 . . . . 0.0 110.599 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm . . . . . 0 CA--C 1.541 0.607 0 C-N-CA 115.374 -2.53 . . . . 0.0 108.791 176.244 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.0 -138.88 3.28 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 114.942 -3.504 . . . . 0.0 109.271 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.5 mm -80.88 86.28 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 116.358 -2.137 . . . . 0.0 108.684 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.63 -72.32 2.0 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 114.323 -3.799 . . . . 0.0 110.158 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.25 167.89 19.45 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 115.214 -2.594 . . . . 0.0 109.493 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -113.3 152.72 29.52 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 115.757 -2.377 . . . . 0.0 109.075 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 114.897 -2.721 . . . . 0.0 109.469 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.094 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 63.0 m -105.14 137.22 43.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 115.933 -2.307 . . . . 0.0 109.854 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.96 114.01 20.38 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 116.89 -1.924 . . . . 0.0 108.532 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 32.4 m -71.97 145.15 48.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 116.505 -2.078 . . . . 0.0 108.996 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 169.04 14.05 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 116.264 -2.174 . . . . 0.0 110.063 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.73 145.81 6.49 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 115.92 -2.312 . . . . 0.0 110.214 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.72 -22.56 39.71 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 114.795 -3.574 . . . . 0.0 109.751 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.857 ' HE1' ' HA ' ' A' ' 85' ' ' THR . 69.4 m-85 -131.53 145.24 51.64 Favored 'General case' 0 CA--C 1.476 -1.899 0 C-N-CA 115.916 -2.314 . . . . 0.0 112.055 -173.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.701 ' N ' ' OG ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -165.56 174.53 9.8 Favored 'General case' 0 N--CA 1.399 -2.996 0 C-N-CA 114.066 -3.054 . . . . 0.0 112.632 164.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 137.76 171.74 12.29 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 116.507 -2.759 . . . . 0.0 110.642 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 78' ' ' GLY . 63.9 tttm -39.39 -52.81 2.05 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 116.976 -1.89 . . . . 0.0 110.179 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 67.6 m-20 -115.16 20.95 14.6 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 116.376 -2.129 . . . . 0.0 108.746 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.0 m 76.53 40.8 0.21 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 115.309 -2.556 . . . . 0.0 108.825 -171.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -88.87 -28.85 20.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 116.213 -2.195 . . . . 0.0 109.003 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.717 ' C ' ' OG ' ' A' ' 84' ' ' SER . 62.9 m-85 -88.72 100.32 13.04 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 116.432 -2.107 . . . . 0.0 107.324 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 1.267 ' CB ' HG23 ' A' ' 85' ' ' THR . 11.1 m 164.77 173.63 0.02 OUTLIER 'General case' 0 C--O 1.272 2.288 0 C-N-CA 114.036 -3.066 . . . . 0.0 110.494 -145.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 1.267 HG23 ' CB ' ' A' ' 84' ' ' SER . 1.5 p 53.01 42.65 32.26 Favored 'General case' 0 C--N 1.268 -2.973 0 C-N-CA 115.887 -2.325 . . . . 0.0 110.166 147.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.482 ' NH1' HH12 ' A' ' 86' ' ' ARG . 77.9 mtt-85 . . . . . 0 N--CA 1.422 -1.846 0 C-N-CA 113.545 -3.262 . . . . 0.0 109.519 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.96 119.14 37.77 Favored 'General case' 0 CA--C 1.476 -1.89 0 C-N-CA 112.745 -3.582 . . . . 0.0 113.717 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.89 -65.9 0.51 Allowed Glycine 0 CA--C 1.557 2.708 0 C-N-CA 114.142 -3.885 . . . . 0.0 110.795 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -121.82 133.29 54.9 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 114.496 -2.882 . . . . 0.0 108.898 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' N ' ' CD ' ' A' ' 49' ' ' GLN . 7.4 mp0 -96.14 -15.24 22.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 114.481 -2.887 . . . . 0.0 110.862 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.15 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.4 t -121.79 20.3 10.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 115.581 -2.447 . . . . 0.0 110.264 -175.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -74.98 33.21 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 116.567 -2.053 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -153.91 23.6 0.71 Allowed Glycine 0 N--CA 1.47 0.961 0 C-N-CA 114.411 -3.757 . . . . 0.0 110.997 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.8 t-160 47.15 75.17 0.69 Allowed Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 115.931 -2.308 . . . . 0.0 109.123 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.49 -34.11 0.44 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 120.566 0.844 . . . . 0.0 111.123 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 10.6 m -71.57 164.1 26.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 115.636 -2.425 . . . . 0.0 109.403 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.7 mt -114.8 170.81 8.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 116.473 -2.091 . . . . 0.0 110.094 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.492 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 35.32 57.28 0.84 Allowed 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 115.811 -2.355 . . . . 0.0 114.732 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 56.7 mt-30 60.5 39.6 18.01 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.113 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 161.52 50.32 Favored Glycine 1 N--CA 1.521 4.352 1 C-N-CA 113.739 -4.077 . . . . 0.0 110.847 175.905 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -89.34 167.05 13.35 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 114.987 -2.685 . . . . 0.0 107.75 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.15 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 48.5 t -136.45 133.28 36.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 113.249 -3.38 . . . . 0.0 110.126 -172.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 115.702 -2.399 . . . . 0.0 107.635 175.645 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.39 -138.99 2.9 Favored Glycine 1 N--CA 1.516 4.01 0 C-N-CA 116.067 -2.968 . . . . 0.0 110.317 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.16 88.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 115.544 -2.462 . . . . 0.0 107.234 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.75 -64.02 4.0 Favored Glycine 0 CA--C 1.545 1.966 0 C-N-CA 115.222 -3.37 . . . . 0.0 110.252 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -76.58 164.72 25.66 Favored 'General case' 0 C--O 1.26 1.629 0 C-N-CA 115.542 -2.463 . . . . 0.0 110.096 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -134.76 163.0 30.78 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 115.65 -2.42 . . . . 0.0 108.624 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 p -137.18 132.28 33.69 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.372 -2.531 . . . . 0.0 108.293 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.131 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 41.4 m -97.53 141.29 30.76 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 114.851 -2.74 . . . . 0.0 110.149 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 111.71 24.31 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 115.764 -2.375 . . . . 0.0 109.057 173.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.18 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.1 m -71.49 148.75 46.48 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 115.979 -2.288 . . . . 0.0 111.232 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.11 168.79 19.48 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 115.114 -2.635 . . . . 0.0 110.248 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.12 140.06 56.24 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 115.216 -2.594 . . . . 0.0 108.888 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.48 -14.91 61.75 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 116.317 -2.849 . . . . 0.0 110.425 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.17 150.18 49.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 116.268 -2.173 . . . . 0.0 110.334 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.73 130.87 11.11 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 115.72 -2.392 . . . . 0.0 108.755 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 154.15 163.36 11.84 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 114.314 -3.803 . . . . 0.0 110.993 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.9 tttm -43.83 -50.26 7.93 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.57 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 42.1 m-20 -110.62 10.98 22.9 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 116.001 -2.28 . . . . 0.0 110.33 175.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.18 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 21.9 m 78.01 30.58 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 116.067 -2.253 . . . . 0.0 108.237 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.44 -32.21 68.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.518 -2.073 . . . . 0.0 109.449 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.13 154.27 20.3 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 114.926 -2.71 . . . . 0.0 109.525 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 85' ' ' THR . 39.8 p -113.79 70.77 0.73 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 114.866 -2.734 . . . . 0.0 109.151 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 84' ' ' SER . 41.1 p 34.36 51.45 0.45 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 117.059 -1.856 . . . . 0.0 110.623 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 . . . . . 0 N--CA 1.489 1.509 0 C-N-CA 114.755 -2.778 . . . . 0.0 108.879 177.574 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.503 ' CB ' ' HB3' ' A' ' 45' ' ' LYS . 56.8 tttp . . . . . 0 CA--C 1.472 -2.03 0 CA-C-O 121.193 0.52 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -144.0 101.5 3.74 Favored 'General case' 0 CA--C 1.458 -2.591 0 C-N-CA 116.398 -2.121 . . . . 0.0 113.555 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.94 -111.91 0.5 Allowed Glycine 0 CA--C 1.578 3.994 0 C-N-CA 117.286 -2.387 . . . . 0.0 108.725 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -113.24 127.18 56.09 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 115.101 -2.64 . . . . 0.0 109.103 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.506 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 7.7 mp0 -89.83 -9.61 48.45 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 116.656 -2.018 . . . . 0.0 109.539 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.533 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.3 t -116.37 1.82 13.09 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 114.425 -2.91 . . . . 0.0 109.979 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -74.99 20.33 0.13 Allowed 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 115.471 -2.492 . . . . 0.0 110.484 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -119.88 13.69 10.6 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 114.004 -3.951 . . . . 0.0 110.137 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 50.09 73.55 0.97 Allowed Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 116.878 -1.929 . . . . 0.0 111.237 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -83.48 -43.6 0.07 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.128 0 N-CA-C 110.082 -0.776 . . . . 0.0 110.082 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.129 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 2.8 m -85.41 147.41 26.51 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 115.387 -2.525 . . . . 0.0 110.05 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.58 ' O ' ' C ' ' A' ' 57' ' ' ASN . 61.2 mt -95.21 179.41 5.2 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 116.839 -1.944 . . . . 0.0 109.365 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.58 ' C ' ' O ' ' A' ' 56' ' ' LEU . 12.5 m-80 28.62 60.92 0.13 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.204 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 55.06 58.3 4.85 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 115.051 -2.66 . . . . 0.0 108.682 165.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.07 171.13 51.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 113.921 -3.99 . . . . 0.0 109.812 171.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -89.15 93.5 9.6 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 115.449 -2.5 . . . . 0.0 108.798 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.6 p -95.55 109.0 21.29 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 115.436 -2.506 . . . . 0.0 108.644 -171.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 tttp . . . . . 0 C--O 1.242 0.689 0 C-N-CA 115.917 -2.313 . . . . 0.0 107.879 176.756 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.96 -127.34 1.03 Allowed Glycine 0 N--CA 1.478 1.475 1 C-N-CA 113.865 -4.017 . . . . 0.0 110.107 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.6 mt -92.71 79.33 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 114.922 -2.711 . . . . 0.0 108.915 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 114.807 -3.568 . . . . 0.0 109.713 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.54 164.37 26.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 114.598 -2.841 . . . . 0.0 110.539 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -137.48 161.38 36.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.196 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -120.43 136.17 54.82 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 115.665 -2.414 . . . . 0.0 110.274 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.129 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 52.4 m -104.85 124.11 48.87 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 115.394 -2.523 . . . . 0.0 109.003 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 119.64 35.62 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 115.886 -2.326 . . . . 0.0 108.754 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.104 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 9.9 m -71.74 149.9 44.96 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 116.265 -2.174 . . . . 0.0 109.584 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.14 164.17 26.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 116.017 -2.273 . . . . 0.0 109.172 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.64 97.84 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 114.466 -2.893 . . . . 0.0 108.602 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.25 -33.32 0.65 Allowed Glycine 0 C--O 1.247 0.917 0 C-N-CA 115.357 -3.306 . . . . 0.0 110.227 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 96.2 m-85 -116.94 159.99 21.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 117.053 -1.859 . . . . 0.0 109.114 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.674 ' HA ' ' SG ' ' A' ' 72' ' ' CYS . 0.7 OUTLIER -159.7 -126.73 0.02 OUTLIER 'General case' 0 C--N 1.363 1.176 0 C-N-CA 114.212 -2.995 . . . . 0.0 109.653 166.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.411 ' N ' ' CZ ' ' A' ' 83' ' ' PHE . . . 68.58 -176.44 28.18 Favored Glycine 0 CA--C 1.554 2.509 1 C-N-CA 113.073 -4.394 . . . . 0.0 110.143 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -48.3 -61.17 2.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.901 -1.92 . . . . 0.0 113.616 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.605 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 81.8 m-20 -106.29 19.57 20.3 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 115.913 -2.315 . . . . 0.0 108.74 -171.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.104 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 10.3 m 73.1 46.6 0.23 Allowed 'General case' 0 C--O 1.252 1.195 0 C-N-CA 116.438 -2.105 . . . . 0.0 107.956 -167.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 77' ' ' GLU . 42.6 tt0 -90.24 -30.14 17.73 Favored 'General case' 0 C--O 1.261 1.672 0 C-N-CA 116.818 -1.953 . . . . 0.0 109.155 -170.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.688 ' HD1' ' O ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -102.31 147.44 26.68 Favored 'General case' 0 N--CA 1.379 -3.988 0 C-N-CA 112.298 -3.761 . . . . 0.0 108.758 -162.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 p -96.73 117.61 31.4 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 114.184 -3.006 . . . . 0.0 108.01 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.5 p -91.21 37.36 0.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 115.601 -2.44 . . . . 0.0 109.343 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 115.774 -2.371 . . . . 0.0 108.561 179.699 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.535 ' CG ' ' HG3' ' A' ' 45' ' ' LYS . 44.7 mttp . . . . . 0 CA--C 1.588 2.417 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -157.01 113.49 3.0 Favored 'General case' 0 N--CA 1.534 3.73 0 C-N-CA 116.115 -2.234 . . . . 0.0 108.233 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.16 -114.49 0.28 Allowed Glycine 1 N--CA 1.554 6.548 1 C-N-CA 113.426 -4.226 . . . . 0.0 109.893 -175.358 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -122.13 143.12 49.73 Favored 'General case' 0 N--CA 1.415 -2.202 0 C-N-CA 115.723 -2.391 . . . . 0.0 109.676 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 86.7 mm-40 -89.02 -19.35 25.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.294 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.542 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.4 t -95.53 11.9 31.43 Favored 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 115.302 -2.559 . . . . 0.0 108.652 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.98 26.61 0.07 Allowed 'General case' 0 C--O 1.258 1.533 0 C-N-CA 115.876 -2.33 . . . . 0.0 109.87 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -150.15 30.02 1.09 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 114.016 -3.945 . . . . 0.0 110.136 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 52' ' ' GLY . 21.8 t-160 40.31 83.87 0.19 Allowed Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 115.977 -2.289 . . . . 0.0 110.424 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -89.34 -27.12 0.38 Allowed 'Trans proline' 0 N--CA 1.426 -2.484 0 O-C-N 123.182 1.096 . . . . 0.0 111.547 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 m -94.16 166.64 12.02 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 114.314 -2.955 . . . . 0.0 110.415 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.1 mt -113.6 175.02 5.63 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 115.898 -2.321 . . . . 0.0 109.56 -177.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 56' ' ' LEU . 42.7 m-80 27.47 62.4 0.1 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.055 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 45.5 mt-30 58.9 47.33 12.56 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 125.248 1.593 . . . . 0.0 109.034 171.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.98 157.08 35.01 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 113.939 -3.981 . . . . 0.0 109.534 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -86.04 155.13 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 114.351 -2.94 . . . . 0.0 107.765 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.0 p -135.38 105.14 6.12 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.456 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp . . . . . 0 N--CA 1.486 1.37 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.338 177.739 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.6 -146.03 4.24 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 114.587 -3.673 . . . . 0.0 110.823 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.26 94.0 2.07 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.477 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 80.11 -71.68 2.73 Favored Glycine 0 C--O 1.259 1.666 0 C-N-CA 115.889 -3.053 . . . . 0.0 112.297 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -77.83 174.53 10.92 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 114.288 -2.965 . . . . 0.0 109.697 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.95 160.96 37.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 116.383 -2.127 . . . . 0.0 108.718 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.1 p -131.3 140.82 49.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 114.479 -2.888 . . . . 0.0 108.592 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 55.8 m -100.44 128.91 46.37 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.463 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.32 119.71 40.3 Favored 'General case' 0 C--O 1.255 1.387 0 C-N-CA 116.018 -2.273 . . . . 0.0 108.481 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.2 m -72.46 155.93 39.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 114.854 -2.738 . . . . 0.0 109.169 -174.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 163.65 26.36 Favored 'General case' 0 C--O 1.25 1.104 0 C-N-CA 114.683 -2.807 . . . . 0.0 108.947 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.54 100.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 114.782 -2.767 . . . . 0.0 108.99 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.27 -42.27 0.65 Allowed Glycine 0 CA--C 1.546 2.031 0 C-N-CA 115.414 -3.279 . . . . 0.0 108.309 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.22 161.33 16.7 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 115.49 -2.484 . . . . 0.0 110.154 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -147.75 142.49 26.71 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 115.477 -2.489 . . . . 0.0 108.639 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.555 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 142.87 158.63 7.61 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 115.914 -3.041 . . . . 0.0 110.478 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 78' ' ' GLY . 38.7 ttmt -39.27 -50.55 1.99 Allowed 'General case' 0 C--O 1.187 -2.232 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.183 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.715 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 59.5 m-20 -107.83 -3.1 19.31 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 116.842 -1.943 . . . . 0.0 109.146 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.5 m 83.27 31.81 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 114.874 -2.73 . . . . 0.0 109.154 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.78 -30.29 63.99 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 116.511 -2.076 . . . . 0.0 109.896 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -89.19 150.45 22.66 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 115.079 -2.649 . . . . 0.0 108.87 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 80.4 p -113.28 152.91 29.26 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 114.192 -3.003 . . . . 0.0 110.002 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 75.3 p -85.65 33.89 0.58 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 114.804 -2.758 . . . . 0.0 109.95 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 . . . . . 0 N--CA 1.472 0.661 0 C-N-CA 116.709 -1.996 . . . . 0.0 110.433 179.142 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.567 ' CG ' ' HG3' ' A' ' 45' ' ' LYS . 31.0 ttmt . . . . . 0 N--CA 1.507 2.402 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -79.74 145.08 33.08 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 116.945 -1.902 . . . . 0.0 109.422 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.91 -81.95 0.31 Allowed Glycine 0 C--N 1.364 2.119 0 C-N-CA 114.651 -3.642 . . . . 0.0 108.384 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -123.97 139.01 54.37 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 115.752 -2.379 . . . . 0.0 110.089 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -96.37 -34.17 11.65 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 116.393 -2.123 . . . . 0.0 110.219 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.092 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.8 t -93.78 20.59 7.4 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 116.43 -2.108 . . . . 0.0 109.516 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.18 23.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 114.879 -2.728 . . . . 0.0 110.969 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -147.2 23.38 1.57 Allowed Glycine 0 N--CA 1.472 1.079 0 C-N-CA 114.412 -3.756 . . . . 0.0 111.328 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 43.77 80.42 0.29 Allowed Pre-proline 0 CA--C 1.581 2.146 0 C-N-CA 116.84 -1.944 . . . . 0.0 111.123 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.19 -32.42 0.3 Allowed 'Trans proline' 0 N--CA 1.412 -3.272 0 C-N-CA 121.707 1.604 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 13.3 m -85.48 140.44 30.68 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 115.796 -2.362 . . . . 0.0 109.264 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.7 mt -101.63 168.7 9.31 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.777 -1.569 . . . . 0.0 110.719 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER 43.55 60.72 2.51 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 116.559 -2.056 . . . . 0.0 110.26 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 46.85 45.56 15.1 Favored 'General case' 1 C--N 1.441 4.571 0 C-N-CA 113.397 -3.321 . . . . 0.0 115.592 174.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.401 ' HA3' ' CD2' ' A' ' 60' ' ' HIS . . . -77.46 -156.62 8.12 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 114.655 -3.641 . . . . 0.0 111.231 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 1.389 ' CB ' ' N ' ' A' ' 71' ' ' THR 0.428 0.0 OUTLIER -79.61 155.32 28.17 Favored 'General case' 1 N--CA 1.367 -4.62 0 CA-C-N 109.742 -3.229 . . . . 0.0 114.009 176.685 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.092 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.2 t -147.26 120.08 8.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 114.632 -2.827 . . . . 0.0 109.151 158.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 115.623 -2.431 . . . . 0.0 106.768 174.629 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.09 -124.44 2.77 Favored Glycine 0 CA--C 1.555 2.559 0 C-N-CA 114.449 -3.739 . . . . 0.0 110.513 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 mt -104.49 98.14 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 114.781 -2.768 . . . . 0.0 109.812 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.27 -69.15 3.05 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 114.843 -3.551 . . . . 0.0 111.298 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.48 166.41 20.36 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 115.316 -2.553 . . . . 0.0 108.882 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -123.46 150.18 44.18 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 115.351 -2.54 . . . . 0.0 109.503 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -120.93 124.27 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 115.158 -2.617 . . . . 0.0 108.888 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.8 m -109.69 146.56 34.65 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 116.337 -2.145 . . . . 0.0 108.02 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 1.389 ' N ' ' CB ' ' A' ' 60' ' ' HIS . 4.3 m -109.52 103.22 12.07 Favored 'General case' 1 N--CA 1.558 4.963 0 C-N-CA 116.788 -1.965 . . . . 0.0 112.071 175.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.106 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 90.2 m -60.83 143.38 54.84 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 115.913 -2.315 . . . . 0.0 107.86 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.2 166.95 15.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.548 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.45 96.57 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 115.711 -2.396 . . . . 0.0 108.822 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.38 -39.71 0.61 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 114.898 -3.525 . . . . 0.0 108.384 -168.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.22 166.81 11.27 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 115.441 -2.503 . . . . 0.0 108.305 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -157.64 112.78 2.73 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 115.091 -2.644 . . . . 0.0 109.229 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.58 174.78 35.5 Favored Glycine 0 C--O 1.212 -1.276 0 C-N-CA 114.472 -3.728 . . . . 0.0 111.223 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -45.32 -58.02 3.6 Favored 'General case' 0 N--CA 1.398 -3.027 0 C-N-CA 115.994 -2.282 . . . . 0.0 111.458 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.697 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 39.2 m-20 -106.28 18.09 22.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 114.924 -2.71 . . . . 0.0 109.121 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.106 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.9 m 76.34 18.56 1.82 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 115.662 -2.415 . . . . 0.0 108.708 -174.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.93 -32.59 73.91 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 116.865 -1.934 . . . . 0.0 110.273 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -91.32 168.02 11.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 115.216 -2.594 . . . . 0.0 110.387 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 89.9 p -117.64 154.76 31.04 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 115.616 -2.434 . . . . 0.0 108.816 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.2 p -91.38 33.96 0.97 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 114.547 -2.861 . . . . 0.0 110.475 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 116.226 -2.189 . . . . 0.0 108.55 179.238 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -139.72 161.68 36.96 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 115.626 -2.43 . . . . 0.0 108.824 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.34 -74.66 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.604 0 C-N-CA 116.158 -2.925 . . . . 0.0 109.718 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -127.09 111.86 14.51 Favored 'General case' 0 C--N 1.381 1.974 0 O-C-N 120.158 -1.789 . . . . 0.0 110.369 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 49' ' ' GLN . 3.3 mp0 -96.51 0.06 49.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 114.709 -2.796 . . . . 0.0 110.073 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.9 t -126.8 18.15 7.32 Favored 'General case' 0 N--CA 1.508 2.437 0 C-N-CA 115.629 -2.429 . . . . 0.0 108.943 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -74.99 33.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 116.318 -2.153 . . . . 0.0 111.068 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -151.42 29.26 0.96 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 114.098 -3.906 . . . . 0.0 110.347 175.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 49.72 80.81 0.28 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.144 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.92 -35.53 0.14 Allowed 'Trans proline' 0 N--CA 1.404 -3.778 0 C-N-CA 121.334 1.356 . . . . 0.0 110.994 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.163 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.1 m -79.52 143.48 34.82 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 115.115 -2.634 . . . . 0.0 111.213 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.599 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.3 mt -102.44 175.02 5.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.512 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 30.02 62.95 0.17 Allowed 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 116.859 -1.936 . . . . 0.0 111.979 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 56.92 83.37 0.1 Allowed 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 117.089 -1.844 . . . . 0.0 109.272 170.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.72 161.44 20.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 115.75 -3.119 . . . . 0.0 109.536 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.529 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 43.4 t-80 -91.01 155.41 18.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 116.395 -2.122 . . . . 0.0 108.317 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 50.7 t -131.6 126.73 35.48 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 114.77 -2.772 . . . . 0.0 110.927 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 114.578 -2.849 . . . . 0.0 108.196 176.319 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.48 -94.69 0.1 Allowed Glycine 0 N--CA 1.473 1.107 0 C-N-CA 114.431 -3.747 . . . . 0.0 111.377 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.2 mt -109.26 58.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 114.658 -2.817 . . . . 0.0 108.524 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.64 -55.02 3.81 Favored Glycine 0 N--CA 1.478 1.469 0 C-N-CA 114.673 -3.632 . . . . 0.0 112.269 173.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.711 ' C ' ' CD1' ' A' ' 68' ' ' TYR . 5.9 p-10 -80.55 -19.46 45.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 115.845 -2.342 . . . . 0.0 112.059 -174.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.711 ' CD1' ' C ' ' A' ' 67' ' ' ASP . 38.7 p90 51.36 166.5 0.01 OUTLIER 'General case' 1 C--N 1.218 -5.113 0 CA-C-N 111.478 -2.601 . . . . 0.0 112.727 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -141.43 129.33 21.84 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 116.13 -2.228 . . . . 0.0 108.905 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.163 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -100.74 127.25 47.23 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.569 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.529 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -94.97 149.95 20.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.91 -2.316 . . . . 0.0 109.49 176.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.102 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 84.4 m -99.27 156.35 17.03 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 115.132 -2.627 . . . . 0.0 109.299 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.47 164.57 26.48 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 115.371 -2.532 . . . . 0.0 109.455 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.82 102.98 0.39 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 115.014 -2.675 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.0 -33.3 1.38 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 114.502 -3.713 . . . . 0.0 110.201 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.69 164.41 12.77 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 116.082 -2.247 . . . . 0.0 109.162 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -159.38 118.49 2.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 115.618 -2.433 . . . . 0.0 109.225 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 169.79 170.11 33.84 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 114.29 -3.814 . . . . 0.0 110.288 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 85.1 tttt -41.0 -54.67 2.72 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 115.648 -2.421 . . . . 0.0 110.711 176.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.642 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 61.4 m-20 -110.83 15.81 21.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 115.731 -2.388 . . . . 0.0 109.862 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.102 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.1 m 74.01 28.34 1.5 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 115.092 -2.643 . . . . 0.0 109.338 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -70.08 -31.51 69.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 116.245 -2.182 . . . . 0.0 110.523 -177.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.81 147.45 23.79 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 114.708 -2.797 . . . . 0.0 109.954 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -110.4 115.71 30.13 Favored 'General case' 0 C--O 1.256 1.425 0 C-N-CA 115.95 -2.3 . . . . 0.0 107.88 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.7 t -97.13 33.39 1.95 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 115.175 -2.61 . . . . 0.0 111.937 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 . . . . . 0 CA--C 1.469 -2.142 0 C-N-CA 115.685 -2.406 . . . . 0.0 111.045 -177.857 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.41 ' HZ2' ' NZ ' ' A' ' 45' ' ' LYS . 23.1 pttm . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -122.31 91.53 3.52 Favored 'General case' 0 C--O 1.3 3.729 1 C-N-CA 110.684 -4.407 . . . . 0.0 108.511 -175.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.62 174.4 48.1 Favored Glycine 0 C--N 1.374 2.664 0 C-N-CA 115.234 -3.365 . . . . 0.0 111.493 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -119.54 119.59 34.26 Favored 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 114.586 -2.846 . . . . 0.0 111.173 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 3.4 mp0 -104.53 7.13 35.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 115.985 -2.286 . . . . 0.0 111.173 -177.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.6 t -128.33 8.48 6.01 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 116.201 -2.2 . . . . 0.0 110.226 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.76 24.32 0.06 Allowed 'General case' 0 C--O 1.249 1.075 0 C-N-CA 115.49 -2.484 . . . . 0.0 112.044 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -144.72 23.74 1.98 Allowed Glycine 0 C--N 1.341 0.836 0 C-N-CA 114.559 -3.686 . . . . 0.0 111.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 45.78 78.63 0.38 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 115.98 -2.288 . . . . 0.0 110.223 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.68 -33.77 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 N-CA-C 110.071 -0.781 . . . . 0.0 110.071 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.112 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.2 m -76.35 152.52 36.32 Favored 'General case' 0 C--O 1.261 1.667 0 C-N-CA 116.159 -2.216 . . . . 0.0 109.568 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.2 mt -105.3 171.6 7.24 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 116.782 -1.967 . . . . 0.0 109.958 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 56' ' ' LEU . 27.8 m-80 36.17 61.45 0.77 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 117.566 -1.653 . . . . 0.0 111.734 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.434 ' NE2' ' H ' ' A' ' 58' ' ' GLN . 2.8 mp0 48.68 51.21 16.03 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 115.664 -2.414 . . . . 0.0 110.109 172.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.6 171.6 45.57 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 114.702 -3.618 . . . . 0.0 109.737 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -88.67 145.95 25.36 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.212 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 51.9 t -134.03 124.64 26.57 Favored 'General case' 0 N--CA 1.417 -2.081 0 C-N-CA 115.449 -2.5 . . . . 0.0 109.126 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.1 tptt . . . . . 0 C--O 1.252 1.205 0 C-N-CA 115.578 -2.449 . . . . 0.0 109.454 -179.881 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.13 -131.09 3.45 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 115.613 -3.184 . . . . 0.0 111.183 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 57.2 mt -87.86 90.48 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 113.724 -3.19 . . . . 0.0 108.038 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 78.77 -72.31 2.44 Favored Glycine 0 N--CA 1.496 2.679 1 C-N-CA 113.859 -4.019 . . . . 0.0 109.257 -178.044 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -72.23 166.25 22.79 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 115.746 -2.382 . . . . 0.0 109.706 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -115.91 163.72 15.47 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 116.303 -2.159 . . . . 0.0 109.568 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 p -128.99 135.25 48.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 115.108 -2.637 . . . . 0.0 109.333 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.112 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 94.9 m -113.43 124.24 51.95 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.382 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.75 122.2 46.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 116.163 -2.215 . . . . 0.0 110.072 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.164 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.3 m -72.91 150.2 42.78 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 114.904 -2.718 . . . . 0.0 110.178 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 169.18 15.55 Favored 'General case' 0 C--O 1.254 1.338 0 C-N-CA 115.622 -2.431 . . . . 0.0 109.984 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.07 105.89 0.76 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 114.859 -2.736 . . . . 0.0 109.952 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.78 -40.56 1.08 Allowed Glycine 0 C--O 1.213 -1.194 0 C-N-CA 115.32 -3.324 . . . . 0.0 110.325 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.19 163.07 15.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 115.475 -2.49 . . . . 0.0 110.099 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -155.49 125.37 6.53 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 115.234 -2.586 . . . . 0.0 109.374 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 160.74 166.86 20.34 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.372 -4.251 . . . . 0.0 111.164 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 22.8 tptm -39.59 -53.72 2.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 116.403 -2.119 . . . . 0.0 109.449 175.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.662 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 41.8 m-20 -113.44 11.91 18.58 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 116.355 -2.138 . . . . 0.0 109.649 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.164 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.4 m 74.39 31.75 1.01 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.094 -2.642 . . . . 0.0 109.571 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.92 -36.25 79.84 Favored 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 116.474 -2.09 . . . . 0.0 110.243 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -89.45 145.85 25.04 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 114.941 -2.704 . . . . 0.0 109.53 -171.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.6 p -113.41 133.26 55.28 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 115.874 -2.33 . . . . 0.0 107.914 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.1 p -95.0 36.84 1.17 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 115.994 -2.282 . . . . 0.0 110.104 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.1 mtm-85 . . . . . 0 CA--C 1.556 1.18 0 C-N-CA 115.373 -2.531 . . . . 0.0 108.639 179.856 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.458 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 2.8 mp0 -98.01 -10.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 116.09 -2.244 . . . . 0.0 109.516 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 45.6 t -113.06 10.93 18.82 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 114.92 -2.712 . . . . 0.0 109.611 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -75.24 19.18 0.17 Allowed 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 115.107 -2.637 . . . . 0.0 111.418 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.68 27.8 3.65 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 114.67 -3.633 . . . . 0.0 111.337 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 48.86 73.94 0.91 Allowed Pre-proline 0 N--CA 1.498 1.943 0 C-N-CA 117.256 -1.778 . . . . 0.0 111.043 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.53 -35.35 1.16 Allowed 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 121.108 1.206 . . . . 0.0 110.686 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.2 m -89.11 148.72 23.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.735 -2.386 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.504 ' O ' ' C ' ' A' ' 57' ' ' ASN . 79.4 mt -100.91 174.5 5.99 Favored 'General case' 0 C--O 1.268 2.049 0 C-N-CA 116.191 -2.203 . . . . 0.0 108.814 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 56' ' ' LEU . 7.0 m-80 34.27 68.57 0.18 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 118.167 -1.413 . . . . 0.0 111.477 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.485 ' C ' ' O ' ' A' ' 57' ' ' ASN . 11.3 pt20 36.51 54.09 1.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.669 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.21 178.09 41.68 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 115.623 -3.18 . . . . 0.0 109.573 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.511 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 45.4 t60 -89.8 136.96 32.73 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 115.436 -2.505 . . . . 0.0 108.437 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.68 129.02 30.02 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 115.287 -2.565 . . . . 0.0 109.237 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 115.661 -2.416 . . . . 0.0 108.121 174.678 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.396 0 CA-C-O 121.918 0.732 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 65' ' ' ILE . 28.2 mt -114.3 55.65 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 114.612 -2.835 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.7 -61.34 2.04 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 114.177 -3.868 . . . . 0.0 111.225 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' O ' ' O ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -78.92 3.74 16.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 115.721 -2.392 . . . . 0.0 110.07 -174.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.571 ' O ' ' O ' ' A' ' 67' ' ' ASP . 53.1 p90 39.68 179.04 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.191 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 p -139.74 145.8 38.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 115.946 -2.302 . . . . 0.0 107.694 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 25.2 m -131.56 119.12 21.04 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 114.955 -2.698 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -108.23 153.31 23.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 116.199 -2.2 . . . . 0.0 108.876 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 85.8 m -98.02 148.51 23.43 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 115.943 -2.303 . . . . 0.0 109.846 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.61 27.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 115.26 -2.576 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.64 102.28 0.71 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 114.902 -2.719 . . . . 0.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.22 -43.91 0.65 Allowed Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 115.411 -3.28 . . . . 0.0 108.902 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.91 155.96 18.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 116.308 -2.157 . . . . 0.0 109.502 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -146.74 142.82 28.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.855 -2.338 . . . . 0.0 108.936 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 140.68 166.82 10.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 114.174 -3.869 . . . . 0.0 109.605 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 78' ' ' GLY . 53.0 tptt -42.4 -54.36 3.85 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.664 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.607 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 21.7 m-20 -109.26 14.34 23.84 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.942 -1.903 . . . . 0.0 109.492 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 4.0 m 72.24 25.17 2.93 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 115.262 -2.575 . . . . 0.0 108.839 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -71.64 -30.38 65.69 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.928 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 . . . . . 0 CA--C 1.506 -0.714 0 C-N-CA 115.918 -2.313 . . . . 0.0 109.021 -177.3 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.928 0.871 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 15.7 mp0 -94.67 -23.84 17.42 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 116.634 -2.026 . . . . 0.0 108.466 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 41.9 t -90.62 20.98 4.24 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 115.702 -2.399 . . . . 0.0 110.422 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.97 26.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.758 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -139.27 19.9 3.02 Favored Glycine 0 C--N 1.319 -0.375 0 C-N-CA 114.782 -3.58 . . . . 0.0 110.289 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.496 ' C ' ' O ' ' A' ' 52' ' ' GLY . 51.5 t60 40.66 72.97 0.93 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 116.797 -1.961 . . . . 0.0 109.809 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 5.1 Cg_exo -81.21 -37.02 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.607 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.9 m -77.68 143.92 37.75 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 114.797 -2.761 . . . . 0.0 111.499 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.653 ' O ' ' C ' ' A' ' 57' ' ' ASN . 83.9 mt -103.43 178.15 4.64 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 116.296 -2.161 . . . . 0.0 110.426 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 56' ' ' LEU . 37.1 m-80 27.81 60.73 0.11 Allowed 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 118.188 -1.405 . . . . 0.0 111.539 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 48.3 tt0 66.87 73.05 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 116.681 -2.007 . . . . 0.0 111.771 168.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.03 160.16 17.57 Favored Glycine 0 C--N 1.363 2.031 1 C-N-CA 112.592 -4.623 . . . . 0.0 110.377 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -88.51 108.94 19.66 Favored 'General case' 0 C--O 1.254 1.29 0 C-N-CA 114.497 -2.881 . . . . 0.0 108.121 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 23.6 p -88.79 112.14 22.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.08 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.8 tptt . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 115.26 -2.576 . . . . 0.0 107.963 177.61 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.205 0 CA-C-O 123.347 1.526 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -92.39 87.22 2.4 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.882 0 C-N-CA 117.036 -1.866 . . . . 0.0 108.568 178.502 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.37 -67.18 3.12 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 114.285 -3.817 . . . . 0.0 111.062 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -74.72 164.5 26.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 116.04 -2.264 . . . . 0.0 110.096 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -129.37 162.14 28.7 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 116.367 -2.133 . . . . 0.0 108.87 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.3 p -132.79 142.52 49.04 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.199 -2.6 . . . . 0.0 109.636 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.0 m -106.1 119.73 39.97 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 115.134 -2.626 . . . . 0.0 109.201 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.29 126.09 41.25 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 115.832 -2.347 . . . . 0.0 109.233 173.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 35.7 m -82.27 158.39 23.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 114.529 -2.868 . . . . 0.0 110.208 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.33 166.9 22.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 115.181 -2.607 . . . . 0.0 108.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.13 112.24 1.83 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 114.585 -2.846 . . . . 0.0 109.202 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.96 -47.49 0.8 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 114.431 -3.747 . . . . 0.0 110.452 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 97.7 m-85 -104.95 167.5 9.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 115.805 -2.358 . . . . 0.0 109.903 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -158.18 -0.69 0.1 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 115.398 -2.521 . . . . 0.0 111.865 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . -63.8 168.51 23.1 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 115.696 -3.145 . . . . 0.0 110.649 175.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -47.71 -52.61 17.78 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.721 -1.992 . . . . 0.0 108.667 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.702 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 50.5 m-20 -93.7 16.84 12.98 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 115.017 -2.673 . . . . 0.0 107.39 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 14.6 m 76.21 23.57 1.21 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 116.079 -2.248 . . . . 0.0 108.443 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.12 -32.51 67.02 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 115.025 -2.67 . . . . 0.0 110.411 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 . . . . . 0 N--CA 1.473 0.716 0 C-N-CA 115.836 -2.345 . . . . 0.0 109.041 -178.525 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 . . . . . 0 C--O 1.203 -1.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 91.3 mm-40 -79.17 -15.82 57.53 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 116.563 -2.055 . . . . 0.0 109.025 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 30.5 p -98.78 18.25 17.45 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 115.539 -2.464 . . . . 0.0 109.25 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -74.25 30.37 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 116.661 -2.016 . . . . 0.0 111.121 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -141.66 28.1 2.31 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 114.478 -3.725 . . . . 0.0 110.462 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' GLY . 72.5 m80 43.62 76.37 0.54 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 115.263 -2.575 . . . . 0.0 110.643 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -89.14 -32.99 0.11 Allowed 'Trans proline' 0 N--CA 1.427 -2.414 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 3.7 m -83.2 156.32 23.26 Favored 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 115.088 -2.645 . . . . 0.0 110.894 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.546 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.3 mt -98.6 173.16 7.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 117.009 -1.877 . . . . 0.0 108.703 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.546 ' C ' ' O ' ' A' ' 56' ' ' LEU . 21.1 m-80 36.99 60.04 1.02 Allowed 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 116.148 -2.221 . . . . 0.0 112.66 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 55.55 31.37 17.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 117.469 -1.693 . . . . 0.0 113.296 166.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.92 158.31 53.11 Favored Glycine 0 N--CA 1.504 3.185 1 C-N-CA 113.353 -4.261 . . . . 0.0 110.405 172.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.448 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 7.6 t-160 -88.38 172.01 9.71 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 115.204 -2.599 . . . . 0.0 109.48 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 30.9 p -139.95 122.76 16.49 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 114.592 -2.843 . . . . 0.0 109.31 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 115.171 -2.611 . . . . 0.0 108.972 176.419 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 CA-C-O 122.799 1.221 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.17 93.28 2.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 C-N-CA 114.86 -2.736 . . . . 0.0 107.741 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 89.36 -69.16 2.59 Favored Glycine 0 CA--C 1.548 2.133 0 C-N-CA 114.437 -3.744 . . . . 0.0 110.076 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -77.76 170.02 17.29 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 115.433 -2.507 . . . . 0.0 109.527 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -132.11 158.24 42.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.166 -2.214 . . . . 0.0 109.572 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -127.36 133.84 50.01 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 116.39 -2.124 . . . . 0.0 108.364 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.3 m -104.97 132.7 50.88 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.742 -2.783 . . . . 0.0 109.909 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -104.72 148.72 26.28 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 115.83 -2.348 . . . . 0.0 109.701 175.311 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.905 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 64.7 m -110.91 143.41 41.59 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 116.298 -2.161 . . . . 0.0 108.8 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.499 ' HB3' ' CD2' ' A' ' 76' ' ' PHE . . . -76.34 170.27 16.67 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 115.392 -2.523 . . . . 0.0 110.173 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.82 140.04 58.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 116.163 -2.215 . . . . 0.0 108.987 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.71 -21.19 43.27 Favored Glycine 0 N--CA 1.427 -1.957 1 C-N-CA 113.474 -4.203 . . . . 0.0 109.904 -174.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.499 ' CD2' ' HB3' ' A' ' 73' ' ' ALA . 65.7 m-85 -133.22 143.32 49.06 Favored 'General case' 0 CA--C 1.471 -2.065 0 C-N-CA 114.725 -2.79 . . . . 0.0 110.051 -170.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.576 ' C ' ' HA ' ' A' ' 81' ' ' CYS . 2.0 pt-20 -164.99 173.36 11.66 Favored 'General case' 1 N--CA 1.367 -4.619 0 C-N-CA 113.843 -3.143 . . . . 0.0 112.775 165.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 139.33 178.2 16.29 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 114.698 -3.62 . . . . 0.0 110.158 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 78' ' ' GLY . 29.1 ttpp -41.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 116.433 -2.107 . . . . 0.0 108.871 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.648 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 57.2 m-20 -118.28 24.49 10.92 Favored 'General case' 0 C--O 1.207 -1.167 0 C-N-CA 115.556 -2.458 . . . . 0.0 109.466 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.905 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.7 m 76.87 39.25 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 115.299 -2.56 . . . . 0.0 106.99 -170.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -88.25 -28.96 20.78 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 116.358 -2.137 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 77' ' ' GLU . 65.4 m-85 . . . . . 0 N--CA 1.483 1.214 0 C-N-CA 114.984 -2.687 . . . . 0.0 108.994 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 49' ' ' GLN . 31.2 t70 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.498 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 2.9 mp0 31.79 33.92 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 117.499 -1.681 . . . . 0.0 113.493 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.2 t -166.87 27.0 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 115.94 -2.304 . . . . 0.0 108.715 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -76.18 24.23 0.14 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 115.682 -2.407 . . . . 0.0 111.24 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -146.06 24.31 1.75 Allowed Glycine 0 N--CA 1.484 1.897 0 C-N-CA 114.062 -3.923 . . . . 0.0 110.56 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 22.2 t-160 42.79 78.37 0.39 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.299 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.51 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 5.0 Cg_exo -82.12 -33.83 0.53 Allowed 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 121.035 1.157 . . . . 0.0 110.961 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.072 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.6 m -75.85 149.27 37.87 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 115.39 -2.524 . . . . 0.0 110.464 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' O ' ' C ' ' A' ' 57' ' ' ASN . 70.7 mt -97.91 174.03 6.78 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 116.114 -2.234 . . . . 0.0 109.746 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.59 ' C ' ' O ' ' A' ' 56' ' ' LEU . 21.5 m-80 33.76 57.29 0.57 Allowed 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 115.845 -2.342 . . . . 0.0 114.118 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 56.62 41.99 27.69 Favored 'General case' 0 N--CA 1.515 2.811 0 C-N-CA 116.047 -2.261 . . . . 0.0 111.749 168.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.47 54.87 Favored Glycine 0 N--CA 1.444 -0.771 1 C-N-CA 113.653 -4.118 . . . . 0.0 110.125 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -93.36 133.12 36.94 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 114.65 -2.82 . . . . 0.0 109.438 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 88.4 m -98.43 105.49 17.64 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 114.742 -2.783 . . . . 0.0 107.338 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 N--CA 1.48 1.058 0 C-N-CA 115.513 -2.475 . . . . 0.0 107.696 176.425 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.605 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.74 85.02 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 C-N-CA 114.767 -2.773 . . . . 0.0 109.034 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.1 -60.56 4.58 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 115.803 -3.094 . . . . 0.0 110.932 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.98 167.52 21.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.554 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.53 159.1 44.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 114.748 -2.781 . . . . 0.0 108.923 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -137.04 132.25 33.94 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 115.146 -2.622 . . . . 0.0 108.395 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.072 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.8 m -91.46 129.09 37.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 116.059 -2.256 . . . . 0.0 109.761 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.3 m -107.46 106.07 16.29 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 114.827 -2.749 . . . . 0.0 109.677 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 77' ' ' GLU . 34.3 m -68.81 142.45 54.87 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 115.473 -2.491 . . . . 0.0 109.95 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.54 169.2 18.7 Favored 'General case' 0 C--O 1.26 1.649 0 C-N-CA 115.503 -2.479 . . . . 0.0 111.69 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.71 143.25 31.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 115.691 -2.404 . . . . 0.0 109.783 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.16 -23.73 34.84 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 115.11 -3.424 . . . . 0.0 110.292 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -131.48 143.87 50.73 Favored 'General case' 0 N--CA 1.407 -2.578 0 C-N-CA 114.484 -2.887 . . . . 0.0 110.243 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.579 ' C ' ' HA ' ' A' ' 81' ' ' CYS . 2.0 pt-20 -164.85 178.07 7.45 Favored 'General case' 1 N--CA 1.37 -4.461 0 C-N-CA 112.766 -3.574 . . . . 0.0 112.747 164.223 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 133.25 175.51 13.99 Favored Glycine 0 N--CA 1.484 1.864 0 C-N-CA 115.308 -3.33 . . . . 0.0 109.745 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.8 tttp -38.66 -52.21 1.66 Allowed 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 116.147 -2.221 . . . . 0.0 110.622 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 61.9 m-20 -119.55 20.39 12.41 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 116.412 -2.115 . . . . 0.0 108.471 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 4.5 m 79.57 43.66 0.06 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 115.884 -2.326 . . . . 0.0 107.816 -171.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -92.0 -30.5 16.03 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.549 -2.06 . . . . 0.0 109.468 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' A' ' 77' ' ' GLU . 59.1 m-85 . . . . . 0 CA--C 1.465 -2.299 0 C-N-CA 115.55 -2.46 . . . . 0.0 107.179 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 94.6 mm-40 -83.0 13.83 3.74 Favored 'General case' 0 C--O 1.257 1.47 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.775 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 25.6 t -140.37 22.8 2.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 115.407 -2.517 . . . . 0.0 109.892 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.79 30.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 115.318 -2.553 . . . . 0.0 112.071 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.97 27.84 0.58 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 114.037 -3.935 . . . . 0.0 110.218 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.1 m80 48.44 71.39 1.61 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 115.6 -2.44 . . . . 0.0 112.086 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -76.97 -31.15 3.98 Favored 'Trans proline' 0 N--CA 1.413 -3.258 0 C-N-CA 122.224 1.949 . . . . 0.0 109.091 -177.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 14.5 m -83.92 158.65 21.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.998 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 57' ' ' ASN . 62.9 mt -104.43 165.48 11.03 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 117.773 -1.571 . . . . 0.0 108.896 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.524 ' C ' ' O ' ' A' ' 56' ' ' LEU . 11.2 m120 34.28 63.73 0.41 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 118.181 -1.407 . . . . 0.0 111.552 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 53.88 59.03 4.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 115.4 -2.52 . . . . 0.0 111.553 169.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.23 170.69 52.81 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 114.223 -3.846 . . . . 0.0 110.91 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -97.09 104.96 17.03 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 115.383 -2.527 . . . . 0.0 108.124 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 53.5 t -95.25 118.57 32.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 114.372 -2.931 . . . . 0.0 109.676 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? . . . . . 0 C--O 1.215 -0.732 0 C-N-CA 116.356 -2.137 . . . . 0.0 108.032 174.559 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.71 100.1 9.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 115.305 -2.558 . . . . 0.0 108.762 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 86.07 -72.81 2.63 Favored Glycine 0 N--CA 1.477 1.386 0 C-N-CA 114.04 -3.933 . . . . 0.0 110.187 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.72 166.52 22.87 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.436 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -128.82 159.63 35.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 115.929 -2.308 . . . . 0.0 108.724 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.3 p -130.54 130.43 44.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 116.068 -2.253 . . . . 0.0 109.394 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 69.3 m -107.35 139.27 42.1 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 115.475 -2.49 . . . . 0.0 109.961 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.08 121.96 36.58 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 116.293 -2.163 . . . . 0.0 109.072 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 33.7 m -73.79 148.05 42.85 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 115.659 -2.416 . . . . 0.0 110.881 -176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.9 166.24 11.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 115.873 -2.331 . . . . 0.0 109.146 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -53.78 115.42 1.98 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.513 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.45 ' O ' ' CE1' ' A' ' 76' ' ' PHE . . . 136.27 -34.67 2.22 Favored Glycine 0 C--O 1.262 1.862 0 C-N-CA 115.007 -3.473 . . . . 0.0 110.363 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 81' ' ' CYS 0.266 28.9 m-85 -133.84 162.84 30.92 Favored 'General case' 0 CA--C 1.568 1.669 0 C-N-CA 118.145 -1.422 . . . . 0.0 107.686 -172.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.063 ' N ' ' O ' ' A' ' 83' ' ' PHE . 3.7 tm-20 -161.25 136.86 7.86 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 113.726 -3.19 . . . . 0.0 112.126 175.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 142.16 178.39 18.17 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 114.52 -3.705 . . . . 0.0 110.604 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' GLY . 62.9 tttm -46.84 -61.33 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 115.339 -2.544 . . . . 0.0 111.342 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.701 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 68.7 m-20 -93.09 5.35 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.1 m 79.91 72.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 115.927 -2.309 . . . . 0.0 106.972 -164.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -107.25 -29.82 9.1 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.002 -176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 1.063 ' O ' ' N ' ' A' ' 77' ' ' GLU . 80.8 m-85 . . . . . 0 C--O 1.19 -2.063 0 C-N-CA 116.904 -1.919 . . . . 0.0 108.049 164.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 . . . . . 0 CA--C 1.552 1.023 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -96.09 -8.56 33.03 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 116.207 -2.197 . . . . 0.0 108.49 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.198 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 18.3 t -102.25 -19.73 14.93 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.212 -2.595 . . . . 0.0 110.97 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -74.77 13.99 0.56 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 114.633 -2.827 . . . . 0.0 109.458 178.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -97.58 12.58 64.62 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 114.503 -3.713 . . . . 0.0 110.095 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.418 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 89.4 m-70 45.43 71.06 1.66 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 115.468 -2.493 . . . . 0.0 110.551 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.0 OUTLIER -84.47 -34.72 0.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.36 0 O-C-N 122.401 0.685 . . . . 0.0 110.674 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 m -92.63 156.26 17.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 116.219 -2.192 . . . . 0.0 109.945 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 57' ' ' ASN . 89.5 mt -103.04 176.29 5.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 116.645 -2.022 . . . . 0.0 109.308 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 56' ' ' LEU . 16.4 m-80 29.81 63.42 0.15 Allowed 'General case' 0 N--CA 1.4 -2.968 0 C-N-CA 116.801 -1.96 . . . . 0.0 113.11 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 51.51 55.75 8.93 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 115.734 -2.387 . . . . 0.0 110.721 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.93 172.24 55.17 Favored Glycine 0 CA--C 1.536 1.349 1 C-N-CA 113.463 -4.208 . . . . 0.0 109.346 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -90.83 87.7 6.76 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 115.276 -2.569 . . . . 0.0 108.795 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.198 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.6 t -89.0 125.12 34.85 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 115.852 -2.339 . . . . 0.0 109.558 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.9 tptt . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 115.863 -2.335 . . . . 0.0 107.985 176.366 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 123.11 1.395 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 67.2 mt -88.63 76.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 116.315 -2.154 . . . . 0.0 108.075 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.27 -68.74 3.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 115.16 -3.4 . . . . 0.0 109.982 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.59 165.5 24.98 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 115.914 -2.315 . . . . 0.0 110.407 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.85 157.42 23.32 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 115.312 -2.555 . . . . 0.0 109.186 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.4 p -124.88 134.27 52.76 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.099 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 90.6 m -108.56 132.33 53.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.728 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 123.41 40.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 115.887 -2.325 . . . . 0.0 109.226 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.8 m -75.08 143.99 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 115.373 -2.531 . . . . 0.0 109.724 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 170.06 15.36 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.612 -2.435 . . . . 0.0 110.292 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -59.12 132.38 53.86 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 115.931 -2.307 . . . . 0.0 109.075 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.41 -20.62 36.97 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 115.453 -3.26 . . . . 0.0 110.007 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.36 152.41 39.02 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 115.742 -2.383 . . . . 0.0 109.067 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -161.68 121.15 2.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.368 -2.533 . . . . 0.0 110.331 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 163.51 173.96 32.81 Favored Glycine 0 CA--C 1.55 2.259 1 C-N-CA 113.278 -4.296 . . . . 0.0 110.293 176.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 78' ' ' GLY . 14.6 tppt? -41.92 -55.69 3.02 Favored 'General case' 0 N--CA 1.417 -2.107 0 C-N-CA 115.881 -2.327 . . . . 0.0 110.896 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.699 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 47.8 m-20 -113.59 17.07 18.53 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.699 -2.401 . . . . 0.0 109.321 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.9 m 76.73 32.51 0.52 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 114.699 -2.8 . . . . 0.0 109.446 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.98 -30.15 62.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 115.165 -2.614 . . . . 0.0 109.735 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 . . . . . 0 N--CA 1.478 0.972 0 C-N-CA 116.022 -2.271 . . . . 0.0 110.387 -175.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 CA--C 1.571 1.768 0 CA-C-O 121.252 0.549 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 12.2 mp0 -94.11 -7.51 42.27 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 114.95 -2.7 . . . . 0.0 111.124 -171.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.7 t -125.08 12.25 8.31 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 115.31 -2.556 . . . . 0.0 110.452 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -75.41 17.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 113.909 -3.116 . . . . 0.0 110.444 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -117.38 17.82 12.29 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 115.554 -3.213 . . . . 0.0 109.537 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 44.07 74.7 0.74 Allowed Pre-proline 0 CA--C 1.568 1.66 0 C-N-CA 115.297 -2.561 . . . . 0.0 111.136 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.06 -40.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.974 0 C-N-CA 121.595 1.53 . . . . 0.0 110.051 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 m -74.97 152.96 38.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 115.175 -2.61 . . . . 0.0 108.842 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' ASN . 75.1 mt -103.9 170.8 7.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 116.464 -2.094 . . . . 0.0 108.877 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LEU . 8.8 m-80 33.81 62.41 0.43 Allowed 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.748 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 49.93 62.35 2.7 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.689 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.97 168.66 32.87 Favored Glycine 0 C--O 1.251 1.158 1 C-N-CA 113.511 -4.185 . . . . 0.0 110.088 172.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.402 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 8.0 t-80 -89.31 164.39 14.94 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.028 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 91.0 m -131.44 119.24 21.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 114.96 -2.696 . . . . 0.0 110.031 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.8 tptt . . . . . 0 C--O 1.25 1.09 0 C-N-CA 115.992 -2.283 . . . . 0.0 107.015 175.625 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.33 81.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 115.788 -2.365 . . . . 0.0 108.162 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.63 -59.19 3.7 Favored Glycine 0 C--N 1.343 0.944 1 C-N-CA 113.53 -4.176 . . . . 0.0 110.838 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.98 168.16 20.57 Favored 'General case' 0 C--O 1.259 1.597 0 C-N-CA 116.587 -2.045 . . . . 0.0 108.744 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.77 161.97 41.79 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 115.942 -2.303 . . . . 0.0 108.591 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 p -139.71 129.41 24.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 116.121 -2.232 . . . . 0.0 109.617 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 65.5 m -88.92 136.41 33.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 114.947 -2.701 . . . . 0.0 109.778 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -109.33 124.38 50.86 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 115.924 -2.31 . . . . 0.0 108.982 175.115 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 66.2 m -77.04 152.95 34.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.994 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.15 171.61 13.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 115.521 -2.471 . . . . 0.0 110.848 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.48 94.19 0.54 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 116.612 -2.035 . . . . 0.0 108.471 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.68 -30.06 0.93 Allowed Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 114.98 -3.486 . . . . 0.0 109.204 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -116.6 163.5 16.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 115.493 -2.483 . . . . 0.0 108.825 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -156.11 139.79 16.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 144.75 168.22 12.58 Favored Glycine 0 C--N 1.294 -1.766 1 C-N-CA 113.807 -4.044 . . . . 0.0 111.434 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 78' ' ' GLY . 39.1 ttpt -50.92 -54.71 21.78 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 115.556 -2.457 . . . . 0.0 109.957 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.724 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 70.7 m-20 -104.17 8.68 36.34 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.085 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.4 m 81.47 43.04 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 115.185 -2.606 . . . . 0.0 108.497 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.34 -18.23 42.88 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 115.455 -2.498 . . . . 0.0 109.854 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.5 2.066 0 C-N-CA 114.95 -2.7 . . . . 0.0 110.072 -178.124 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 . . . . . 0 N--CA 1.514 2.765 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 10.2 mp0 -97.99 -8.16 28.51 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.38 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.114 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.4 t -115.01 -10.76 12.21 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 115.238 -2.585 . . . . 0.0 111.288 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.99 20.17 0.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 116.003 -2.279 . . . . 0.0 111.26 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -132.31 24.9 3.91 Favored Glycine 0 C--N 1.311 -0.837 0 C-N-CA 114.344 -3.788 . . . . 0.0 111.294 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 49.62 84.13 0.21 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.96 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -95.47 -32.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.932 0 O-C-N 123.67 1.352 . . . . 0.0 109.115 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 34.1 m -81.56 163.01 22.94 Favored 'General case' 0 C--O 1.255 1.342 0 C-N-CA 114.007 -3.077 . . . . 0.0 110.937 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.523 ' O ' ' C ' ' A' ' 57' ' ' ASN . 94.5 mt -113.93 172.91 6.71 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 115.717 -2.393 . . . . 0.0 109.481 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER 43.05 49.58 5.38 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 116.881 -1.928 . . . . 0.0 110.334 172.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 57.62 48.22 14.57 Favored 'General case' 0 C--O 1.272 2.284 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.2 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.78 160.56 34.15 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 114.917 -3.516 . . . . 0.0 111.01 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -87.5 158.29 18.97 Favored 'General case' 0 C--N 1.275 -2.647 0 C-N-CA 115.219 -2.592 . . . . 0.0 109.02 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.114 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 38.9 t -144.84 128.33 17.0 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 114.14 -3.024 . . . . 0.0 111.305 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.7 tptp . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 115.666 -2.414 . . . . 0.0 108.149 175.169 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.311 0 CA-C-O 123.837 1.798 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.39 89.51 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 114.643 -2.823 . . . . 0.0 109.829 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.665 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 80.79 -68.68 3.35 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 115.232 -3.366 . . . . 0.0 110.156 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.83 -174.47 3.06 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 114.243 -2.983 . . . . 0.0 109.569 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -139.19 166.87 23.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 116.184 -2.206 . . . . 0.0 110.737 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 p -133.18 143.52 49.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.5 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.9 m -117.53 141.49 48.3 Favored 'General case' 0 C--O 1.213 -0.843 0 C-N-CA 113.595 -3.242 . . . . 0.0 110.143 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.59 162.27 13.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 115.525 -2.47 . . . . 0.0 108.139 172.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.824 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 74.0 m -111.08 154.81 23.73 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 114.293 -2.963 . . . . 0.0 108.366 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.13 165.45 20.34 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 113.783 -3.167 . . . . 0.0 110.704 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.22 97.64 0.19 Allowed 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.31 -2.556 . . . . 0.0 109.604 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.68 -42.98 0.59 Allowed Glycine 0 N--CA 1.428 -1.858 0 C-N-CA 114.667 -3.635 . . . . 0.0 109.435 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -105.09 166.6 10.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.181 -2.608 . . . . 0.0 108.7 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -159.04 123.24 3.95 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 114.941 -2.703 . . . . 0.0 109.46 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 162.68 167.21 22.77 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 116.345 -2.836 . . . . 0.0 111.338 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 78' ' ' GLY . 10.8 tmtt? -44.27 -55.53 4.82 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 116.3 -2.16 . . . . 0.0 110.125 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.779 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 26.3 m-20 -102.13 5.36 40.31 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 115.095 -2.642 . . . . 0.0 109.428 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.824 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 25.0 m 79.21 14.82 1.05 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 115.46 -2.496 . . . . 0.0 109.569 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.68 -27.01 47.79 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 115.434 -2.506 . . . . 0.0 111.693 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 C--N 1.315 -0.916 0 C-N-CA 115.404 -2.518 . . . . 0.0 110.3 -172.87 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--O 1.214 -0.781 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -98.68 -17.81 18.38 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 114.514 -2.875 . . . . 0.0 109.751 -174.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.445 ' C ' ' H ' ' A' ' 52' ' ' GLY . 36.8 t -82.65 -15.67 51.15 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 115.363 -2.535 . . . . 0.0 109.247 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.94 20.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 115.748 -2.381 . . . . 0.0 110.745 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -111.55 9.85 28.23 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 114.362 -3.78 . . . . 0.0 110.715 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.489 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 13.4 t-160 50.98 67.3 4.43 Favored Pre-proline 0 C--N 1.366 1.287 0 C-N-CA 116.41 -2.116 . . . . 0.0 109.067 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.2 Cg_endo -83.77 -30.46 0.77 Allowed 'Trans proline' 0 N--CA 1.419 -2.871 0 C-N-CA 121.071 1.181 . . . . 0.0 110.431 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.952 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.3 m -87.66 147.86 25.06 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 116.314 -2.154 . . . . 0.0 110.727 -175.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 57' ' ' ASN . 76.9 mt -94.85 172.7 8.0 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.472 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.557 ' C ' ' O ' ' A' ' 56' ' ' LEU . 16.8 m-80 32.68 61.83 0.36 Allowed 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 117.337 -1.745 . . . . 0.0 114.245 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 52.55 41.9 31.23 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.956 -1.498 . . . . 0.0 110.786 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.59 174.03 52.81 Favored Glycine 0 C--N 1.373 2.638 0 C-N-CA 113.946 -3.978 . . . . 0.0 109.008 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -88.76 147.95 24.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 115.123 -2.631 . . . . 0.0 108.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.9 t -140.18 123.99 17.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 115.699 -2.401 . . . . 0.0 110.599 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm . . . . . 0 CA--C 1.541 0.607 0 C-N-CA 115.374 -2.53 . . . . 0.0 108.791 176.244 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.463 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.5 mm -80.88 86.28 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 116.358 -2.137 . . . . 0.0 108.684 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.63 -72.32 2.0 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 114.323 -3.799 . . . . 0.0 110.158 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.25 167.89 19.45 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 115.214 -2.594 . . . . 0.0 109.493 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -113.3 152.72 29.52 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 115.757 -2.377 . . . . 0.0 109.075 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 114.897 -2.721 . . . . 0.0 109.469 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.952 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 63.0 m -105.14 137.22 43.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 115.933 -2.307 . . . . 0.0 109.854 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.96 114.01 20.38 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 116.89 -1.924 . . . . 0.0 108.532 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 32.4 m -71.97 145.15 48.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 116.505 -2.078 . . . . 0.0 108.996 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 169.04 14.05 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 116.264 -2.174 . . . . 0.0 110.063 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.73 145.81 6.49 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 115.92 -2.312 . . . . 0.0 110.214 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.72 -22.56 39.71 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 114.795 -3.574 . . . . 0.0 109.751 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.53 145.24 51.64 Favored 'General case' 0 CA--C 1.476 -1.899 0 C-N-CA 115.916 -2.314 . . . . 0.0 112.055 -173.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.6 ' C ' ' HA ' ' A' ' 81' ' ' CYS . 0.8 OUTLIER -165.56 174.53 9.8 Favored 'General case' 0 N--CA 1.399 -2.996 0 C-N-CA 114.066 -3.054 . . . . 0.0 112.632 164.027 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 137.76 171.74 12.29 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 116.507 -2.759 . . . . 0.0 110.642 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 78' ' ' GLY . 63.9 tttm -39.39 -52.81 2.05 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 116.976 -1.89 . . . . 0.0 110.179 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 67.6 m-20 -115.16 20.95 14.6 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 116.376 -2.129 . . . . 0.0 108.746 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.0 m 76.53 40.8 0.21 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 115.309 -2.556 . . . . 0.0 108.825 -171.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -88.87 -28.85 20.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 116.213 -2.195 . . . . 0.0 109.003 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 77' ' ' GLU . 62.9 m-85 . . . . . 0 CA--C 1.498 -1.04 0 C-N-CA 116.432 -2.107 . . . . 0.0 107.324 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 7.4 mp0 -96.14 -15.24 22.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 114.481 -2.887 . . . . 0.0 110.862 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.4 t -121.79 20.3 10.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 115.581 -2.447 . . . . 0.0 110.264 -175.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -74.98 33.21 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 116.567 -2.053 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -153.91 23.6 0.71 Allowed Glycine 0 N--CA 1.47 0.961 0 C-N-CA 114.411 -3.757 . . . . 0.0 110.997 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.8 t-160 47.15 75.17 0.69 Allowed Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 115.931 -2.308 . . . . 0.0 109.123 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.4 Cg_endo -82.49 -34.11 0.44 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 120.566 0.844 . . . . 0.0 111.123 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 10.6 m -71.57 164.1 26.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 115.636 -2.425 . . . . 0.0 109.403 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.7 mt -114.8 170.81 8.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 116.473 -2.091 . . . . 0.0 110.094 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.492 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 35.32 57.28 0.84 Allowed 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 115.811 -2.355 . . . . 0.0 114.732 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 56.7 mt-30 60.5 39.6 18.01 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.113 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 161.52 50.32 Favored Glycine 1 N--CA 1.521 4.352 1 C-N-CA 113.739 -4.077 . . . . 0.0 110.847 175.905 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -89.34 167.05 13.35 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 114.987 -2.685 . . . . 0.0 107.75 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 48.5 t -136.45 133.28 36.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 113.249 -3.38 . . . . 0.0 110.126 -172.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 115.702 -2.399 . . . . 0.0 107.635 175.645 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.01 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.16 88.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 115.544 -2.462 . . . . 0.0 107.234 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.75 -64.02 4.0 Favored Glycine 0 CA--C 1.545 1.966 0 C-N-CA 115.222 -3.37 . . . . 0.0 110.252 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -76.58 164.72 25.66 Favored 'General case' 0 C--O 1.26 1.629 0 C-N-CA 115.542 -2.463 . . . . 0.0 110.096 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -134.76 163.0 30.78 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 115.65 -2.42 . . . . 0.0 108.624 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 p -137.18 132.28 33.69 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.372 -2.531 . . . . 0.0 108.293 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 41.4 m -97.53 141.29 30.76 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 114.851 -2.74 . . . . 0.0 110.149 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 111.71 24.31 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 115.764 -2.375 . . . . 0.0 109.057 173.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.941 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.1 m -71.49 148.75 46.48 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 115.979 -2.288 . . . . 0.0 111.232 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.11 168.79 19.48 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 115.114 -2.635 . . . . 0.0 110.248 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.12 140.06 56.24 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 115.216 -2.594 . . . . 0.0 108.888 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.48 -14.91 61.75 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 116.317 -2.849 . . . . 0.0 110.425 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.17 150.18 49.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 116.268 -2.173 . . . . 0.0 110.334 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.73 130.87 11.11 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 115.72 -2.392 . . . . 0.0 108.755 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 154.15 163.36 11.84 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 114.314 -3.803 . . . . 0.0 110.993 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.9 tttm -43.83 -50.26 7.93 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.57 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 42.1 m-20 -110.62 10.98 22.9 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 116.001 -2.28 . . . . 0.0 110.33 175.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.941 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 21.9 m 78.01 30.58 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 116.067 -2.253 . . . . 0.0 108.237 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.44 -32.21 68.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.518 -2.073 . . . . 0.0 109.449 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--N 1.319 -0.728 0 C-N-CA 114.926 -2.71 . . . . 0.0 109.525 -176.498 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.475 0.775 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 7.7 mp0 -89.83 -9.61 48.45 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 116.656 -2.018 . . . . 0.0 109.539 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.466 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.3 t -116.37 1.82 13.09 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 114.425 -2.91 . . . . 0.0 109.979 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -74.99 20.33 0.13 Allowed 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 115.471 -2.492 . . . . 0.0 110.484 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -119.88 13.69 10.6 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 114.004 -3.951 . . . . 0.0 110.137 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 50.09 73.55 0.97 Allowed Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 116.878 -1.929 . . . . 0.0 111.237 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -83.48 -43.6 0.07 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.128 0 N-CA-C 110.082 -0.776 . . . . 0.0 110.082 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.986 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 2.8 m -85.41 147.41 26.51 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 115.387 -2.525 . . . . 0.0 110.05 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.58 ' O ' ' C ' ' A' ' 57' ' ' ASN . 61.2 mt -95.21 179.41 5.2 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 116.839 -1.944 . . . . 0.0 109.365 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.58 ' C ' ' O ' ' A' ' 56' ' ' LEU . 12.5 m-80 28.62 60.92 0.13 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.204 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 55.06 58.3 4.85 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 115.051 -2.66 . . . . 0.0 108.682 165.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.07 171.13 51.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 113.921 -3.99 . . . . 0.0 109.812 171.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -89.15 93.5 9.6 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 115.449 -2.5 . . . . 0.0 108.798 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.6 p -95.55 109.0 21.29 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 115.436 -2.506 . . . . 0.0 108.644 -171.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 tttp . . . . . 0 C--O 1.242 0.689 0 C-N-CA 115.917 -2.313 . . . . 0.0 107.879 176.756 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.475 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.6 mt -92.71 79.33 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 114.922 -2.711 . . . . 0.0 108.915 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 114.807 -3.568 . . . . 0.0 109.713 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.54 164.37 26.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 114.598 -2.841 . . . . 0.0 110.539 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -137.48 161.38 36.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.196 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -120.43 136.17 54.82 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 115.665 -2.414 . . . . 0.0 110.274 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.986 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 52.4 m -104.85 124.11 48.87 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 115.394 -2.523 . . . . 0.0 109.003 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 119.64 35.62 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 115.886 -2.326 . . . . 0.0 108.754 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 9.9 m -71.74 149.9 44.96 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 116.265 -2.174 . . . . 0.0 109.584 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.14 164.17 26.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 116.017 -2.273 . . . . 0.0 109.172 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.64 97.84 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 114.466 -2.893 . . . . 0.0 108.602 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.25 -33.32 0.65 Allowed Glycine 0 C--O 1.247 0.917 0 C-N-CA 115.357 -3.306 . . . . 0.0 110.227 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 96.2 m-85 -116.94 159.99 21.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 117.053 -1.859 . . . . 0.0 109.114 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.759 ' H ' ' HD1' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -159.7 -126.73 0.02 OUTLIER 'General case' 0 C--N 1.363 1.176 0 C-N-CA 114.212 -2.995 . . . . 0.0 109.653 166.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.411 ' N ' ' CZ ' ' A' ' 83' ' ' PHE . . . 68.58 -176.44 28.18 Favored Glycine 0 CA--C 1.554 2.509 1 C-N-CA 113.073 -4.394 . . . . 0.0 110.143 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -48.3 -61.17 2.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.901 -1.92 . . . . 0.0 113.616 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 81.8 m-20 -106.29 19.57 20.3 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 115.913 -2.315 . . . . 0.0 108.74 -171.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 10.3 m 73.1 46.6 0.23 Allowed 'General case' 0 C--O 1.252 1.195 0 C-N-CA 116.438 -2.105 . . . . 0.0 107.956 -167.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 77' ' ' GLU . 42.6 tt0 -90.24 -30.14 17.73 Favored 'General case' 0 C--O 1.261 1.672 0 C-N-CA 116.818 -1.953 . . . . 0.0 109.155 -170.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.759 ' HD1' ' H ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.379 -3.988 0 C-N-CA 112.298 -3.761 . . . . 0.0 108.758 -162.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.415 -2.202 0 CA-C-O 121.643 0.735 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 86.7 mm-40 -89.02 -19.35 25.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.294 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.4 t -95.53 11.9 31.43 Favored 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 115.302 -2.559 . . . . 0.0 108.652 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.98 26.61 0.07 Allowed 'General case' 0 C--O 1.258 1.533 0 C-N-CA 115.876 -2.33 . . . . 0.0 109.87 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -150.15 30.02 1.09 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 114.016 -3.945 . . . . 0.0 110.136 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 52' ' ' GLY . 21.8 t-160 40.31 83.87 0.19 Allowed Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 115.977 -2.289 . . . . 0.0 110.424 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -89.34 -27.12 0.38 Allowed 'Trans proline' 0 N--CA 1.426 -2.484 0 O-C-N 123.182 1.096 . . . . 0.0 111.547 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.937 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 m -94.16 166.64 12.02 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 114.314 -2.955 . . . . 0.0 110.415 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.1 mt -113.6 175.02 5.63 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 115.898 -2.321 . . . . 0.0 109.56 -177.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 56' ' ' LEU . 42.7 m-80 27.47 62.4 0.1 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.055 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 45.5 mt-30 58.9 47.33 12.56 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 125.248 1.593 . . . . 0.0 109.034 171.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.98 157.08 35.01 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 113.939 -3.981 . . . . 0.0 109.534 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -86.04 155.13 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 114.351 -2.94 . . . . 0.0 107.765 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.0 p -135.38 105.14 6.12 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.456 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp . . . . . 0 N--CA 1.486 1.37 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.338 177.739 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.363 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.26 94.0 2.07 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.477 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 80.11 -71.68 2.73 Favored Glycine 0 C--O 1.259 1.666 0 C-N-CA 115.889 -3.053 . . . . 0.0 112.297 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -77.83 174.53 10.92 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 114.288 -2.965 . . . . 0.0 109.697 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.95 160.96 37.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 116.383 -2.127 . . . . 0.0 108.718 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.1 p -131.3 140.82 49.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 114.479 -2.888 . . . . 0.0 108.592 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.937 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 55.8 m -100.44 128.91 46.37 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.463 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.32 119.71 40.3 Favored 'General case' 0 C--O 1.255 1.387 0 C-N-CA 116.018 -2.273 . . . . 0.0 108.481 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.2 m -72.46 155.93 39.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 114.854 -2.738 . . . . 0.0 109.169 -174.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 163.65 26.36 Favored 'General case' 0 C--O 1.25 1.104 0 C-N-CA 114.683 -2.807 . . . . 0.0 108.947 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.54 100.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 114.782 -2.767 . . . . 0.0 108.99 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.27 -42.27 0.65 Allowed Glycine 0 CA--C 1.546 2.031 0 C-N-CA 115.414 -3.279 . . . . 0.0 108.309 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.22 161.33 16.7 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 115.49 -2.484 . . . . 0.0 110.154 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -147.75 142.49 26.71 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 115.477 -2.489 . . . . 0.0 108.639 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.555 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 142.87 158.63 7.61 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 115.914 -3.041 . . . . 0.0 110.478 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 78' ' ' GLY . 38.7 ttmt -39.27 -50.55 1.99 Allowed 'General case' 0 C--O 1.187 -2.232 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.183 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.715 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 59.5 m-20 -107.83 -3.1 19.31 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 116.842 -1.943 . . . . 0.0 109.146 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.5 m 83.27 31.81 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 114.874 -2.73 . . . . 0.0 109.154 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.78 -30.29 63.99 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 116.511 -2.076 . . . . 0.0 109.896 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 115.079 -2.649 . . . . 0.0 108.87 -173.145 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.9 0.381 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -96.37 -34.17 11.65 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 116.393 -2.123 . . . . 0.0 110.219 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.05 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.8 t -93.78 20.59 7.4 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 116.43 -2.108 . . . . 0.0 109.516 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.18 23.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 114.879 -2.728 . . . . 0.0 110.969 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -147.2 23.38 1.57 Allowed Glycine 0 N--CA 1.472 1.079 0 C-N-CA 114.412 -3.756 . . . . 0.0 111.328 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 43.77 80.42 0.29 Allowed Pre-proline 0 CA--C 1.581 2.146 0 C-N-CA 116.84 -1.944 . . . . 0.0 111.123 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.19 -32.42 0.3 Allowed 'Trans proline' 0 N--CA 1.412 -3.272 0 C-N-CA 121.707 1.604 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 13.3 m -85.48 140.44 30.68 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 115.796 -2.362 . . . . 0.0 109.264 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.7 mt -101.63 168.7 9.31 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.777 -1.569 . . . . 0.0 110.719 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER 43.55 60.72 2.51 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 116.559 -2.056 . . . . 0.0 110.26 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 46.85 45.56 15.1 Favored 'General case' 1 C--N 1.441 4.571 0 C-N-CA 113.397 -3.321 . . . . 0.0 115.592 174.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 60' ' ' HIS . . . -77.46 -156.62 8.12 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 114.655 -3.641 . . . . 0.0 111.231 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 1.389 ' CB ' ' N ' ' A' ' 71' ' ' THR 0.428 0.0 OUTLIER -79.61 155.32 28.17 Favored 'General case' 1 N--CA 1.367 -4.62 0 CA-C-N 109.742 -3.229 . . . . 0.0 114.009 176.685 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.05 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.2 t -147.26 120.08 8.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 114.632 -2.827 . . . . 0.0 109.151 158.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 115.623 -2.431 . . . . 0.0 106.768 174.629 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.559 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 mt -104.49 98.14 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 114.781 -2.768 . . . . 0.0 109.812 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.27 -69.15 3.05 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 114.843 -3.551 . . . . 0.0 111.298 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.48 166.41 20.36 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 115.316 -2.553 . . . . 0.0 108.882 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -123.46 150.18 44.18 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 115.351 -2.54 . . . . 0.0 109.503 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -120.93 124.27 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 115.158 -2.617 . . . . 0.0 108.888 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.8 m -109.69 146.56 34.65 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 116.337 -2.145 . . . . 0.0 108.02 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 1.389 ' N ' ' CB ' ' A' ' 60' ' ' HIS . 4.3 m -109.52 103.22 12.07 Favored 'General case' 1 N--CA 1.558 4.963 0 C-N-CA 116.788 -1.965 . . . . 0.0 112.071 175.606 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 90.2 m -60.83 143.38 54.84 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 115.913 -2.315 . . . . 0.0 107.86 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.2 166.95 15.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.548 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.45 96.57 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 115.711 -2.396 . . . . 0.0 108.822 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.38 -39.71 0.61 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 114.898 -3.525 . . . . 0.0 108.384 -168.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.22 166.81 11.27 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 115.441 -2.503 . . . . 0.0 108.305 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 37.7 tt0 -157.64 112.78 2.73 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 115.091 -2.644 . . . . 0.0 109.229 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.58 174.78 35.5 Favored Glycine 0 C--O 1.212 -1.276 0 C-N-CA 114.472 -3.728 . . . . 0.0 111.223 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -45.32 -58.02 3.6 Favored 'General case' 0 N--CA 1.398 -3.027 0 C-N-CA 115.994 -2.282 . . . . 0.0 111.458 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.663 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 39.2 m-20 -106.28 18.09 22.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 114.924 -2.71 . . . . 0.0 109.121 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.9 m 76.34 18.56 1.82 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 115.662 -2.415 . . . . 0.0 108.708 -174.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.93 -32.59 73.91 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 116.865 -1.934 . . . . 0.0 110.273 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 77' ' ' GLU . 87.0 m-85 . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 115.216 -2.594 . . . . 0.0 110.387 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 119.575 -0.25 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 3.3 mp0 -96.51 0.06 49.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 114.709 -2.796 . . . . 0.0 110.073 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.155 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.9 t -126.8 18.15 7.32 Favored 'General case' 0 N--CA 1.508 2.437 0 C-N-CA 115.629 -2.429 . . . . 0.0 108.943 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -74.99 33.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 116.318 -2.153 . . . . 0.0 111.068 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.42 29.26 0.96 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 114.098 -3.906 . . . . 0.0 110.347 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 49.72 80.81 0.28 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.144 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -85.92 -35.53 0.14 Allowed 'Trans proline' 0 N--CA 1.404 -3.778 0 C-N-CA 121.334 1.356 . . . . 0.0 110.994 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.1 m -79.52 143.48 34.82 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 115.115 -2.634 . . . . 0.0 111.213 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.599 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.3 mt -102.44 175.02 5.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.512 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 30.02 62.95 0.17 Allowed 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 116.859 -1.936 . . . . 0.0 111.979 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 56.92 83.37 0.1 Allowed 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 117.089 -1.844 . . . . 0.0 109.272 170.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.72 161.44 20.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 115.75 -3.119 . . . . 0.0 109.536 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.554 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 43.4 t-80 -91.01 155.41 18.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 116.395 -2.122 . . . . 0.0 108.317 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.155 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 50.7 t -131.6 126.73 35.48 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 114.77 -2.772 . . . . 0.0 110.927 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 114.578 -2.849 . . . . 0.0 108.196 176.319 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.107 0 CA-C-O 122.107 0.837 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.2 mt -109.26 58.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 114.658 -2.817 . . . . 0.0 108.524 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.424 ' CA ' ' HG2' ' A' ' 49' ' ' GLN . . . 89.64 -55.02 3.81 Favored Glycine 0 N--CA 1.478 1.469 0 C-N-CA 114.673 -3.632 . . . . 0.0 112.269 173.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.711 ' C ' ' CD1' ' A' ' 68' ' ' TYR . 5.9 p-10 -80.55 -19.46 45.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 115.845 -2.342 . . . . 0.0 112.059 -174.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.711 ' CD1' ' C ' ' A' ' 67' ' ' ASP . 38.7 p90 51.36 166.5 0.01 OUTLIER 'General case' 1 C--N 1.218 -5.113 0 CA-C-N 111.478 -2.601 . . . . 0.0 112.727 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -141.43 129.33 21.84 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 116.13 -2.228 . . . . 0.0 108.905 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -100.74 127.25 47.23 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.569 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -94.97 149.95 20.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.91 -2.316 . . . . 0.0 109.49 176.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.898 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 84.4 m -99.27 156.35 17.03 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 115.132 -2.627 . . . . 0.0 109.299 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.47 164.57 26.48 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 115.371 -2.532 . . . . 0.0 109.455 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.82 102.98 0.39 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 115.014 -2.675 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.0 -33.3 1.38 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 114.502 -3.713 . . . . 0.0 110.201 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.69 164.41 12.77 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 116.082 -2.247 . . . . 0.0 109.162 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -159.38 118.49 2.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 115.618 -2.433 . . . . 0.0 109.225 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 169.79 170.11 33.84 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 114.29 -3.814 . . . . 0.0 110.288 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 85.1 tttt -41.0 -54.67 2.72 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 115.648 -2.421 . . . . 0.0 110.711 176.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.641 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 61.4 m-20 -110.83 15.81 21.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 115.731 -2.388 . . . . 0.0 109.862 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.898 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.1 m 74.01 28.34 1.5 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 115.092 -2.643 . . . . 0.0 109.338 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -70.08 -31.51 69.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 116.245 -2.182 . . . . 0.0 110.523 -177.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 114.708 -2.797 . . . . 0.0 109.954 -175.616 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 CA--C 1.574 1.903 0 CA-C-O 117.483 -1.246 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 3.4 mp0 -104.53 7.13 35.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 115.985 -2.286 . . . . 0.0 111.173 -177.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.6 t -128.33 8.48 6.01 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 116.201 -2.2 . . . . 0.0 110.226 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.76 24.32 0.06 Allowed 'General case' 0 C--O 1.249 1.075 0 C-N-CA 115.49 -2.484 . . . . 0.0 112.044 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -144.72 23.74 1.98 Allowed Glycine 0 C--N 1.341 0.836 0 C-N-CA 114.559 -3.686 . . . . 0.0 111.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 45.78 78.63 0.38 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 115.98 -2.288 . . . . 0.0 110.223 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.68 -33.77 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 N-CA-C 110.071 -0.781 . . . . 0.0 110.071 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.031 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.2 m -76.35 152.52 36.32 Favored 'General case' 0 C--O 1.261 1.667 0 C-N-CA 116.159 -2.216 . . . . 0.0 109.568 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.2 mt -105.3 171.6 7.24 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 116.782 -1.967 . . . . 0.0 109.958 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 56' ' ' LEU . 27.8 m-80 36.17 61.45 0.77 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 117.566 -1.653 . . . . 0.0 111.734 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 48.68 51.21 16.03 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 115.664 -2.414 . . . . 0.0 110.109 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.6 171.6 45.57 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 114.702 -3.618 . . . . 0.0 109.737 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -88.67 145.95 25.36 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.212 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 51.9 t -134.03 124.64 26.57 Favored 'General case' 0 N--CA 1.417 -2.081 0 C-N-CA 115.449 -2.5 . . . . 0.0 109.126 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.1 tptt . . . . . 0 C--O 1.252 1.205 0 C-N-CA 115.578 -2.449 . . . . 0.0 109.454 -179.881 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.631 0 CA-C-O 122.544 1.08 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 57.2 mt -87.86 90.48 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 113.724 -3.19 . . . . 0.0 108.038 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 78.77 -72.31 2.44 Favored Glycine 0 N--CA 1.496 2.679 1 C-N-CA 113.859 -4.019 . . . . 0.0 109.257 -178.044 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -72.23 166.25 22.79 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 115.746 -2.382 . . . . 0.0 109.706 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -115.91 163.72 15.47 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 116.303 -2.159 . . . . 0.0 109.568 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 p -128.99 135.25 48.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 115.108 -2.637 . . . . 0.0 109.333 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.031 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 94.9 m -113.43 124.24 51.95 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.382 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.75 122.2 46.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 116.163 -2.215 . . . . 0.0 110.072 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.813 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.3 m -72.91 150.2 42.78 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 114.904 -2.718 . . . . 0.0 110.178 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 169.18 15.55 Favored 'General case' 0 C--O 1.254 1.338 0 C-N-CA 115.622 -2.431 . . . . 0.0 109.984 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.07 105.89 0.76 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 114.859 -2.736 . . . . 0.0 109.952 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.78 -40.56 1.08 Allowed Glycine 0 C--O 1.213 -1.194 0 C-N-CA 115.32 -3.324 . . . . 0.0 110.325 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.19 163.07 15.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 115.475 -2.49 . . . . 0.0 110.099 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -155.49 125.37 6.53 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 115.234 -2.586 . . . . 0.0 109.374 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 160.74 166.86 20.34 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.372 -4.251 . . . . 0.0 111.164 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 22.8 tptm -39.59 -53.72 2.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 116.403 -2.119 . . . . 0.0 109.449 175.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.663 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 41.8 m-20 -113.44 11.91 18.58 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 116.355 -2.138 . . . . 0.0 109.649 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.813 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.4 m 74.39 31.75 1.01 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.094 -2.642 . . . . 0.0 109.571 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.92 -36.25 79.84 Favored 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 116.474 -2.09 . . . . 0.0 110.243 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 C--N 1.305 -1.352 0 C-N-CA 114.941 -2.704 . . . . 0.0 109.53 -171.983 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm . . . . . 0 C--O 1.173 -2.939 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -106.47 72.05 0.9 Allowed 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 115.81 -2.356 . . . . 0.0 108.875 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.36 -82.31 0.26 Allowed Glycine 0 C--N 1.385 3.285 1 C-N-CA 113.731 -4.08 . . . . 0.0 109.217 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -107.85 129.2 55.09 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 115.797 -2.361 . . . . 0.0 110.237 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.458 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 2.8 mp0 -98.01 -10.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 116.09 -2.244 . . . . 0.0 109.516 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 45.6 t -113.06 10.93 18.82 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 114.92 -2.712 . . . . 0.0 109.611 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -75.24 19.18 0.17 Allowed 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 115.107 -2.637 . . . . 0.0 111.418 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.68 27.8 3.65 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 114.67 -3.633 . . . . 0.0 111.337 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 48.86 73.94 0.91 Allowed Pre-proline 0 N--CA 1.498 1.943 0 C-N-CA 117.256 -1.778 . . . . 0.0 111.043 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.53 -35.35 1.16 Allowed 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 121.108 1.206 . . . . 0.0 110.686 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.2 m -89.11 148.72 23.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.735 -2.386 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.504 ' O ' ' C ' ' A' ' 57' ' ' ASN . 79.4 mt -100.91 174.5 5.99 Favored 'General case' 0 C--O 1.268 2.049 0 C-N-CA 116.191 -2.203 . . . . 0.0 108.814 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 56' ' ' LEU . 7.0 m-80 34.27 68.57 0.18 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 118.167 -1.413 . . . . 0.0 111.477 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.485 ' C ' ' O ' ' A' ' 57' ' ' ASN . 11.3 pt20 36.51 54.09 1.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.669 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.21 178.09 41.68 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 115.623 -3.18 . . . . 0.0 109.573 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.511 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 45.4 t60 -89.8 136.96 32.73 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 115.436 -2.505 . . . . 0.0 108.437 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.68 129.02 30.02 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 115.287 -2.565 . . . . 0.0 109.237 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 115.661 -2.416 . . . . 0.0 108.121 174.678 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.31 -92.12 0.09 OUTLIER Glycine 0 N--CA 1.477 1.396 0 C-N-CA 113.936 -3.983 . . . . 0.0 111.964 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 65' ' ' ILE . 28.2 mt -114.3 55.65 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 114.612 -2.835 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.7 -61.34 2.04 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 114.177 -3.868 . . . . 0.0 111.225 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' O ' ' O ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -78.92 3.74 16.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 115.721 -2.392 . . . . 0.0 110.07 -174.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.571 ' O ' ' O ' ' A' ' 67' ' ' ASP . 53.1 p90 39.68 179.04 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.191 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 p -139.74 145.8 38.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 115.946 -2.302 . . . . 0.0 107.694 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 25.2 m -131.56 119.12 21.04 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 114.955 -2.698 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -108.23 153.31 23.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 116.199 -2.2 . . . . 0.0 108.876 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 85.8 m -98.02 148.51 23.43 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 115.943 -2.303 . . . . 0.0 109.846 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.61 27.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 115.26 -2.576 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.64 102.28 0.71 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 114.902 -2.719 . . . . 0.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.22 -43.91 0.65 Allowed Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 115.411 -3.28 . . . . 0.0 108.902 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.91 155.96 18.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 116.308 -2.157 . . . . 0.0 109.502 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -146.74 142.82 28.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.855 -2.338 . . . . 0.0 108.936 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 140.68 166.82 10.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 114.174 -3.869 . . . . 0.0 109.605 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 78' ' ' GLY . 53.0 tptt -42.4 -54.36 3.85 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.664 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.607 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 21.7 m-20 -109.26 14.34 23.84 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.942 -1.903 . . . . 0.0 109.492 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 4.0 m 72.24 25.17 2.93 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 115.262 -2.575 . . . . 0.0 108.839 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -71.64 -30.38 65.69 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.928 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -88.44 144.23 26.5 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 115.918 -2.313 . . . . 0.0 109.021 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.9 p -111.32 150.05 30.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 115.683 -2.407 . . . . 0.0 108.094 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.6 p -86.9 38.23 0.79 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 114.462 -2.895 . . . . 0.0 110.946 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 C--O 1.19 -2.064 0 C-N-CA 117.037 -1.865 . . . . 0.0 109.846 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 89.2 mttt . . . . . 0 C--O 1.161 -3.571 0 CA-C-O 125.067 2.365 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.71 142.18 27.64 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 115.057 -2.657 . . . . 0.0 107.882 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.61 -157.48 7.77 Favored Glycine 0 CA--C 1.555 2.58 1 C-N-CA 112.625 -4.607 . . . . 0.0 114.037 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -110.04 121.0 44.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 115.674 -2.41 . . . . 0.0 109.58 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 15.7 mp0 -94.67 -23.84 17.42 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 116.634 -2.026 . . . . 0.0 108.466 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 41.9 t -90.62 20.98 4.24 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 115.702 -2.399 . . . . 0.0 110.422 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.97 26.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.758 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -139.27 19.9 3.02 Favored Glycine 0 C--N 1.319 -0.375 0 C-N-CA 114.782 -3.58 . . . . 0.0 110.289 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.496 ' C ' ' O ' ' A' ' 52' ' ' GLY . 51.5 t60 40.66 72.97 0.93 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 116.797 -1.961 . . . . 0.0 109.809 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 5.1 Cg_exo -81.21 -37.02 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.607 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.9 m -77.68 143.92 37.75 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 114.797 -2.761 . . . . 0.0 111.499 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.653 ' O ' ' C ' ' A' ' 57' ' ' ASN . 83.9 mt -103.43 178.15 4.64 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 116.296 -2.161 . . . . 0.0 110.426 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 56' ' ' LEU . 37.1 m-80 27.81 60.73 0.11 Allowed 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 118.188 -1.405 . . . . 0.0 111.539 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 48.3 tt0 66.87 73.05 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 116.681 -2.007 . . . . 0.0 111.771 168.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.03 160.16 17.57 Favored Glycine 0 C--N 1.363 2.031 1 C-N-CA 112.592 -4.623 . . . . 0.0 110.377 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -88.51 108.94 19.66 Favored 'General case' 0 C--O 1.254 1.29 0 C-N-CA 114.497 -2.881 . . . . 0.0 108.121 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 23.6 p -88.79 112.14 22.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.08 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.8 tptt . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 115.26 -2.576 . . . . 0.0 107.963 177.61 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.28 -135.93 3.33 Favored Glycine 0 CA--C 1.549 2.205 0 C-N-CA 114.133 -3.889 . . . . 0.0 110.127 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -92.39 87.22 2.4 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.882 0 C-N-CA 117.036 -1.866 . . . . 0.0 108.568 178.502 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.37 -67.18 3.12 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 114.285 -3.817 . . . . 0.0 111.062 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -74.72 164.5 26.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 116.04 -2.264 . . . . 0.0 110.096 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -129.37 162.14 28.7 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 116.367 -2.133 . . . . 0.0 108.87 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.3 p -132.79 142.52 49.04 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.199 -2.6 . . . . 0.0 109.636 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.0 m -106.1 119.73 39.97 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 115.134 -2.626 . . . . 0.0 109.201 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.29 126.09 41.25 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 115.832 -2.347 . . . . 0.0 109.233 173.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 35.7 m -82.27 158.39 23.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 114.529 -2.868 . . . . 0.0 110.208 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.33 166.9 22.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 115.181 -2.607 . . . . 0.0 108.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.13 112.24 1.83 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 114.585 -2.846 . . . . 0.0 109.202 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.96 -47.49 0.8 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 114.431 -3.747 . . . . 0.0 110.452 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 97.7 m-85 -104.95 167.5 9.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 115.805 -2.358 . . . . 0.0 109.903 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -158.18 -0.69 0.1 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 115.398 -2.521 . . . . 0.0 111.865 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . -63.8 168.51 23.1 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 115.696 -3.145 . . . . 0.0 110.649 175.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -47.71 -52.61 17.78 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.721 -1.992 . . . . 0.0 108.667 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.702 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 50.5 m-20 -93.7 16.84 12.98 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 115.017 -2.673 . . . . 0.0 107.39 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 14.6 m 76.21 23.57 1.21 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 116.079 -2.248 . . . . 0.0 108.443 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.12 -32.51 67.02 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 115.025 -2.67 . . . . 0.0 110.411 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -87.98 151.62 22.65 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 115.836 -2.345 . . . . 0.0 109.041 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -111.11 141.6 44.4 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 115.145 -2.622 . . . . 0.0 109.013 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.0 p -92.71 35.93 1.03 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 115.767 -2.373 . . . . 0.0 109.836 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 . . . . . 0 N--CA 1.509 2.525 0 C-N-CA 115.026 -2.67 . . . . 0.0 109.436 -178.574 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 122.623 1.201 . . . . 0.0 108.739 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -82.2 162.91 22.23 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.218 -2.176 . . . . 0.0 110.68 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.72 -125.87 1.27 Allowed Glycine 0 N--CA 1.507 3.395 1 C-N-CA 112.498 -4.668 . . . . 0.0 109.785 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -89.49 103.12 15.78 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 115.87 -2.332 . . . . 0.0 110.678 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 91.3 mm-40 -79.17 -15.82 57.53 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 116.563 -2.055 . . . . 0.0 109.025 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 30.5 p -98.78 18.25 17.45 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 115.539 -2.464 . . . . 0.0 109.25 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -74.25 30.37 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 116.661 -2.016 . . . . 0.0 111.121 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -141.66 28.1 2.31 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 114.478 -3.725 . . . . 0.0 110.462 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' GLY . 72.5 m80 43.62 76.37 0.54 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 115.263 -2.575 . . . . 0.0 110.643 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -89.14 -32.99 0.11 Allowed 'Trans proline' 0 N--CA 1.427 -2.414 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 3.7 m -83.2 156.32 23.26 Favored 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 115.088 -2.645 . . . . 0.0 110.894 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.546 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.3 mt -98.6 173.16 7.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 117.009 -1.877 . . . . 0.0 108.703 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.578 ' HB2' HG21 ' A' ' 85' ' ' THR . 12.8 m120 36.99 60.04 1.02 Allowed 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 116.148 -2.221 . . . . 0.0 112.66 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 55.55 31.37 17.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 117.469 -1.693 . . . . 0.0 113.296 166.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.92 158.31 53.11 Favored Glycine 0 N--CA 1.504 3.185 1 C-N-CA 113.353 -4.261 . . . . 0.0 110.405 172.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.448 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 7.6 t-160 -88.38 172.01 9.71 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 115.204 -2.599 . . . . 0.0 109.48 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 30.9 p -139.95 122.76 16.49 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 114.592 -2.843 . . . . 0.0 109.31 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 63' ' ' LAA . 5.3 tmtt? . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 115.171 -2.611 . . . . 0.0 108.972 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LAA . . . . . 0.696 ' O ' ' O ' ' A' ' 62' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.3 -153.04 7.56 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 114.038 -3.934 . . . . 0.0 111.025 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.17 93.28 2.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 C-N-CA 114.86 -2.736 . . . . 0.0 107.741 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 89.36 -69.16 2.59 Favored Glycine 0 CA--C 1.548 2.133 0 C-N-CA 114.437 -3.744 . . . . 0.0 110.076 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -77.76 170.02 17.29 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 115.433 -2.507 . . . . 0.0 109.527 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 63' ' ' LAA . 29.1 p90 -132.11 158.24 42.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.166 -2.214 . . . . 0.0 109.572 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -127.36 133.84 50.01 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 116.39 -2.124 . . . . 0.0 108.364 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.3 m -104.97 132.7 50.88 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.742 -2.783 . . . . 0.0 109.909 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -104.72 148.72 26.28 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 115.83 -2.348 . . . . 0.0 109.701 175.311 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.905 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 64.7 m -110.91 143.41 41.59 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 116.298 -2.161 . . . . 0.0 108.8 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.499 ' HB3' ' CD2' ' A' ' 76' ' ' PHE . . . -76.34 170.27 16.67 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 115.392 -2.523 . . . . 0.0 110.173 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.82 140.04 58.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 116.163 -2.215 . . . . 0.0 108.987 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.71 -21.19 43.27 Favored Glycine 0 N--CA 1.427 -1.957 1 C-N-CA 113.474 -4.203 . . . . 0.0 109.904 -174.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 1.005 ' CD1' HG22 ' A' ' 85' ' ' THR . 65.7 m-85 -133.22 143.32 49.06 Favored 'General case' 0 CA--C 1.471 -2.065 0 C-N-CA 114.725 -2.79 . . . . 0.0 110.051 -170.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.736 ' N ' ' OG ' ' A' ' 84' ' ' SER . 2.0 pt-20 -164.99 173.36 11.66 Favored 'General case' 1 N--CA 1.367 -4.619 0 C-N-CA 113.843 -3.143 . . . . 0.0 112.775 165.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 139.33 178.2 16.29 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 114.698 -3.62 . . . . 0.0 110.158 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 78' ' ' GLY . 29.1 ttpp -41.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 116.433 -2.107 . . . . 0.0 108.871 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.648 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 57.2 m-20 -118.28 24.49 10.92 Favored 'General case' 0 C--O 1.207 -1.167 0 C-N-CA 115.556 -2.458 . . . . 0.0 109.466 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.905 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.7 m 76.87 39.25 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 115.299 -2.56 . . . . 0.0 106.99 -170.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -88.25 -28.96 20.78 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 116.358 -2.137 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.64 ' C ' ' OG ' ' A' ' 84' ' ' SER . 65.4 m-85 -89.53 101.62 14.3 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 114.984 -2.687 . . . . 0.0 108.994 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 1.403 ' CB ' HG23 ' A' ' 85' ' ' THR 0.292 24.6 m 164.36 174.33 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 113.01 -3.476 . . . . 0.0 109.972 -143.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 1.403 HG23 ' CB ' ' A' ' 84' ' ' SER . 2.5 p 54.55 45.73 26.33 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 114.362 -2.935 . . . . 0.0 111.905 148.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 . . . . . 0 C--O 1.188 -2.133 0 C-N-CA 116.887 -1.925 . . . . 0.0 109.568 -175.584 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.2 pttp . . . . . 0 N--CA 1.431 -1.406 0 CA-C-O 121.886 0.851 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -142.02 125.15 16.32 Favored 'General case' 0 C--O 1.261 1.68 0 C-N-CA 117.316 -1.754 . . . . 0.0 106.278 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.26 -53.0 0.01 OUTLIER Glycine 0 N--CA 1.502 3.081 1 C-N-CA 113.62 -4.133 . . . . 0.0 111.613 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 49' ' ' GLN . 31.2 t70 -136.67 10.64 3.15 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 116.43 -2.108 . . . . 0.0 108.97 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 2.9 mp0 31.79 33.92 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 117.499 -1.681 . . . . 0.0 113.493 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.2 t -166.87 27.0 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 115.94 -2.304 . . . . 0.0 108.715 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -76.18 24.23 0.14 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 115.682 -2.407 . . . . 0.0 111.24 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -146.06 24.31 1.75 Allowed Glycine 0 N--CA 1.484 1.897 0 C-N-CA 114.062 -3.923 . . . . 0.0 110.56 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 22.2 t-160 42.79 78.37 0.39 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.299 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.51 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 5.0 Cg_exo -82.12 -33.83 0.53 Allowed 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 121.035 1.157 . . . . 0.0 110.961 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.072 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.6 m -75.85 149.27 37.87 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 115.39 -2.524 . . . . 0.0 110.464 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' O ' ' C ' ' A' ' 57' ' ' ASN . 70.7 mt -97.91 174.03 6.78 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 116.114 -2.234 . . . . 0.0 109.746 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.64 ' HB2' HG21 ' A' ' 85' ' ' THR . 21.5 m-80 33.76 57.29 0.57 Allowed 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 115.845 -2.342 . . . . 0.0 114.118 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 56.62 41.99 27.69 Favored 'General case' 0 N--CA 1.515 2.811 0 C-N-CA 116.047 -2.261 . . . . 0.0 111.749 168.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.47 54.87 Favored Glycine 0 N--CA 1.444 -0.771 1 C-N-CA 113.653 -4.118 . . . . 0.0 110.125 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -93.36 133.12 36.94 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 114.65 -2.82 . . . . 0.0 109.438 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 88.4 m -98.43 105.49 17.64 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 114.742 -2.783 . . . . 0.0 107.338 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 N--CA 1.48 1.058 0 C-N-CA 115.513 -2.475 . . . . 0.0 107.696 176.425 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.67 -131.8 2.07 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 114.9 -3.524 . . . . 0.0 110.26 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.74 85.02 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 C-N-CA 114.767 -2.773 . . . . 0.0 109.034 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.1 -60.56 4.58 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 115.803 -3.094 . . . . 0.0 110.932 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.98 167.52 21.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.554 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.53 159.1 44.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 114.748 -2.781 . . . . 0.0 108.923 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -137.04 132.25 33.94 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 115.146 -2.622 . . . . 0.0 108.395 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.072 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.8 m -91.46 129.09 37.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 116.059 -2.256 . . . . 0.0 109.761 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.3 m -107.46 106.07 16.29 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 114.827 -2.749 . . . . 0.0 109.677 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 77' ' ' GLU . 34.3 m -68.81 142.45 54.87 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 115.473 -2.491 . . . . 0.0 109.95 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.54 169.2 18.7 Favored 'General case' 0 C--O 1.26 1.649 0 C-N-CA 115.503 -2.479 . . . . 0.0 111.69 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.71 143.25 31.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 115.691 -2.404 . . . . 0.0 109.783 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.16 -23.73 34.84 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 115.11 -3.424 . . . . 0.0 110.292 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 1.067 ' CD1' HG22 ' A' ' 85' ' ' THR . 73.7 m-85 -131.48 143.87 50.73 Favored 'General case' 0 N--CA 1.407 -2.578 0 C-N-CA 114.484 -2.887 . . . . 0.0 110.243 -169.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' ' OG ' ' A' ' 84' ' ' SER . 2.0 pt-20 -164.85 178.07 7.45 Favored 'General case' 1 N--CA 1.37 -4.461 0 C-N-CA 112.766 -3.574 . . . . 0.0 112.747 164.223 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 133.25 175.51 13.99 Favored Glycine 0 N--CA 1.484 1.864 0 C-N-CA 115.308 -3.33 . . . . 0.0 109.745 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.8 tttp -38.66 -52.21 1.66 Allowed 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 116.147 -2.221 . . . . 0.0 110.622 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 61.9 m-20 -119.55 20.39 12.41 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 116.412 -2.115 . . . . 0.0 108.471 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 4.5 m 79.57 43.66 0.06 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 115.884 -2.326 . . . . 0.0 107.816 -171.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -92.0 -30.5 16.03 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.549 -2.06 . . . . 0.0 109.468 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.547 ' C ' ' OG ' ' A' ' 84' ' ' SER . 59.1 m-85 -88.82 99.51 12.43 Favored 'General case' 0 CA--C 1.465 -2.299 0 C-N-CA 115.55 -2.46 . . . . 0.0 107.179 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 1.46 ' CB ' HG23 ' A' ' 85' ' ' THR 0.263 20.6 m 166.47 175.82 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 113.959 -3.096 . . . . 0.0 109.118 -146.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 1.46 HG23 ' CB ' ' A' ' 84' ' ' SER . 1.5 p 51.48 44.39 29.05 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 116.064 -2.255 . . . . 0.0 111.276 148.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 . . . . . 0 C--N 1.372 1.553 0 CA-C-O 115.228 -2.32 . . . . 0.0 107.702 -179.382 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . 0.265 17.6 ptpt . . . . . 0 C--O 1.203 -1.378 0 CA-C-O 122.937 1.351 . . . . 0.0 107.965 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -102.67 151.07 22.8 Favored 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 113.866 -3.134 . . . . 0.0 110.066 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.95 -173.57 38.56 Favored Glycine 0 C--N 1.289 -2.079 0 C-N-CA 114.575 -3.679 . . . . 0.0 112.356 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -88.04 134.84 33.65 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 115.518 -2.473 . . . . 0.0 108.079 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 94.6 mm-40 -83.0 13.83 3.74 Favored 'General case' 0 C--O 1.257 1.47 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.775 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 25.6 t -140.37 22.8 2.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 115.407 -2.517 . . . . 0.0 109.892 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.79 30.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 115.318 -2.553 . . . . 0.0 112.071 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.97 27.84 0.58 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 114.037 -3.935 . . . . 0.0 110.218 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.1 m80 48.44 71.39 1.61 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 115.6 -2.44 . . . . 0.0 112.086 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -76.97 -31.15 3.98 Favored 'Trans proline' 0 N--CA 1.413 -3.258 0 C-N-CA 122.224 1.949 . . . . 0.0 109.091 -177.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 14.5 m -83.92 158.65 21.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.998 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 57' ' ' ASN . 62.9 mt -104.43 165.48 11.03 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 117.773 -1.571 . . . . 0.0 108.896 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.755 ' CB ' ' HA ' ' A' ' 85' ' ' THR . 11.2 m120 34.28 63.73 0.41 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 118.181 -1.407 . . . . 0.0 111.552 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 53.88 59.03 4.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 115.4 -2.52 . . . . 0.0 111.553 169.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.23 170.69 52.81 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 114.223 -3.846 . . . . 0.0 110.91 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -97.09 104.96 17.03 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 115.383 -2.527 . . . . 0.0 108.124 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 53.5 t -95.25 118.57 32.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 114.372 -2.931 . . . . 0.0 109.676 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? . . . . . 0 C--O 1.215 -0.732 0 C-N-CA 116.356 -2.137 . . . . 0.0 108.032 174.559 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.7 -133.76 6.49 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 114.531 -3.7 . . . . 0.0 110.984 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.71 100.1 9.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 115.305 -2.558 . . . . 0.0 108.762 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 86.07 -72.81 2.63 Favored Glycine 0 N--CA 1.477 1.386 0 C-N-CA 114.04 -3.933 . . . . 0.0 110.187 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.72 166.52 22.87 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.436 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -128.82 159.63 35.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 115.929 -2.308 . . . . 0.0 108.724 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.3 p -130.54 130.43 44.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 116.068 -2.253 . . . . 0.0 109.394 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 69.3 m -107.35 139.27 42.1 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 115.475 -2.49 . . . . 0.0 109.961 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.08 121.96 36.58 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 116.293 -2.163 . . . . 0.0 109.072 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 33.7 m -73.79 148.05 42.85 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 115.659 -2.416 . . . . 0.0 110.881 -176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.9 166.24 11.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 115.873 -2.331 . . . . 0.0 109.146 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -53.78 115.42 1.98 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.513 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 1.033 ' C ' ' HB2' ' A' ' 84' ' ' SER . . . 136.27 -34.67 2.22 Favored Glycine 0 C--O 1.262 1.862 0 C-N-CA 115.007 -3.473 . . . . 0.0 110.363 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 1.146 ' HA ' ' C ' ' A' ' 84' ' ' SER 0.266 28.9 m-85 -133.84 162.84 30.92 Favored 'General case' 0 CA--C 1.568 1.669 0 C-N-CA 118.145 -1.422 . . . . 0.0 107.686 -172.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.063 ' N ' ' O ' ' A' ' 83' ' ' PHE . 3.7 tm-20 -161.25 136.86 7.86 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 113.726 -3.19 . . . . 0.0 112.126 175.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 142.16 178.39 18.17 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 114.52 -3.705 . . . . 0.0 110.604 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' GLY . 62.9 tttm -46.84 -61.33 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 115.339 -2.544 . . . . 0.0 111.342 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.701 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 68.7 m-20 -93.09 5.35 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.1 m 79.91 72.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 115.927 -2.309 . . . . 0.0 106.972 -164.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.967 ' C ' HG21 ' A' ' 85' ' ' THR . 40.1 tt0 -107.25 -29.82 9.1 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.002 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 1.063 ' O ' ' N ' ' A' ' 77' ' ' GLU . 80.8 m-85 -90.52 151.33 21.4 Favored 'General case' 0 C--O 1.19 -2.063 0 C-N-CA 116.904 -1.919 . . . . 0.0 108.049 164.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 1.297 ' O ' HG23 ' A' ' 85' ' ' THR 0.3 2.2 p 41.38 116.23 0.0 OUTLIER 'General case' 1 CA--C 1.421 -4.015 0 C-N-CA 113.724 -3.19 . . . . 0.0 108.963 -160.192 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 1.297 HG23 ' O ' ' A' ' 84' ' ' SER . 2.7 p 163.82 39.74 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 1 CA-C-N 108.002 -4.181 . . . . 0.0 108.764 -148.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.743 ' H ' ' HE1' ' A' ' 76' ' ' PHE . 1.7 mpp_? . . . . . 0 CA--C 1.561 1.367 0 C-N-CA 114.509 -2.877 . . . . 0.0 109.133 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -128.2 137.73 52.17 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 116.651 -2.02 . . . . 0.0 111.429 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.46 -169.76 30.03 Favored Glycine 0 N--CA 1.481 1.684 1 C-N-CA 112.23 -4.795 . . . . 0.0 109.754 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -100.3 118.5 36.69 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 116.34 -2.144 . . . . 0.0 108.539 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -96.09 -8.56 33.03 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 116.207 -2.197 . . . . 0.0 108.49 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.198 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 18.3 t -102.25 -19.73 14.93 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.212 -2.595 . . . . 0.0 110.97 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -74.77 13.99 0.56 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 114.633 -2.827 . . . . 0.0 109.458 178.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -97.58 12.58 64.62 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 114.503 -3.713 . . . . 0.0 110.095 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.418 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 89.4 m-70 45.43 71.06 1.66 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 115.468 -2.493 . . . . 0.0 110.551 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.0 OUTLIER -84.47 -34.72 0.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.36 0 O-C-N 122.401 0.685 . . . . 0.0 110.674 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 m -92.63 156.26 17.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 116.219 -2.192 . . . . 0.0 109.945 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 57' ' ' ASN . 89.5 mt -103.04 176.29 5.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 116.645 -2.022 . . . . 0.0 109.308 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 56' ' ' LEU . 16.4 m-80 29.81 63.42 0.15 Allowed 'General case' 0 N--CA 1.4 -2.968 0 C-N-CA 116.801 -1.96 . . . . 0.0 113.11 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 51.51 55.75 8.93 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 115.734 -2.387 . . . . 0.0 110.721 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.93 172.24 55.17 Favored Glycine 0 CA--C 1.536 1.349 1 C-N-CA 113.463 -4.208 . . . . 0.0 109.346 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -90.83 87.7 6.76 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 115.276 -2.569 . . . . 0.0 108.795 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.198 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.6 t -89.0 125.12 34.85 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 115.852 -2.339 . . . . 0.0 109.558 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.9 tptt . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 115.863 -2.335 . . . . 0.0 107.985 176.366 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.6 -123.19 1.64 Allowed Glycine 0 N--CA 1.478 1.459 0 C-N-CA 114.348 -3.787 . . . . 0.0 110.495 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 67.2 mt -88.63 76.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 116.315 -2.154 . . . . 0.0 108.075 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.27 -68.74 3.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 115.16 -3.4 . . . . 0.0 109.982 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.59 165.5 24.98 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 115.914 -2.315 . . . . 0.0 110.407 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.85 157.42 23.32 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 115.312 -2.555 . . . . 0.0 109.186 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.4 p -124.88 134.27 52.76 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.099 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 90.6 m -108.56 132.33 53.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.728 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 123.41 40.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 115.887 -2.325 . . . . 0.0 109.226 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.8 m -75.08 143.99 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 115.373 -2.531 . . . . 0.0 109.724 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 170.06 15.36 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.612 -2.435 . . . . 0.0 110.292 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -59.12 132.38 53.86 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 115.931 -2.307 . . . . 0.0 109.075 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.41 -20.62 36.97 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 115.453 -3.26 . . . . 0.0 110.007 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.36 152.41 39.02 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 115.742 -2.383 . . . . 0.0 109.067 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -161.68 121.15 2.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.368 -2.533 . . . . 0.0 110.331 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 163.51 173.96 32.81 Favored Glycine 0 CA--C 1.55 2.259 1 C-N-CA 113.278 -4.296 . . . . 0.0 110.293 176.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 78' ' ' GLY . 14.6 tppt? -41.92 -55.69 3.02 Favored 'General case' 0 N--CA 1.417 -2.107 0 C-N-CA 115.881 -2.327 . . . . 0.0 110.896 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.699 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 47.8 m-20 -113.59 17.07 18.53 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.699 -2.401 . . . . 0.0 109.321 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.9 m 76.73 32.51 0.52 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 114.699 -2.8 . . . . 0.0 109.446 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.98 -30.15 62.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 115.165 -2.614 . . . . 0.0 109.735 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -90.0 160.38 16.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 116.022 -2.271 . . . . 0.0 110.387 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' ' C ' ' A' ' 85' ' ' THR . 11.0 p -120.89 70.57 0.91 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 115.899 -2.32 . . . . 0.0 109.368 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.596 ' C ' ' O ' ' A' ' 84' ' ' SER . 27.5 p 32.58 53.9 0.34 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 115.782 -2.367 . . . . 0.0 110.083 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 . . . . . 0 N--CA 1.5 2.029 0 C-N-CA 113.977 -3.089 . . . . 0.0 108.553 -178.892 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.7 mttm . . . . . 1 N--CA 1.541 4.123 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -90.62 132.45 35.74 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-N 110.121 -3.218 . . . . 0.0 107.711 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.73 -87.17 0.43 Allowed Glycine 1 CA--C 1.596 5.121 0 C-N-CA 116.707 -2.663 . . . . 0.0 109.599 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -128.16 124.98 38.18 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 116.129 -2.228 . . . . 0.0 109.593 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 12.2 mp0 -94.11 -7.51 42.27 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 114.95 -2.7 . . . . 0.0 111.124 -171.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.7 t -125.08 12.25 8.31 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 115.31 -2.556 . . . . 0.0 110.452 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -75.41 17.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 113.909 -3.116 . . . . 0.0 110.444 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -117.38 17.82 12.29 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 115.554 -3.213 . . . . 0.0 109.537 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 44.07 74.7 0.74 Allowed Pre-proline 0 CA--C 1.568 1.66 0 C-N-CA 115.297 -2.561 . . . . 0.0 111.136 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.06 -40.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.974 0 C-N-CA 121.595 1.53 . . . . 0.0 110.051 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 m -74.97 152.96 38.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 115.175 -2.61 . . . . 0.0 108.842 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' ASN . 75.1 mt -103.9 170.8 7.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 116.464 -2.094 . . . . 0.0 108.877 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LEU . 8.8 m-80 33.81 62.41 0.43 Allowed 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.748 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 49.93 62.35 2.7 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.689 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.97 168.66 32.87 Favored Glycine 0 C--O 1.251 1.158 1 C-N-CA 113.511 -4.185 . . . . 0.0 110.088 172.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.402 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 8.0 t-80 -89.31 164.39 14.94 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.028 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 91.0 m -131.44 119.24 21.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 114.96 -2.696 . . . . 0.0 110.031 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.8 tptt . . . . . 0 C--O 1.25 1.09 0 C-N-CA 115.992 -2.283 . . . . 0.0 107.015 175.625 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.45 -145.48 4.19 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 115.517 -3.23 . . . . 0.0 110.041 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.33 81.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 115.788 -2.365 . . . . 0.0 108.162 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.63 -59.19 3.7 Favored Glycine 0 C--N 1.343 0.944 1 C-N-CA 113.53 -4.176 . . . . 0.0 110.838 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.98 168.16 20.57 Favored 'General case' 0 C--O 1.259 1.597 0 C-N-CA 116.587 -2.045 . . . . 0.0 108.744 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.77 161.97 41.79 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 115.942 -2.303 . . . . 0.0 108.591 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 p -139.71 129.41 24.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 116.121 -2.232 . . . . 0.0 109.617 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 65.5 m -88.92 136.41 33.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 114.947 -2.701 . . . . 0.0 109.778 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -109.33 124.38 50.86 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 115.924 -2.31 . . . . 0.0 108.982 175.115 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 66.2 m -77.04 152.95 34.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.994 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.15 171.61 13.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 115.521 -2.471 . . . . 0.0 110.848 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.48 94.19 0.54 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 116.612 -2.035 . . . . 0.0 108.471 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.68 -30.06 0.93 Allowed Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 114.98 -3.486 . . . . 0.0 109.204 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -116.6 163.5 16.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 115.493 -2.483 . . . . 0.0 108.825 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -156.11 139.79 16.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 144.75 168.22 12.58 Favored Glycine 0 C--N 1.294 -1.766 1 C-N-CA 113.807 -4.044 . . . . 0.0 111.434 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 78' ' ' GLY . 39.1 ttpt -50.92 -54.71 21.78 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 115.556 -2.457 . . . . 0.0 109.957 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.724 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 70.7 m-20 -104.17 8.68 36.34 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.085 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.4 m 81.47 43.04 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 115.185 -2.606 . . . . 0.0 108.497 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.34 -18.23 42.88 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 115.455 -2.498 . . . . 0.0 109.854 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -104.28 170.84 7.67 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 114.95 -2.7 . . . . 0.0 110.072 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.498 ' O ' ' C ' ' A' ' 85' ' ' THR . 41.1 p -121.05 82.69 1.96 Allowed 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 114.92 -2.712 . . . . 0.0 109.725 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.498 ' C ' ' O ' ' A' ' 84' ' ' SER . 24.7 p 27.78 51.9 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 117.133 -1.827 . . . . 0.0 111.002 -175.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 115.25 -2.58 . . . . 0.0 109.31 -178.721 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . 0.262 59.5 tttp . . . . . 0 CA--C 1.604 3.024 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -100.36 159.79 14.85 Favored 'General case' 0 CA--C 1.586 2.342 0 C-N-CA 113.826 -3.15 . . . . 0.0 108.432 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.77 175.39 3.77 Favored Glycine 0 C--O 1.197 -2.186 0 C-N-CA 115.363 -3.303 . . . . 0.0 111.071 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -90.44 133.53 34.96 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 115.876 -2.329 . . . . 0.0 109.831 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 10.2 mp0 -97.99 -8.16 28.51 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.38 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.114 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.4 t -115.01 -10.76 12.21 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 115.238 -2.585 . . . . 0.0 111.288 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.99 20.17 0.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 116.003 -2.279 . . . . 0.0 111.26 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -132.31 24.9 3.91 Favored Glycine 0 C--N 1.311 -0.837 0 C-N-CA 114.344 -3.788 . . . . 0.0 111.294 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 49.62 84.13 0.21 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.96 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -95.47 -32.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.932 0 O-C-N 123.67 1.352 . . . . 0.0 109.115 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 34.1 m -81.56 163.01 22.94 Favored 'General case' 0 C--O 1.255 1.342 0 C-N-CA 114.007 -3.077 . . . . 0.0 110.937 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.523 ' O ' ' C ' ' A' ' 57' ' ' ASN . 94.5 mt -113.93 172.91 6.71 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 115.717 -2.393 . . . . 0.0 109.481 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER 43.05 49.58 5.38 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 116.881 -1.928 . . . . 0.0 110.334 172.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 57.62 48.22 14.57 Favored 'General case' 0 C--O 1.272 2.284 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.2 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.78 160.56 34.15 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 114.917 -3.516 . . . . 0.0 111.01 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -87.5 158.29 18.97 Favored 'General case' 0 C--N 1.275 -2.647 0 C-N-CA 115.219 -2.592 . . . . 0.0 109.02 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.114 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 38.9 t -144.84 128.33 17.0 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 114.14 -3.024 . . . . 0.0 111.305 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.7 tptp . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 115.666 -2.414 . . . . 0.0 108.149 175.169 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.46 -124.23 1.98 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 114.385 -3.769 . . . . 0.0 110.536 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.39 89.51 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 114.643 -2.823 . . . . 0.0 109.829 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.665 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 80.79 -68.68 3.35 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 115.232 -3.366 . . . . 0.0 110.156 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.83 -174.47 3.06 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 114.243 -2.983 . . . . 0.0 109.569 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -139.19 166.87 23.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 116.184 -2.206 . . . . 0.0 110.737 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 p -133.18 143.52 49.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.5 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.9 m -117.53 141.49 48.3 Favored 'General case' 0 C--O 1.213 -0.843 0 C-N-CA 113.595 -3.242 . . . . 0.0 110.143 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.59 162.27 13.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 115.525 -2.47 . . . . 0.0 108.139 172.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.824 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 74.0 m -111.08 154.81 23.73 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 114.293 -2.963 . . . . 0.0 108.366 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.13 165.45 20.34 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 113.783 -3.167 . . . . 0.0 110.704 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.22 97.64 0.19 Allowed 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.31 -2.556 . . . . 0.0 109.604 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.68 -42.98 0.59 Allowed Glycine 0 N--CA 1.428 -1.858 0 C-N-CA 114.667 -3.635 . . . . 0.0 109.435 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -105.09 166.6 10.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.181 -2.608 . . . . 0.0 108.7 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -159.04 123.24 3.95 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 114.941 -2.703 . . . . 0.0 109.46 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 162.68 167.21 22.77 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 116.345 -2.836 . . . . 0.0 111.338 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 78' ' ' GLY . 10.8 tmtt? -44.27 -55.53 4.82 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 116.3 -2.16 . . . . 0.0 110.125 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.779 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 26.3 m-20 -102.13 5.36 40.31 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 115.095 -2.642 . . . . 0.0 109.428 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.824 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 25.0 m 79.21 14.82 1.05 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 115.46 -2.496 . . . . 0.0 109.569 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.68 -27.01 47.79 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 115.434 -2.506 . . . . 0.0 111.693 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.42 151.89 19.03 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 115.404 -2.518 . . . . 0.0 110.3 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.4 p -114.99 148.75 38.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 114.787 -2.765 . . . . 0.0 109.126 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.8 p -102.05 35.8 2.28 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 115.505 -2.478 . . . . 0.0 108.934 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 . . . . . 0 CA--C 1.578 2.031 0 C-N-CA 115.697 -2.401 . . . . 0.0 109.529 176.112 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 pttt . . . . . 0 N--CA 1.42 -1.948 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -137.55 29.88 2.64 Favored 'General case' 0 N--CA 1.527 3.409 0 C-N-CA 116.659 -2.016 . . . . 0.0 108.921 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.02 -173.22 54.98 Favored Glycine 0 C--N 1.351 1.385 0 C-N-CA 114.2 -3.857 . . . . 0.0 110.582 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.39 117.84 26.11 Favored 'General case' 0 C--O 1.214 -0.781 0 C-N-CA 115.209 -2.596 . . . . 0.0 109.654 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -98.68 -17.81 18.38 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 114.514 -2.875 . . . . 0.0 109.751 -174.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.445 ' C ' ' H ' ' A' ' 52' ' ' GLY . 36.8 t -82.65 -15.67 51.15 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 115.363 -2.535 . . . . 0.0 109.247 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.94 20.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 115.748 -2.381 . . . . 0.0 110.745 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -111.55 9.85 28.23 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 114.362 -3.78 . . . . 0.0 110.715 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.489 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 13.4 t-160 50.98 67.3 4.43 Favored Pre-proline 0 C--N 1.366 1.287 0 C-N-CA 116.41 -2.116 . . . . 0.0 109.067 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.2 Cg_endo -83.77 -30.46 0.77 Allowed 'Trans proline' 0 N--CA 1.419 -2.871 0 C-N-CA 121.071 1.181 . . . . 0.0 110.431 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.952 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.3 m -87.66 147.86 25.06 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 116.314 -2.154 . . . . 0.0 110.727 -175.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 57' ' ' ASN . 76.9 mt -94.85 172.7 8.0 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.472 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.618 ' HB2' HG21 ' A' ' 85' ' ' THR . 16.8 m-80 32.68 61.83 0.36 Allowed 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 117.337 -1.745 . . . . 0.0 114.245 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 52.55 41.9 31.23 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.956 -1.498 . . . . 0.0 110.786 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.59 174.03 52.81 Favored Glycine 0 C--N 1.373 2.638 0 C-N-CA 113.946 -3.978 . . . . 0.0 109.008 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -88.76 147.95 24.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 115.123 -2.631 . . . . 0.0 108.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.9 t -140.18 123.99 17.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 115.699 -2.401 . . . . 0.0 110.599 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm . . . . . 0 CA--C 1.541 0.607 0 C-N-CA 115.374 -2.53 . . . . 0.0 108.791 176.244 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.0 -138.88 3.28 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 114.942 -3.504 . . . . 0.0 109.271 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.5 mm -80.88 86.28 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 116.358 -2.137 . . . . 0.0 108.684 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.63 -72.32 2.0 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 114.323 -3.799 . . . . 0.0 110.158 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.25 167.89 19.45 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 115.214 -2.594 . . . . 0.0 109.493 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -113.3 152.72 29.52 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 115.757 -2.377 . . . . 0.0 109.075 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 114.897 -2.721 . . . . 0.0 109.469 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.952 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 63.0 m -105.14 137.22 43.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 115.933 -2.307 . . . . 0.0 109.854 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.96 114.01 20.38 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 116.89 -1.924 . . . . 0.0 108.532 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 32.4 m -71.97 145.15 48.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 116.505 -2.078 . . . . 0.0 108.996 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 169.04 14.05 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 116.264 -2.174 . . . . 0.0 110.063 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.73 145.81 6.49 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 115.92 -2.312 . . . . 0.0 110.214 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.72 -22.56 39.71 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 114.795 -3.574 . . . . 0.0 109.751 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 1.185 ' CD1' HG22 ' A' ' 85' ' ' THR . 69.4 m-85 -131.53 145.24 51.64 Favored 'General case' 0 CA--C 1.476 -1.899 0 C-N-CA 115.916 -2.314 . . . . 0.0 112.055 -173.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.701 ' N ' ' OG ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -165.56 174.53 9.8 Favored 'General case' 0 N--CA 1.399 -2.996 0 C-N-CA 114.066 -3.054 . . . . 0.0 112.632 164.027 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 137.76 171.74 12.29 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 116.507 -2.759 . . . . 0.0 110.642 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 78' ' ' GLY . 63.9 tttm -39.39 -52.81 2.05 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 116.976 -1.89 . . . . 0.0 110.179 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 67.6 m-20 -115.16 20.95 14.6 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 116.376 -2.129 . . . . 0.0 108.746 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.0 m 76.53 40.8 0.21 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 115.309 -2.556 . . . . 0.0 108.825 -171.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -88.87 -28.85 20.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 116.213 -2.195 . . . . 0.0 109.003 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.717 ' C ' ' OG ' ' A' ' 84' ' ' SER . 62.9 m-85 -88.72 100.32 13.04 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 116.432 -2.107 . . . . 0.0 107.324 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 1.469 ' CB ' HG23 ' A' ' 85' ' ' THR . 11.1 m 164.77 173.63 0.02 OUTLIER 'General case' 0 C--O 1.272 2.288 0 C-N-CA 114.036 -3.066 . . . . 0.0 110.494 -145.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 1.469 HG23 ' CB ' ' A' ' 84' ' ' SER . 1.5 p 53.01 42.65 32.26 Favored 'General case' 0 C--N 1.268 -2.973 0 C-N-CA 115.887 -2.325 . . . . 0.0 110.166 147.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 86' ' ' ARG . 77.9 mtt-85 . . . . . 0 N--CA 1.422 -1.846 0 C-N-CA 113.545 -3.262 . . . . 0.0 109.519 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.96 119.14 37.77 Favored 'General case' 0 CA--C 1.476 -1.89 0 C-N-CA 112.745 -3.582 . . . . 0.0 113.717 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.89 -65.9 0.51 Allowed Glycine 0 CA--C 1.557 2.708 0 C-N-CA 114.142 -3.885 . . . . 0.0 110.795 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -121.82 133.29 54.9 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 114.496 -2.882 . . . . 0.0 108.898 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 7.4 mp0 -96.14 -15.24 22.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 114.481 -2.887 . . . . 0.0 110.862 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.4 t -121.79 20.3 10.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 115.581 -2.447 . . . . 0.0 110.264 -175.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -74.98 33.21 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 116.567 -2.053 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -153.91 23.6 0.71 Allowed Glycine 0 N--CA 1.47 0.961 0 C-N-CA 114.411 -3.757 . . . . 0.0 110.997 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.8 t-160 47.15 75.17 0.69 Allowed Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 115.931 -2.308 . . . . 0.0 109.123 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.4 Cg_endo -82.49 -34.11 0.44 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 120.566 0.844 . . . . 0.0 111.123 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 10.6 m -71.57 164.1 26.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 115.636 -2.425 . . . . 0.0 109.403 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.7 mt -114.8 170.81 8.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 116.473 -2.091 . . . . 0.0 110.094 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.492 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 35.32 57.28 0.84 Allowed 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 115.811 -2.355 . . . . 0.0 114.732 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 56.7 mt-30 60.5 39.6 18.01 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.113 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 161.52 50.32 Favored Glycine 1 N--CA 1.521 4.352 1 C-N-CA 113.739 -4.077 . . . . 0.0 110.847 175.905 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -89.34 167.05 13.35 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 114.987 -2.685 . . . . 0.0 107.75 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 48.5 t -136.45 133.28 36.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 113.249 -3.38 . . . . 0.0 110.126 -172.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 115.702 -2.399 . . . . 0.0 107.635 175.645 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.39 -138.99 2.9 Favored Glycine 1 N--CA 1.516 4.01 0 C-N-CA 116.067 -2.968 . . . . 0.0 110.317 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.16 88.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 115.544 -2.462 . . . . 0.0 107.234 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.75 -64.02 4.0 Favored Glycine 0 CA--C 1.545 1.966 0 C-N-CA 115.222 -3.37 . . . . 0.0 110.252 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -76.58 164.72 25.66 Favored 'General case' 0 C--O 1.26 1.629 0 C-N-CA 115.542 -2.463 . . . . 0.0 110.096 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -134.76 163.0 30.78 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 115.65 -2.42 . . . . 0.0 108.624 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 p -137.18 132.28 33.69 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.372 -2.531 . . . . 0.0 108.293 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 41.4 m -97.53 141.29 30.76 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 114.851 -2.74 . . . . 0.0 110.149 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 111.71 24.31 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 115.764 -2.375 . . . . 0.0 109.057 173.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.941 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.1 m -71.49 148.75 46.48 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 115.979 -2.288 . . . . 0.0 111.232 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.11 168.79 19.48 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 115.114 -2.635 . . . . 0.0 110.248 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.12 140.06 56.24 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 115.216 -2.594 . . . . 0.0 108.888 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.48 -14.91 61.75 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 116.317 -2.849 . . . . 0.0 110.425 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.17 150.18 49.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 116.268 -2.173 . . . . 0.0 110.334 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.73 130.87 11.11 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 115.72 -2.392 . . . . 0.0 108.755 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 154.15 163.36 11.84 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 114.314 -3.803 . . . . 0.0 110.993 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.9 tttm -43.83 -50.26 7.93 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.57 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 42.1 m-20 -110.62 10.98 22.9 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 116.001 -2.28 . . . . 0.0 110.33 175.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.941 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 21.9 m 78.01 30.58 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 116.067 -2.253 . . . . 0.0 108.237 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.44 -32.21 68.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.518 -2.073 . . . . 0.0 109.449 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.13 154.27 20.3 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 114.926 -2.71 . . . . 0.0 109.525 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 85' ' ' THR . 39.8 p -113.79 70.77 0.73 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 114.866 -2.734 . . . . 0.0 109.151 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 84' ' ' SER . 41.1 p 34.36 51.45 0.45 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 117.059 -1.856 . . . . 0.0 110.623 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 . . . . . 0 N--CA 1.489 1.509 0 C-N-CA 114.755 -2.778 . . . . 0.0 108.879 177.574 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 tttp . . . . . 0 CA--C 1.472 -2.03 0 CA-C-O 121.193 0.52 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -144.0 101.5 3.74 Favored 'General case' 0 CA--C 1.458 -2.591 0 C-N-CA 116.398 -2.121 . . . . 0.0 113.555 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.94 -111.91 0.5 Allowed Glycine 0 CA--C 1.578 3.994 0 C-N-CA 117.286 -2.387 . . . . 0.0 108.725 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -113.24 127.18 56.09 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 115.101 -2.64 . . . . 0.0 109.103 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.506 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 7.7 mp0 -89.83 -9.61 48.45 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 116.656 -2.018 . . . . 0.0 109.539 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.466 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.3 t -116.37 1.82 13.09 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 114.425 -2.91 . . . . 0.0 109.979 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -74.99 20.33 0.13 Allowed 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 115.471 -2.492 . . . . 0.0 110.484 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -119.88 13.69 10.6 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 114.004 -3.951 . . . . 0.0 110.137 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 50.09 73.55 0.97 Allowed Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 116.878 -1.929 . . . . 0.0 111.237 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -83.48 -43.6 0.07 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.128 0 N-CA-C 110.082 -0.776 . . . . 0.0 110.082 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.986 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 2.8 m -85.41 147.41 26.51 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 115.387 -2.525 . . . . 0.0 110.05 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.58 ' O ' ' C ' ' A' ' 57' ' ' ASN . 61.2 mt -95.21 179.41 5.2 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 116.839 -1.944 . . . . 0.0 109.365 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.58 ' C ' ' O ' ' A' ' 56' ' ' LEU . 12.5 m-80 28.62 60.92 0.13 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.204 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 55.06 58.3 4.85 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 115.051 -2.66 . . . . 0.0 108.682 165.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.07 171.13 51.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 113.921 -3.99 . . . . 0.0 109.812 171.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -89.15 93.5 9.6 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 115.449 -2.5 . . . . 0.0 108.798 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.6 p -95.55 109.0 21.29 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 115.436 -2.506 . . . . 0.0 108.644 -171.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 tttp . . . . . 0 C--O 1.242 0.689 0 C-N-CA 115.917 -2.313 . . . . 0.0 107.879 176.756 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.96 -127.34 1.03 Allowed Glycine 0 N--CA 1.478 1.475 1 C-N-CA 113.865 -4.017 . . . . 0.0 110.107 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.6 mt -92.71 79.33 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 114.922 -2.711 . . . . 0.0 108.915 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 114.807 -3.568 . . . . 0.0 109.713 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.54 164.37 26.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 114.598 -2.841 . . . . 0.0 110.539 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -137.48 161.38 36.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.196 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -120.43 136.17 54.82 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 115.665 -2.414 . . . . 0.0 110.274 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.986 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 52.4 m -104.85 124.11 48.87 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 115.394 -2.523 . . . . 0.0 109.003 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 119.64 35.62 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 115.886 -2.326 . . . . 0.0 108.754 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 9.9 m -71.74 149.9 44.96 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 116.265 -2.174 . . . . 0.0 109.584 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.14 164.17 26.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 116.017 -2.273 . . . . 0.0 109.172 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.64 97.84 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 114.466 -2.893 . . . . 0.0 108.602 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.25 -33.32 0.65 Allowed Glycine 0 C--O 1.247 0.917 0 C-N-CA 115.357 -3.306 . . . . 0.0 110.227 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 96.2 m-85 -116.94 159.99 21.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 117.053 -1.859 . . . . 0.0 109.114 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.759 ' H ' ' HD1' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -159.7 -126.73 0.02 OUTLIER 'General case' 0 C--N 1.363 1.176 0 C-N-CA 114.212 -2.995 . . . . 0.0 109.653 166.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.411 ' N ' ' CZ ' ' A' ' 83' ' ' PHE . . . 68.58 -176.44 28.18 Favored Glycine 0 CA--C 1.554 2.509 1 C-N-CA 113.073 -4.394 . . . . 0.0 110.143 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -48.3 -61.17 2.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.901 -1.92 . . . . 0.0 113.616 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 81.8 m-20 -106.29 19.57 20.3 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 115.913 -2.315 . . . . 0.0 108.74 -171.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 10.3 m 73.1 46.6 0.23 Allowed 'General case' 0 C--O 1.252 1.195 0 C-N-CA 116.438 -2.105 . . . . 0.0 107.956 -167.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 77' ' ' GLU . 42.6 tt0 -90.24 -30.14 17.73 Favored 'General case' 0 C--O 1.261 1.672 0 C-N-CA 116.818 -1.953 . . . . 0.0 109.155 -170.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.759 ' HD1' ' H ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -102.31 147.44 26.68 Favored 'General case' 0 N--CA 1.379 -3.988 0 C-N-CA 112.298 -3.761 . . . . 0.0 108.758 -162.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 p -96.73 117.61 31.4 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 114.184 -3.006 . . . . 0.0 108.01 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.5 p -91.21 37.36 0.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 115.601 -2.44 . . . . 0.0 109.343 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 115.774 -2.371 . . . . 0.0 108.561 179.699 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.7 mttp . . . . . 0 CA--C 1.588 2.417 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -157.01 113.49 3.0 Favored 'General case' 0 N--CA 1.534 3.73 0 C-N-CA 116.115 -2.234 . . . . 0.0 108.233 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.16 -114.49 0.28 Allowed Glycine 1 N--CA 1.554 6.548 1 C-N-CA 113.426 -4.226 . . . . 0.0 109.893 -175.358 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -122.13 143.12 49.73 Favored 'General case' 0 N--CA 1.415 -2.202 0 C-N-CA 115.723 -2.391 . . . . 0.0 109.676 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 86.7 mm-40 -89.02 -19.35 25.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.294 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.4 t -95.53 11.9 31.43 Favored 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 115.302 -2.559 . . . . 0.0 108.652 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.98 26.61 0.07 Allowed 'General case' 0 C--O 1.258 1.533 0 C-N-CA 115.876 -2.33 . . . . 0.0 109.87 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -150.15 30.02 1.09 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 114.016 -3.945 . . . . 0.0 110.136 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 52' ' ' GLY . 21.8 t-160 40.31 83.87 0.19 Allowed Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 115.977 -2.289 . . . . 0.0 110.424 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -89.34 -27.12 0.38 Allowed 'Trans proline' 0 N--CA 1.426 -2.484 0 O-C-N 123.182 1.096 . . . . 0.0 111.547 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.937 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 m -94.16 166.64 12.02 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 114.314 -2.955 . . . . 0.0 110.415 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.1 mt -113.6 175.02 5.63 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 115.898 -2.321 . . . . 0.0 109.56 -177.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 56' ' ' LEU . 42.7 m-80 27.47 62.4 0.1 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.055 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 45.5 mt-30 58.9 47.33 12.56 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 125.248 1.593 . . . . 0.0 109.034 171.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.98 157.08 35.01 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 113.939 -3.981 . . . . 0.0 109.534 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -86.04 155.13 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 114.351 -2.94 . . . . 0.0 107.765 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.0 p -135.38 105.14 6.12 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.456 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp . . . . . 0 N--CA 1.486 1.37 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.338 177.739 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.6 -146.03 4.24 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 114.587 -3.673 . . . . 0.0 110.823 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.26 94.0 2.07 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.477 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 80.11 -71.68 2.73 Favored Glycine 0 C--O 1.259 1.666 0 C-N-CA 115.889 -3.053 . . . . 0.0 112.297 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -77.83 174.53 10.92 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 114.288 -2.965 . . . . 0.0 109.697 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.95 160.96 37.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 116.383 -2.127 . . . . 0.0 108.718 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.1 p -131.3 140.82 49.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 114.479 -2.888 . . . . 0.0 108.592 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.937 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 55.8 m -100.44 128.91 46.37 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.463 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.32 119.71 40.3 Favored 'General case' 0 C--O 1.255 1.387 0 C-N-CA 116.018 -2.273 . . . . 0.0 108.481 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.2 m -72.46 155.93 39.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 114.854 -2.738 . . . . 0.0 109.169 -174.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 163.65 26.36 Favored 'General case' 0 C--O 1.25 1.104 0 C-N-CA 114.683 -2.807 . . . . 0.0 108.947 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.54 100.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 114.782 -2.767 . . . . 0.0 108.99 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.27 -42.27 0.65 Allowed Glycine 0 CA--C 1.546 2.031 0 C-N-CA 115.414 -3.279 . . . . 0.0 108.309 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.22 161.33 16.7 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 115.49 -2.484 . . . . 0.0 110.154 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -147.75 142.49 26.71 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 115.477 -2.489 . . . . 0.0 108.639 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.555 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 142.87 158.63 7.61 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 115.914 -3.041 . . . . 0.0 110.478 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 78' ' ' GLY . 38.7 ttmt -39.27 -50.55 1.99 Allowed 'General case' 0 C--O 1.187 -2.232 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.183 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.715 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 59.5 m-20 -107.83 -3.1 19.31 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 116.842 -1.943 . . . . 0.0 109.146 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.5 m 83.27 31.81 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 114.874 -2.73 . . . . 0.0 109.154 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.78 -30.29 63.99 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 116.511 -2.076 . . . . 0.0 109.896 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -89.19 150.45 22.66 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 115.079 -2.649 . . . . 0.0 108.87 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 80.4 p -113.28 152.91 29.26 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 114.192 -3.003 . . . . 0.0 110.002 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 75.3 p -85.65 33.89 0.58 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 114.804 -2.758 . . . . 0.0 109.95 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 . . . . . 0 N--CA 1.472 0.661 0 C-N-CA 116.709 -1.996 . . . . 0.0 110.433 179.142 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt . . . . . 0 N--CA 1.507 2.402 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -79.74 145.08 33.08 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 116.945 -1.902 . . . . 0.0 109.422 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.91 -81.95 0.31 Allowed Glycine 0 C--N 1.364 2.119 0 C-N-CA 114.651 -3.642 . . . . 0.0 108.384 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -123.97 139.01 54.37 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 115.752 -2.379 . . . . 0.0 110.089 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -96.37 -34.17 11.65 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 116.393 -2.123 . . . . 0.0 110.219 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.05 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.8 t -93.78 20.59 7.4 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 116.43 -2.108 . . . . 0.0 109.516 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.18 23.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 114.879 -2.728 . . . . 0.0 110.969 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -147.2 23.38 1.57 Allowed Glycine 0 N--CA 1.472 1.079 0 C-N-CA 114.412 -3.756 . . . . 0.0 111.328 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 43.77 80.42 0.29 Allowed Pre-proline 0 CA--C 1.581 2.146 0 C-N-CA 116.84 -1.944 . . . . 0.0 111.123 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.19 -32.42 0.3 Allowed 'Trans proline' 0 N--CA 1.412 -3.272 0 C-N-CA 121.707 1.604 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 13.3 m -85.48 140.44 30.68 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 115.796 -2.362 . . . . 0.0 109.264 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.7 mt -101.63 168.7 9.31 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.777 -1.569 . . . . 0.0 110.719 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER 43.55 60.72 2.51 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 116.559 -2.056 . . . . 0.0 110.26 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 46.85 45.56 15.1 Favored 'General case' 1 C--N 1.441 4.571 0 C-N-CA 113.397 -3.321 . . . . 0.0 115.592 174.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 60' ' ' HIS . . . -77.46 -156.62 8.12 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 114.655 -3.641 . . . . 0.0 111.231 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 1.389 ' CB ' ' N ' ' A' ' 71' ' ' THR 0.428 0.0 OUTLIER -79.61 155.32 28.17 Favored 'General case' 1 N--CA 1.367 -4.62 0 CA-C-N 109.742 -3.229 . . . . 0.0 114.009 176.685 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.05 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.2 t -147.26 120.08 8.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 114.632 -2.827 . . . . 0.0 109.151 158.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 115.623 -2.431 . . . . 0.0 106.768 174.629 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.09 -124.44 2.77 Favored Glycine 0 CA--C 1.555 2.559 0 C-N-CA 114.449 -3.739 . . . . 0.0 110.513 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 mt -104.49 98.14 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 114.781 -2.768 . . . . 0.0 109.812 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.27 -69.15 3.05 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 114.843 -3.551 . . . . 0.0 111.298 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.48 166.41 20.36 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 115.316 -2.553 . . . . 0.0 108.882 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -123.46 150.18 44.18 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 115.351 -2.54 . . . . 0.0 109.503 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -120.93 124.27 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 115.158 -2.617 . . . . 0.0 108.888 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.8 m -109.69 146.56 34.65 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 116.337 -2.145 . . . . 0.0 108.02 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 1.389 ' N ' ' CB ' ' A' ' 60' ' ' HIS . 4.3 m -109.52 103.22 12.07 Favored 'General case' 1 N--CA 1.558 4.963 0 C-N-CA 116.788 -1.965 . . . . 0.0 112.071 175.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 90.2 m -60.83 143.38 54.84 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 115.913 -2.315 . . . . 0.0 107.86 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.2 166.95 15.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.548 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.45 96.57 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 115.711 -2.396 . . . . 0.0 108.822 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.38 -39.71 0.61 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 114.898 -3.525 . . . . 0.0 108.384 -168.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.22 166.81 11.27 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 115.441 -2.503 . . . . 0.0 108.305 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 37.7 tt0 -157.64 112.78 2.73 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 115.091 -2.644 . . . . 0.0 109.229 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.58 174.78 35.5 Favored Glycine 0 C--O 1.212 -1.276 0 C-N-CA 114.472 -3.728 . . . . 0.0 111.223 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -45.32 -58.02 3.6 Favored 'General case' 0 N--CA 1.398 -3.027 0 C-N-CA 115.994 -2.282 . . . . 0.0 111.458 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.663 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 39.2 m-20 -106.28 18.09 22.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 114.924 -2.71 . . . . 0.0 109.121 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.9 m 76.34 18.56 1.82 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 115.662 -2.415 . . . . 0.0 108.708 -174.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.93 -32.59 73.91 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 116.865 -1.934 . . . . 0.0 110.273 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 77' ' ' GLU . 87.0 m-85 -91.32 168.02 11.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 115.216 -2.594 . . . . 0.0 110.387 -176.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 89.9 p -117.64 154.76 31.04 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 115.616 -2.434 . . . . 0.0 108.816 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.2 p -91.38 33.96 0.97 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 114.547 -2.861 . . . . 0.0 110.475 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 116.226 -2.189 . . . . 0.0 108.55 179.238 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -139.72 161.68 36.96 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 115.626 -2.43 . . . . 0.0 108.824 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.34 -74.66 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.604 0 C-N-CA 116.158 -2.925 . . . . 0.0 109.718 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -127.09 111.86 14.51 Favored 'General case' 0 C--N 1.381 1.974 0 O-C-N 120.158 -1.789 . . . . 0.0 110.369 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 3.3 mp0 -96.51 0.06 49.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 114.709 -2.796 . . . . 0.0 110.073 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.155 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.9 t -126.8 18.15 7.32 Favored 'General case' 0 N--CA 1.508 2.437 0 C-N-CA 115.629 -2.429 . . . . 0.0 108.943 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -74.99 33.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 116.318 -2.153 . . . . 0.0 111.068 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.42 29.26 0.96 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 114.098 -3.906 . . . . 0.0 110.347 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 49.72 80.81 0.28 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.144 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -85.92 -35.53 0.14 Allowed 'Trans proline' 0 N--CA 1.404 -3.778 0 C-N-CA 121.334 1.356 . . . . 0.0 110.994 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.1 m -79.52 143.48 34.82 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 115.115 -2.634 . . . . 0.0 111.213 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.599 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.3 mt -102.44 175.02 5.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.512 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 30.02 62.95 0.17 Allowed 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 116.859 -1.936 . . . . 0.0 111.979 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 56.92 83.37 0.1 Allowed 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 117.089 -1.844 . . . . 0.0 109.272 170.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.72 161.44 20.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 115.75 -3.119 . . . . 0.0 109.536 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.554 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 43.4 t-80 -91.01 155.41 18.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 116.395 -2.122 . . . . 0.0 108.317 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.155 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 50.7 t -131.6 126.73 35.48 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 114.77 -2.772 . . . . 0.0 110.927 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 114.578 -2.849 . . . . 0.0 108.196 176.319 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.48 -94.69 0.1 Allowed Glycine 0 N--CA 1.473 1.107 0 C-N-CA 114.431 -3.747 . . . . 0.0 111.377 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.2 mt -109.26 58.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 114.658 -2.817 . . . . 0.0 108.524 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.424 ' CA ' ' HG2' ' A' ' 49' ' ' GLN . . . 89.64 -55.02 3.81 Favored Glycine 0 N--CA 1.478 1.469 0 C-N-CA 114.673 -3.632 . . . . 0.0 112.269 173.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.711 ' C ' ' CD1' ' A' ' 68' ' ' TYR . 5.9 p-10 -80.55 -19.46 45.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 115.845 -2.342 . . . . 0.0 112.059 -174.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.711 ' CD1' ' C ' ' A' ' 67' ' ' ASP . 38.7 p90 51.36 166.5 0.01 OUTLIER 'General case' 1 C--N 1.218 -5.113 0 CA-C-N 111.478 -2.601 . . . . 0.0 112.727 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -141.43 129.33 21.84 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 116.13 -2.228 . . . . 0.0 108.905 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -100.74 127.25 47.23 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.569 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -94.97 149.95 20.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.91 -2.316 . . . . 0.0 109.49 176.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.898 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 84.4 m -99.27 156.35 17.03 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 115.132 -2.627 . . . . 0.0 109.299 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.47 164.57 26.48 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 115.371 -2.532 . . . . 0.0 109.455 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.82 102.98 0.39 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 115.014 -2.675 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.0 -33.3 1.38 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 114.502 -3.713 . . . . 0.0 110.201 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.69 164.41 12.77 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 116.082 -2.247 . . . . 0.0 109.162 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -159.38 118.49 2.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 115.618 -2.433 . . . . 0.0 109.225 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 169.79 170.11 33.84 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 114.29 -3.814 . . . . 0.0 110.288 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 85.1 tttt -41.0 -54.67 2.72 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 115.648 -2.421 . . . . 0.0 110.711 176.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.641 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 61.4 m-20 -110.83 15.81 21.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 115.731 -2.388 . . . . 0.0 109.862 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.898 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.1 m 74.01 28.34 1.5 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 115.092 -2.643 . . . . 0.0 109.338 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -70.08 -31.51 69.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 116.245 -2.182 . . . . 0.0 110.523 -177.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.81 147.45 23.79 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 114.708 -2.797 . . . . 0.0 109.954 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -110.4 115.71 30.13 Favored 'General case' 0 C--O 1.256 1.425 0 C-N-CA 115.95 -2.3 . . . . 0.0 107.88 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 85' ' ' THR . 6.7 t -97.13 33.39 1.95 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 115.175 -2.61 . . . . 0.0 111.937 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 . . . . . 0 CA--C 1.469 -2.142 0 C-N-CA 115.685 -2.406 . . . . 0.0 111.045 -177.857 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 pttm . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -122.31 91.53 3.52 Favored 'General case' 0 C--O 1.3 3.729 1 C-N-CA 110.684 -4.407 . . . . 0.0 108.511 -175.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.62 174.4 48.1 Favored Glycine 0 C--N 1.374 2.664 0 C-N-CA 115.234 -3.365 . . . . 0.0 111.493 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -119.54 119.59 34.26 Favored 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 114.586 -2.846 . . . . 0.0 111.173 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 3.4 mp0 -104.53 7.13 35.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 115.985 -2.286 . . . . 0.0 111.173 -177.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.6 t -128.33 8.48 6.01 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 116.201 -2.2 . . . . 0.0 110.226 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.76 24.32 0.06 Allowed 'General case' 0 C--O 1.249 1.075 0 C-N-CA 115.49 -2.484 . . . . 0.0 112.044 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -144.72 23.74 1.98 Allowed Glycine 0 C--N 1.341 0.836 0 C-N-CA 114.559 -3.686 . . . . 0.0 111.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 45.78 78.63 0.38 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 115.98 -2.288 . . . . 0.0 110.223 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.68 -33.77 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 N-CA-C 110.071 -0.781 . . . . 0.0 110.071 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.031 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.2 m -76.35 152.52 36.32 Favored 'General case' 0 C--O 1.261 1.667 0 C-N-CA 116.159 -2.216 . . . . 0.0 109.568 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.2 mt -105.3 171.6 7.24 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 116.782 -1.967 . . . . 0.0 109.958 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 56' ' ' LEU . 27.8 m-80 36.17 61.45 0.77 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 117.566 -1.653 . . . . 0.0 111.734 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 48.68 51.21 16.03 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 115.664 -2.414 . . . . 0.0 110.109 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.6 171.6 45.57 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 114.702 -3.618 . . . . 0.0 109.737 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -88.67 145.95 25.36 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.212 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 51.9 t -134.03 124.64 26.57 Favored 'General case' 0 N--CA 1.417 -2.081 0 C-N-CA 115.449 -2.5 . . . . 0.0 109.126 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.1 tptt . . . . . 0 C--O 1.252 1.205 0 C-N-CA 115.578 -2.449 . . . . 0.0 109.454 -179.881 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.13 -131.09 3.45 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 115.613 -3.184 . . . . 0.0 111.183 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 57.2 mt -87.86 90.48 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 113.724 -3.19 . . . . 0.0 108.038 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 78.77 -72.31 2.44 Favored Glycine 0 N--CA 1.496 2.679 1 C-N-CA 113.859 -4.019 . . . . 0.0 109.257 -178.044 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -72.23 166.25 22.79 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 115.746 -2.382 . . . . 0.0 109.706 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -115.91 163.72 15.47 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 116.303 -2.159 . . . . 0.0 109.568 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 p -128.99 135.25 48.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 115.108 -2.637 . . . . 0.0 109.333 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.031 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 94.9 m -113.43 124.24 51.95 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.382 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.75 122.2 46.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 116.163 -2.215 . . . . 0.0 110.072 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.813 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.3 m -72.91 150.2 42.78 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 114.904 -2.718 . . . . 0.0 110.178 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 169.18 15.55 Favored 'General case' 0 C--O 1.254 1.338 0 C-N-CA 115.622 -2.431 . . . . 0.0 109.984 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.07 105.89 0.76 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 114.859 -2.736 . . . . 0.0 109.952 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.78 -40.56 1.08 Allowed Glycine 0 C--O 1.213 -1.194 0 C-N-CA 115.32 -3.324 . . . . 0.0 110.325 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.19 163.07 15.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 115.475 -2.49 . . . . 0.0 110.099 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -155.49 125.37 6.53 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 115.234 -2.586 . . . . 0.0 109.374 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 160.74 166.86 20.34 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.372 -4.251 . . . . 0.0 111.164 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 22.8 tptm -39.59 -53.72 2.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 116.403 -2.119 . . . . 0.0 109.449 175.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.663 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 41.8 m-20 -113.44 11.91 18.58 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 116.355 -2.138 . . . . 0.0 109.649 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.813 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.4 m 74.39 31.75 1.01 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.094 -2.642 . . . . 0.0 109.571 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.92 -36.25 79.84 Favored 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 116.474 -2.09 . . . . 0.0 110.243 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -89.45 145.85 25.04 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 114.941 -2.704 . . . . 0.0 109.53 -171.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.6 p -113.41 133.26 55.28 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 115.874 -2.33 . . . . 0.0 107.914 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.1 p -95.0 36.84 1.17 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 115.994 -2.282 . . . . 0.0 110.104 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.1 mtm-85 . . . . . 0 CA--C 1.556 1.18 0 C-N-CA 115.373 -2.531 . . . . 0.0 108.639 179.856 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.458 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 2.8 mp0 -98.01 -10.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 116.09 -2.244 . . . . 0.0 109.516 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 45.6 t -113.06 10.93 18.82 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 114.92 -2.712 . . . . 0.0 109.611 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -75.24 19.18 0.17 Allowed 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 115.107 -2.637 . . . . 0.0 111.418 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.68 27.8 3.65 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 114.67 -3.633 . . . . 0.0 111.337 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 48.86 73.94 0.91 Allowed Pre-proline 0 N--CA 1.498 1.943 0 C-N-CA 117.256 -1.778 . . . . 0.0 111.043 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.53 -35.35 1.16 Allowed 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 121.108 1.206 . . . . 0.0 110.686 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.2 m -89.11 148.72 23.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.735 -2.386 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.504 ' O ' ' C ' ' A' ' 57' ' ' ASN . 79.4 mt -100.91 174.5 5.99 Favored 'General case' 0 C--O 1.268 2.049 0 C-N-CA 116.191 -2.203 . . . . 0.0 108.814 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 56' ' ' LEU . 7.0 m-80 34.27 68.57 0.18 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 118.167 -1.413 . . . . 0.0 111.477 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.485 ' C ' ' O ' ' A' ' 57' ' ' ASN . 11.3 pt20 36.51 54.09 1.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.669 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.21 178.09 41.68 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 115.623 -3.18 . . . . 0.0 109.573 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.511 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 45.4 t60 -89.8 136.96 32.73 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 115.436 -2.505 . . . . 0.0 108.437 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.68 129.02 30.02 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 115.287 -2.565 . . . . 0.0 109.237 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 115.661 -2.416 . . . . 0.0 108.121 174.678 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.396 0 CA-C-O 121.918 0.732 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 65' ' ' ILE . 28.2 mt -114.3 55.65 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 114.612 -2.835 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.7 -61.34 2.04 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 114.177 -3.868 . . . . 0.0 111.225 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.571 ' O ' ' O ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -78.92 3.74 16.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 115.721 -2.392 . . . . 0.0 110.07 -174.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.571 ' O ' ' O ' ' A' ' 67' ' ' ASP . 53.1 p90 39.68 179.04 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.191 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 p -139.74 145.8 38.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 115.946 -2.302 . . . . 0.0 107.694 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 25.2 m -131.56 119.12 21.04 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 114.955 -2.698 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -108.23 153.31 23.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 116.199 -2.2 . . . . 0.0 108.876 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 85.8 m -98.02 148.51 23.43 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 115.943 -2.303 . . . . 0.0 109.846 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.61 27.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 115.26 -2.576 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.64 102.28 0.71 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 114.902 -2.719 . . . . 0.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.22 -43.91 0.65 Allowed Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 115.411 -3.28 . . . . 0.0 108.902 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.91 155.96 18.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 116.308 -2.157 . . . . 0.0 109.502 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -146.74 142.82 28.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.855 -2.338 . . . . 0.0 108.936 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 140.68 166.82 10.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 114.174 -3.869 . . . . 0.0 109.605 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 78' ' ' GLY . 53.0 tptt -42.4 -54.36 3.85 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.664 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.607 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 21.7 m-20 -109.26 14.34 23.84 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.942 -1.903 . . . . 0.0 109.492 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 4.0 m 72.24 25.17 2.93 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 115.262 -2.575 . . . . 0.0 108.839 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -71.64 -30.38 65.69 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.928 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 . . . . . 0 CA--C 1.506 -0.714 0 C-N-CA 115.918 -2.313 . . . . 0.0 109.021 -177.3 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.928 0.871 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 15.7 mp0 -94.67 -23.84 17.42 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 116.634 -2.026 . . . . 0.0 108.466 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 41.9 t -90.62 20.98 4.24 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 115.702 -2.399 . . . . 0.0 110.422 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.97 26.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.758 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -139.27 19.9 3.02 Favored Glycine 0 C--N 1.319 -0.375 0 C-N-CA 114.782 -3.58 . . . . 0.0 110.289 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.496 ' C ' ' O ' ' A' ' 52' ' ' GLY . 51.5 t60 40.66 72.97 0.93 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 116.797 -1.961 . . . . 0.0 109.809 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 5.1 Cg_exo -81.21 -37.02 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.607 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.9 m -77.68 143.92 37.75 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 114.797 -2.761 . . . . 0.0 111.499 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.653 ' O ' ' C ' ' A' ' 57' ' ' ASN . 83.9 mt -103.43 178.15 4.64 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 116.296 -2.161 . . . . 0.0 110.426 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 56' ' ' LEU . 37.1 m-80 27.81 60.73 0.11 Allowed 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 118.188 -1.405 . . . . 0.0 111.539 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 48.3 tt0 66.87 73.05 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 116.681 -2.007 . . . . 0.0 111.771 168.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.03 160.16 17.57 Favored Glycine 0 C--N 1.363 2.031 1 C-N-CA 112.592 -4.623 . . . . 0.0 110.377 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -88.51 108.94 19.66 Favored 'General case' 0 C--O 1.254 1.29 0 C-N-CA 114.497 -2.881 . . . . 0.0 108.121 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 23.6 p -88.79 112.14 22.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.08 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.8 tptt . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 115.26 -2.576 . . . . 0.0 107.963 177.61 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.205 0 CA-C-O 123.347 1.526 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -92.39 87.22 2.4 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.882 0 C-N-CA 117.036 -1.866 . . . . 0.0 108.568 178.502 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.37 -67.18 3.12 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 114.285 -3.817 . . . . 0.0 111.062 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -74.72 164.5 26.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 116.04 -2.264 . . . . 0.0 110.096 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -129.37 162.14 28.7 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 116.367 -2.133 . . . . 0.0 108.87 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.3 p -132.79 142.52 49.04 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.199 -2.6 . . . . 0.0 109.636 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.0 m -106.1 119.73 39.97 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 115.134 -2.626 . . . . 0.0 109.201 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.29 126.09 41.25 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 115.832 -2.347 . . . . 0.0 109.233 173.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 35.7 m -82.27 158.39 23.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 114.529 -2.868 . . . . 0.0 110.208 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.33 166.9 22.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 115.181 -2.607 . . . . 0.0 108.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.13 112.24 1.83 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 114.585 -2.846 . . . . 0.0 109.202 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.96 -47.49 0.8 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 114.431 -3.747 . . . . 0.0 110.452 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 97.7 m-85 -104.95 167.5 9.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 115.805 -2.358 . . . . 0.0 109.903 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -158.18 -0.69 0.1 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 115.398 -2.521 . . . . 0.0 111.865 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . -63.8 168.51 23.1 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 115.696 -3.145 . . . . 0.0 110.649 175.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -47.71 -52.61 17.78 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.721 -1.992 . . . . 0.0 108.667 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.702 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 50.5 m-20 -93.7 16.84 12.98 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 115.017 -2.673 . . . . 0.0 107.39 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 14.6 m 76.21 23.57 1.21 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 116.079 -2.248 . . . . 0.0 108.443 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.12 -32.51 67.02 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 115.025 -2.67 . . . . 0.0 110.411 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 . . . . . 0 N--CA 1.473 0.716 0 C-N-CA 115.836 -2.345 . . . . 0.0 109.041 -178.525 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 . . . . . 0 C--O 1.203 -1.359 0 CA-C-O 121.135 0.493 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 91.3 mm-40 -79.17 -15.82 57.53 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 116.563 -2.055 . . . . 0.0 109.025 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 30.5 p -98.78 18.25 17.45 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 115.539 -2.464 . . . . 0.0 109.25 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -74.25 30.37 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 116.661 -2.016 . . . . 0.0 111.121 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -141.66 28.1 2.31 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 114.478 -3.725 . . . . 0.0 110.462 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' GLY . 72.5 m80 43.62 76.37 0.54 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 115.263 -2.575 . . . . 0.0 110.643 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -89.14 -32.99 0.11 Allowed 'Trans proline' 0 N--CA 1.427 -2.414 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 3.7 m -83.2 156.32 23.26 Favored 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 115.088 -2.645 . . . . 0.0 110.894 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.546 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.3 mt -98.6 173.16 7.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 117.009 -1.877 . . . . 0.0 108.703 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.546 ' C ' ' O ' ' A' ' 56' ' ' LEU . 21.1 m-80 36.99 60.04 1.02 Allowed 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 116.148 -2.221 . . . . 0.0 112.66 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 55.55 31.37 17.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 117.469 -1.693 . . . . 0.0 113.296 166.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.92 158.31 53.11 Favored Glycine 0 N--CA 1.504 3.185 1 C-N-CA 113.353 -4.261 . . . . 0.0 110.405 172.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.448 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 7.6 t-160 -88.38 172.01 9.71 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 115.204 -2.599 . . . . 0.0 109.48 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 30.9 p -139.95 122.76 16.49 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 114.592 -2.843 . . . . 0.0 109.31 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 115.171 -2.611 . . . . 0.0 108.972 176.419 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 CA-C-O 122.799 1.221 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.17 93.28 2.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 C-N-CA 114.86 -2.736 . . . . 0.0 107.741 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 89.36 -69.16 2.59 Favored Glycine 0 CA--C 1.548 2.133 0 C-N-CA 114.437 -3.744 . . . . 0.0 110.076 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -77.76 170.02 17.29 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 115.433 -2.507 . . . . 0.0 109.527 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -132.11 158.24 42.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.166 -2.214 . . . . 0.0 109.572 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -127.36 133.84 50.01 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 116.39 -2.124 . . . . 0.0 108.364 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.3 m -104.97 132.7 50.88 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.742 -2.783 . . . . 0.0 109.909 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -104.72 148.72 26.28 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 115.83 -2.348 . . . . 0.0 109.701 175.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.905 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 64.7 m -110.91 143.41 41.59 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 116.298 -2.161 . . . . 0.0 108.8 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.499 ' HB3' ' CD2' ' A' ' 76' ' ' PHE . . . -76.34 170.27 16.67 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 115.392 -2.523 . . . . 0.0 110.173 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.82 140.04 58.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 116.163 -2.215 . . . . 0.0 108.987 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.71 -21.19 43.27 Favored Glycine 0 N--CA 1.427 -1.957 1 C-N-CA 113.474 -4.203 . . . . 0.0 109.904 -174.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.499 ' CD2' ' HB3' ' A' ' 73' ' ' ALA . 65.7 m-85 -133.22 143.32 49.06 Favored 'General case' 0 CA--C 1.471 -2.065 0 C-N-CA 114.725 -2.79 . . . . 0.0 110.051 -170.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.576 ' C ' ' HA ' ' A' ' 81' ' ' CYS . 2.0 pt-20 -164.99 173.36 11.66 Favored 'General case' 1 N--CA 1.367 -4.619 0 C-N-CA 113.843 -3.143 . . . . 0.0 112.775 165.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 139.33 178.2 16.29 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 114.698 -3.62 . . . . 0.0 110.158 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 78' ' ' GLY . 29.1 ttpp -41.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 116.433 -2.107 . . . . 0.0 108.871 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.648 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 57.2 m-20 -118.28 24.49 10.92 Favored 'General case' 0 C--O 1.207 -1.167 0 C-N-CA 115.556 -2.458 . . . . 0.0 109.466 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.905 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.7 m 76.87 39.25 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 115.299 -2.56 . . . . 0.0 106.99 -170.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -88.25 -28.96 20.78 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 116.358 -2.137 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 77' ' ' GLU . 65.4 m-85 . . . . . 0 N--CA 1.483 1.214 0 C-N-CA 114.984 -2.687 . . . . 0.0 108.994 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 49' ' ' GLN . 31.2 t70 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.498 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 2.9 mp0 31.79 33.92 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 117.499 -1.681 . . . . 0.0 113.493 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.2 t -166.87 27.0 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 115.94 -2.304 . . . . 0.0 108.715 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -76.18 24.23 0.14 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 115.682 -2.407 . . . . 0.0 111.24 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -146.06 24.31 1.75 Allowed Glycine 0 N--CA 1.484 1.897 0 C-N-CA 114.062 -3.923 . . . . 0.0 110.56 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 22.2 t-160 42.79 78.37 0.39 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.299 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.51 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 5.0 Cg_exo -82.12 -33.83 0.53 Allowed 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 121.035 1.157 . . . . 0.0 110.961 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.072 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.6 m -75.85 149.27 37.87 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 115.39 -2.524 . . . . 0.0 110.464 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' O ' ' C ' ' A' ' 57' ' ' ASN . 70.7 mt -97.91 174.03 6.78 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 116.114 -2.234 . . . . 0.0 109.746 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.59 ' C ' ' O ' ' A' ' 56' ' ' LEU . 21.5 m-80 33.76 57.29 0.57 Allowed 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 115.845 -2.342 . . . . 0.0 114.118 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 56.62 41.99 27.69 Favored 'General case' 0 N--CA 1.515 2.811 0 C-N-CA 116.047 -2.261 . . . . 0.0 111.749 168.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.47 54.87 Favored Glycine 0 N--CA 1.444 -0.771 1 C-N-CA 113.653 -4.118 . . . . 0.0 110.125 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -93.36 133.12 36.94 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 114.65 -2.82 . . . . 0.0 109.438 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 88.4 m -98.43 105.49 17.64 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 114.742 -2.783 . . . . 0.0 107.338 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 N--CA 1.48 1.058 0 C-N-CA 115.513 -2.475 . . . . 0.0 107.696 176.425 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.605 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.74 85.02 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 C-N-CA 114.767 -2.773 . . . . 0.0 109.034 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.1 -60.56 4.58 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 115.803 -3.094 . . . . 0.0 110.932 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.98 167.52 21.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.554 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.53 159.1 44.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 114.748 -2.781 . . . . 0.0 108.923 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -137.04 132.25 33.94 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 115.146 -2.622 . . . . 0.0 108.395 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.072 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.8 m -91.46 129.09 37.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 116.059 -2.256 . . . . 0.0 109.761 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.3 m -107.46 106.07 16.29 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 114.827 -2.749 . . . . 0.0 109.677 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 77' ' ' GLU . 34.3 m -68.81 142.45 54.87 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 115.473 -2.491 . . . . 0.0 109.95 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.54 169.2 18.7 Favored 'General case' 0 C--O 1.26 1.649 0 C-N-CA 115.503 -2.479 . . . . 0.0 111.69 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.71 143.25 31.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 115.691 -2.404 . . . . 0.0 109.783 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.16 -23.73 34.84 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 115.11 -3.424 . . . . 0.0 110.292 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -131.48 143.87 50.73 Favored 'General case' 0 N--CA 1.407 -2.578 0 C-N-CA 114.484 -2.887 . . . . 0.0 110.243 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.579 ' C ' ' HA ' ' A' ' 81' ' ' CYS . 2.0 pt-20 -164.85 178.07 7.45 Favored 'General case' 1 N--CA 1.37 -4.461 0 C-N-CA 112.766 -3.574 . . . . 0.0 112.747 164.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 133.25 175.51 13.99 Favored Glycine 0 N--CA 1.484 1.864 0 C-N-CA 115.308 -3.33 . . . . 0.0 109.745 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.8 tttp -38.66 -52.21 1.66 Allowed 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 116.147 -2.221 . . . . 0.0 110.622 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 61.9 m-20 -119.55 20.39 12.41 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 116.412 -2.115 . . . . 0.0 108.471 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 4.5 m 79.57 43.66 0.06 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 115.884 -2.326 . . . . 0.0 107.816 -171.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -92.0 -30.5 16.03 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.549 -2.06 . . . . 0.0 109.468 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' A' ' 77' ' ' GLU . 59.1 m-85 . . . . . 0 CA--C 1.465 -2.299 0 C-N-CA 115.55 -2.46 . . . . 0.0 107.179 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 94.6 mm-40 -83.0 13.83 3.74 Favored 'General case' 0 C--O 1.257 1.47 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.775 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 25.6 t -140.37 22.8 2.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 115.407 -2.517 . . . . 0.0 109.892 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.79 30.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 115.318 -2.553 . . . . 0.0 112.071 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.97 27.84 0.58 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 114.037 -3.935 . . . . 0.0 110.218 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.1 m80 48.44 71.39 1.61 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 115.6 -2.44 . . . . 0.0 112.086 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -76.97 -31.15 3.98 Favored 'Trans proline' 0 N--CA 1.413 -3.258 0 C-N-CA 122.224 1.949 . . . . 0.0 109.091 -177.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 14.5 m -83.92 158.65 21.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.998 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 57' ' ' ASN . 62.9 mt -104.43 165.48 11.03 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 117.773 -1.571 . . . . 0.0 108.896 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.524 ' C ' ' O ' ' A' ' 56' ' ' LEU . 15.9 m-80 34.28 63.73 0.41 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 118.181 -1.407 . . . . 0.0 111.552 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 53.88 59.03 4.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 115.4 -2.52 . . . . 0.0 111.553 169.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.23 170.69 52.81 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 114.223 -3.846 . . . . 0.0 110.91 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -97.09 104.96 17.03 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 115.383 -2.527 . . . . 0.0 108.124 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 53.5 t -95.25 118.57 32.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 114.372 -2.931 . . . . 0.0 109.676 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? . . . . . 0 C--O 1.215 -0.732 0 C-N-CA 116.356 -2.137 . . . . 0.0 108.032 174.559 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.71 100.1 9.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 115.305 -2.558 . . . . 0.0 108.762 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 86.07 -72.81 2.63 Favored Glycine 0 N--CA 1.477 1.386 0 C-N-CA 114.04 -3.933 . . . . 0.0 110.187 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.72 166.52 22.87 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.436 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -128.82 159.63 35.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 115.929 -2.308 . . . . 0.0 108.724 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.3 p -130.54 130.43 44.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 116.068 -2.253 . . . . 0.0 109.394 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 69.3 m -107.35 139.27 42.1 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 115.475 -2.49 . . . . 0.0 109.961 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.08 121.96 36.58 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 116.293 -2.163 . . . . 0.0 109.072 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 33.7 m -73.79 148.05 42.85 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 115.659 -2.416 . . . . 0.0 110.881 -176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.9 166.24 11.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 115.873 -2.331 . . . . 0.0 109.146 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -53.78 115.42 1.98 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.513 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.45 ' O ' ' CE1' ' A' ' 76' ' ' PHE . . . 136.27 -34.67 2.22 Favored Glycine 0 C--O 1.262 1.862 0 C-N-CA 115.007 -3.473 . . . . 0.0 110.363 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 81' ' ' CYS 0.266 28.9 m-85 -133.84 162.84 30.92 Favored 'General case' 0 CA--C 1.568 1.669 0 C-N-CA 118.145 -1.422 . . . . 0.0 107.686 -172.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.063 ' N ' ' O ' ' A' ' 83' ' ' PHE . 3.7 tm-20 -161.25 136.86 7.86 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 113.726 -3.19 . . . . 0.0 112.126 175.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 142.16 178.39 18.17 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 114.52 -3.705 . . . . 0.0 110.604 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' GLY . 62.9 tttm -46.84 -61.33 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 115.339 -2.544 . . . . 0.0 111.342 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.701 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 68.7 m-20 -93.09 5.35 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.1 m 79.91 72.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 115.927 -2.309 . . . . 0.0 106.972 -164.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -107.25 -29.82 9.1 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.002 -176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 1.063 ' O ' ' N ' ' A' ' 77' ' ' GLU . 80.8 m-85 . . . . . 0 C--O 1.19 -2.063 0 C-N-CA 116.904 -1.919 . . . . 0.0 108.049 164.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 . . . . . 0 CA--C 1.552 1.023 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -96.09 -8.56 33.03 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 116.207 -2.197 . . . . 0.0 108.49 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.198 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 18.3 t -102.25 -19.73 14.93 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.212 -2.595 . . . . 0.0 110.97 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -74.77 13.99 0.56 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 114.633 -2.827 . . . . 0.0 109.458 178.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -97.58 12.58 64.62 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 114.503 -3.713 . . . . 0.0 110.095 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.418 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 89.4 m-70 45.43 71.06 1.66 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 115.468 -2.493 . . . . 0.0 110.551 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.0 OUTLIER -84.47 -34.72 0.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.36 0 O-C-N 122.401 0.685 . . . . 0.0 110.674 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 m -92.63 156.26 17.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 116.219 -2.192 . . . . 0.0 109.945 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 57' ' ' ASN . 89.5 mt -103.04 176.29 5.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 116.645 -2.022 . . . . 0.0 109.308 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 56' ' ' LEU . 16.4 m-80 29.81 63.42 0.15 Allowed 'General case' 0 N--CA 1.4 -2.968 0 C-N-CA 116.801 -1.96 . . . . 0.0 113.11 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 51.51 55.75 8.93 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 115.734 -2.387 . . . . 0.0 110.721 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.93 172.24 55.17 Favored Glycine 0 CA--C 1.536 1.349 1 C-N-CA 113.463 -4.208 . . . . 0.0 109.346 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -90.83 87.7 6.76 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 115.276 -2.569 . . . . 0.0 108.795 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.198 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.6 t -89.0 125.12 34.85 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 115.852 -2.339 . . . . 0.0 109.558 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.9 tptt . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 115.863 -2.335 . . . . 0.0 107.985 176.366 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 123.11 1.395 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 67.2 mt -88.63 76.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 116.315 -2.154 . . . . 0.0 108.075 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.27 -68.74 3.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 115.16 -3.4 . . . . 0.0 109.982 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.59 165.5 24.98 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 115.914 -2.315 . . . . 0.0 110.407 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.85 157.42 23.32 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 115.312 -2.555 . . . . 0.0 109.186 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.4 p -124.88 134.27 52.76 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.099 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 90.6 m -108.56 132.33 53.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.728 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 123.41 40.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 115.887 -2.325 . . . . 0.0 109.226 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.8 m -75.08 143.99 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 115.373 -2.531 . . . . 0.0 109.724 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 170.06 15.36 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.612 -2.435 . . . . 0.0 110.292 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -59.12 132.38 53.86 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 115.931 -2.307 . . . . 0.0 109.075 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.41 -20.62 36.97 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 115.453 -3.26 . . . . 0.0 110.007 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.36 152.41 39.02 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 115.742 -2.383 . . . . 0.0 109.067 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -161.68 121.15 2.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.368 -2.533 . . . . 0.0 110.331 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 163.51 173.96 32.81 Favored Glycine 0 CA--C 1.55 2.259 1 C-N-CA 113.278 -4.296 . . . . 0.0 110.293 176.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 78' ' ' GLY . 14.6 tppt? -41.92 -55.69 3.02 Favored 'General case' 0 N--CA 1.417 -2.107 0 C-N-CA 115.881 -2.327 . . . . 0.0 110.896 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.699 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 47.8 m-20 -113.59 17.07 18.53 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.699 -2.401 . . . . 0.0 109.321 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.9 m 76.73 32.51 0.52 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 114.699 -2.8 . . . . 0.0 109.446 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.98 -30.15 62.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 115.165 -2.614 . . . . 0.0 109.735 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 . . . . . 0 N--CA 1.478 0.972 0 C-N-CA 116.022 -2.271 . . . . 0.0 110.387 -175.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 CA--C 1.571 1.768 0 CA-C-O 121.252 0.549 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 12.2 mp0 -94.11 -7.51 42.27 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 114.95 -2.7 . . . . 0.0 111.124 -171.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.7 t -125.08 12.25 8.31 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 115.31 -2.556 . . . . 0.0 110.452 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -75.41 17.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 113.909 -3.116 . . . . 0.0 110.444 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -117.38 17.82 12.29 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 115.554 -3.213 . . . . 0.0 109.537 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 44.07 74.7 0.74 Allowed Pre-proline 0 CA--C 1.568 1.66 0 C-N-CA 115.297 -2.561 . . . . 0.0 111.136 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.06 -40.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.974 0 C-N-CA 121.595 1.53 . . . . 0.0 110.051 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 m -74.97 152.96 38.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 115.175 -2.61 . . . . 0.0 108.842 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' ASN . 75.1 mt -103.9 170.8 7.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 116.464 -2.094 . . . . 0.0 108.877 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LEU . 8.8 m-80 33.81 62.41 0.43 Allowed 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.748 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 49.93 62.35 2.7 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.689 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.97 168.66 32.87 Favored Glycine 0 C--O 1.251 1.158 1 C-N-CA 113.511 -4.185 . . . . 0.0 110.088 172.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.402 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 8.0 t-80 -89.31 164.39 14.94 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.028 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 91.0 m -131.44 119.24 21.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 114.96 -2.696 . . . . 0.0 110.031 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.8 tptt . . . . . 0 C--O 1.25 1.09 0 C-N-CA 115.992 -2.283 . . . . 0.0 107.015 175.625 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.33 81.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 115.788 -2.365 . . . . 0.0 108.162 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.63 -59.19 3.7 Favored Glycine 0 C--N 1.343 0.944 1 C-N-CA 113.53 -4.176 . . . . 0.0 110.838 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.98 168.16 20.57 Favored 'General case' 0 C--O 1.259 1.597 0 C-N-CA 116.587 -2.045 . . . . 0.0 108.744 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.77 161.97 41.79 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 115.942 -2.303 . . . . 0.0 108.591 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 p -139.71 129.41 24.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 116.121 -2.232 . . . . 0.0 109.617 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 65.5 m -88.92 136.41 33.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 114.947 -2.701 . . . . 0.0 109.778 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -109.33 124.38 50.86 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 115.924 -2.31 . . . . 0.0 108.982 175.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 66.2 m -77.04 152.95 34.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.994 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.15 171.61 13.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 115.521 -2.471 . . . . 0.0 110.848 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.48 94.19 0.54 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 116.612 -2.035 . . . . 0.0 108.471 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.68 -30.06 0.93 Allowed Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 114.98 -3.486 . . . . 0.0 109.204 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -116.6 163.5 16.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 115.493 -2.483 . . . . 0.0 108.825 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -156.11 139.79 16.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 144.75 168.22 12.58 Favored Glycine 0 C--N 1.294 -1.766 1 C-N-CA 113.807 -4.044 . . . . 0.0 111.434 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 78' ' ' GLY . 39.1 ttpt -50.92 -54.71 21.78 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 115.556 -2.457 . . . . 0.0 109.957 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.724 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 70.7 m-20 -104.17 8.68 36.34 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.085 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.4 m 81.47 43.04 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 115.185 -2.606 . . . . 0.0 108.497 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.34 -18.23 42.88 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 115.455 -2.498 . . . . 0.0 109.854 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.5 2.066 0 C-N-CA 114.95 -2.7 . . . . 0.0 110.072 -178.124 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 . . . . . 0 N--CA 1.514 2.765 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 10.2 mp0 -97.99 -8.16 28.51 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.38 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.114 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.4 t -115.01 -10.76 12.21 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 115.238 -2.585 . . . . 0.0 111.288 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.99 20.17 0.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 116.003 -2.279 . . . . 0.0 111.26 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -132.31 24.9 3.91 Favored Glycine 0 C--N 1.311 -0.837 0 C-N-CA 114.344 -3.788 . . . . 0.0 111.294 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 49.62 84.13 0.21 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.96 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -95.47 -32.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.932 0 O-C-N 123.67 1.352 . . . . 0.0 109.115 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 34.1 m -81.56 163.01 22.94 Favored 'General case' 0 C--O 1.255 1.342 0 C-N-CA 114.007 -3.077 . . . . 0.0 110.937 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.523 ' O ' ' C ' ' A' ' 57' ' ' ASN . 94.5 mt -113.93 172.91 6.71 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 115.717 -2.393 . . . . 0.0 109.481 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.621 HD21 ' HA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 43.05 49.58 5.38 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 116.881 -1.928 . . . . 0.0 110.334 172.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.462 ' NE2' ' N ' ' A' ' 58' ' ' GLN . 9.6 mp0 57.62 48.22 14.57 Favored 'General case' 0 C--O 1.272 2.284 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.2 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.78 160.56 34.15 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 114.917 -3.516 . . . . 0.0 111.01 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -87.5 158.29 18.97 Favored 'General case' 0 C--N 1.275 -2.647 0 C-N-CA 115.219 -2.592 . . . . 0.0 109.02 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.114 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 38.9 t -144.84 128.33 17.0 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 114.14 -3.024 . . . . 0.0 111.305 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.7 tptp . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 115.666 -2.414 . . . . 0.0 108.149 175.169 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.311 0 CA-C-O 123.837 1.798 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.39 89.51 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 114.643 -2.823 . . . . 0.0 109.829 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.665 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 80.79 -68.68 3.35 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 115.232 -3.366 . . . . 0.0 110.156 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.83 -174.47 3.06 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 114.243 -2.983 . . . . 0.0 109.569 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -139.19 166.87 23.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 116.184 -2.206 . . . . 0.0 110.737 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 p -133.18 143.52 49.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.5 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.9 m -117.53 141.49 48.3 Favored 'General case' 0 C--O 1.213 -0.843 0 C-N-CA 113.595 -3.242 . . . . 0.0 110.143 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.59 162.27 13.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 115.525 -2.47 . . . . 0.0 108.139 172.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.824 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 74.0 m -111.08 154.81 23.73 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 114.293 -2.963 . . . . 0.0 108.366 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.13 165.45 20.34 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 113.783 -3.167 . . . . 0.0 110.704 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.22 97.64 0.19 Allowed 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.31 -2.556 . . . . 0.0 109.604 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.68 -42.98 0.59 Allowed Glycine 0 N--CA 1.428 -1.858 0 C-N-CA 114.667 -3.635 . . . . 0.0 109.435 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -105.09 166.6 10.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.181 -2.608 . . . . 0.0 108.7 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -159.04 123.24 3.95 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 114.941 -2.703 . . . . 0.0 109.46 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 162.68 167.21 22.77 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 116.345 -2.836 . . . . 0.0 111.338 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 78' ' ' GLY . 10.8 tmtt? -44.27 -55.53 4.82 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 116.3 -2.16 . . . . 0.0 110.125 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.779 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 26.3 m-20 -102.13 5.36 40.31 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 115.095 -2.642 . . . . 0.0 109.428 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.824 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 25.0 m 79.21 14.82 1.05 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 115.46 -2.496 . . . . 0.0 109.569 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.621 ' HA ' HD21 ' A' ' 57' ' ' ASN . 29.2 tt0 -55.68 -27.01 47.79 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 115.434 -2.506 . . . . 0.0 111.693 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 C--N 1.315 -0.916 0 C-N-CA 115.404 -2.518 . . . . 0.0 110.3 -172.87 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 C--O 1.214 -0.781 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -98.68 -17.81 18.38 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 114.514 -2.875 . . . . 0.0 109.751 -174.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.445 ' C ' ' H ' ' A' ' 52' ' ' GLY . 36.8 t -82.65 -15.67 51.15 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 115.363 -2.535 . . . . 0.0 109.247 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.94 20.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 115.748 -2.381 . . . . 0.0 110.745 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -111.55 9.85 28.23 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 114.362 -3.78 . . . . 0.0 110.715 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.489 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 13.4 t-160 50.98 67.3 4.43 Favored Pre-proline 0 C--N 1.366 1.287 0 C-N-CA 116.41 -2.116 . . . . 0.0 109.067 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.2 Cg_endo -83.77 -30.46 0.77 Allowed 'Trans proline' 0 N--CA 1.419 -2.871 0 C-N-CA 121.071 1.181 . . . . 0.0 110.431 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.952 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.3 m -87.66 147.86 25.06 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 116.314 -2.154 . . . . 0.0 110.727 -175.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 57' ' ' ASN . 76.9 mt -94.85 172.7 8.0 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.472 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.557 ' C ' ' O ' ' A' ' 56' ' ' LEU . 16.8 m-80 32.68 61.83 0.36 Allowed 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 117.337 -1.745 . . . . 0.0 114.245 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 52.55 41.9 31.23 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.956 -1.498 . . . . 0.0 110.786 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.59 174.03 52.81 Favored Glycine 0 C--N 1.373 2.638 0 C-N-CA 113.946 -3.978 . . . . 0.0 109.008 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -88.76 147.95 24.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 115.123 -2.631 . . . . 0.0 108.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.9 t -140.18 123.99 17.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 115.699 -2.401 . . . . 0.0 110.599 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm . . . . . 0 CA--C 1.541 0.607 0 C-N-CA 115.374 -2.53 . . . . 0.0 108.791 176.244 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.463 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.5 mm -80.88 86.28 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 116.358 -2.137 . . . . 0.0 108.684 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.63 -72.32 2.0 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 114.323 -3.799 . . . . 0.0 110.158 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.25 167.89 19.45 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 115.214 -2.594 . . . . 0.0 109.493 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -113.3 152.72 29.52 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 115.757 -2.377 . . . . 0.0 109.075 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 114.897 -2.721 . . . . 0.0 109.469 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.952 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 63.0 m -105.14 137.22 43.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 115.933 -2.307 . . . . 0.0 109.854 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.96 114.01 20.38 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 116.89 -1.924 . . . . 0.0 108.532 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 32.4 m -71.97 145.15 48.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 116.505 -2.078 . . . . 0.0 108.996 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 169.04 14.05 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 116.264 -2.174 . . . . 0.0 110.063 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.73 145.81 6.49 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 115.92 -2.312 . . . . 0.0 110.214 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.72 -22.56 39.71 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 114.795 -3.574 . . . . 0.0 109.751 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.53 145.24 51.64 Favored 'General case' 0 CA--C 1.476 -1.899 0 C-N-CA 115.916 -2.314 . . . . 0.0 112.055 -173.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.6 ' C ' ' HA ' ' A' ' 81' ' ' CYS . 0.8 OUTLIER -165.56 174.53 9.8 Favored 'General case' 0 N--CA 1.399 -2.996 0 C-N-CA 114.066 -3.054 . . . . 0.0 112.632 164.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 137.76 171.74 12.29 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 116.507 -2.759 . . . . 0.0 110.642 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 78' ' ' GLY . 63.9 tttm -39.39 -52.81 2.05 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 116.976 -1.89 . . . . 0.0 110.179 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 67.6 m-20 -115.16 20.95 14.6 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 116.376 -2.129 . . . . 0.0 108.746 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.0 m 76.53 40.8 0.21 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 115.309 -2.556 . . . . 0.0 108.825 -171.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -88.87 -28.85 20.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 116.213 -2.195 . . . . 0.0 109.003 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 77' ' ' GLU . 62.9 m-85 . . . . . 0 CA--C 1.498 -1.04 0 C-N-CA 116.432 -2.107 . . . . 0.0 107.324 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 7.4 mp0 -96.14 -15.24 22.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 114.481 -2.887 . . . . 0.0 110.862 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.4 t -121.79 20.3 10.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 115.581 -2.447 . . . . 0.0 110.264 -175.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -74.98 33.21 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 116.567 -2.053 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -153.91 23.6 0.71 Allowed Glycine 0 N--CA 1.47 0.961 0 C-N-CA 114.411 -3.757 . . . . 0.0 110.997 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.8 t-160 47.15 75.17 0.69 Allowed Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 115.931 -2.308 . . . . 0.0 109.123 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.4 Cg_endo -82.49 -34.11 0.44 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 120.566 0.844 . . . . 0.0 111.123 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 10.6 m -71.57 164.1 26.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 115.636 -2.425 . . . . 0.0 109.403 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.7 mt -114.8 170.81 8.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 116.473 -2.091 . . . . 0.0 110.094 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.492 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 35.32 57.28 0.84 Allowed 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 115.811 -2.355 . . . . 0.0 114.732 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 56.7 mt-30 60.5 39.6 18.01 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.113 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 161.52 50.32 Favored Glycine 1 N--CA 1.521 4.352 1 C-N-CA 113.739 -4.077 . . . . 0.0 110.847 175.905 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -89.34 167.05 13.35 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 114.987 -2.685 . . . . 0.0 107.75 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 48.5 t -136.45 133.28 36.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 113.249 -3.38 . . . . 0.0 110.126 -172.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 115.702 -2.399 . . . . 0.0 107.635 175.645 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.01 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.16 88.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 115.544 -2.462 . . . . 0.0 107.234 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.75 -64.02 4.0 Favored Glycine 0 CA--C 1.545 1.966 0 C-N-CA 115.222 -3.37 . . . . 0.0 110.252 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -76.58 164.72 25.66 Favored 'General case' 0 C--O 1.26 1.629 0 C-N-CA 115.542 -2.463 . . . . 0.0 110.096 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -134.76 163.0 30.78 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 115.65 -2.42 . . . . 0.0 108.624 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 p -137.18 132.28 33.69 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.372 -2.531 . . . . 0.0 108.293 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 41.4 m -97.53 141.29 30.76 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 114.851 -2.74 . . . . 0.0 110.149 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 111.71 24.31 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 115.764 -2.375 . . . . 0.0 109.057 173.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.941 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.1 m -71.49 148.75 46.48 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 115.979 -2.288 . . . . 0.0 111.232 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.11 168.79 19.48 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 115.114 -2.635 . . . . 0.0 110.248 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.12 140.06 56.24 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 115.216 -2.594 . . . . 0.0 108.888 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.48 -14.91 61.75 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 116.317 -2.849 . . . . 0.0 110.425 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.17 150.18 49.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 116.268 -2.173 . . . . 0.0 110.334 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.73 130.87 11.11 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 115.72 -2.392 . . . . 0.0 108.755 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 154.15 163.36 11.84 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 114.314 -3.803 . . . . 0.0 110.993 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.9 tttm -43.83 -50.26 7.93 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.57 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 42.1 m-20 -110.62 10.98 22.9 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 116.001 -2.28 . . . . 0.0 110.33 175.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.941 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 21.9 m 78.01 30.58 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 116.067 -2.253 . . . . 0.0 108.237 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.44 -32.21 68.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.518 -2.073 . . . . 0.0 109.449 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--N 1.319 -0.728 0 C-N-CA 114.926 -2.71 . . . . 0.0 109.525 -176.498 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 N--CA 1.475 0.775 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 7.7 mp0 -89.83 -9.61 48.45 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 116.656 -2.018 . . . . 0.0 109.539 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.466 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.3 t -116.37 1.82 13.09 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 114.425 -2.91 . . . . 0.0 109.979 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -74.99 20.33 0.13 Allowed 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 115.471 -2.492 . . . . 0.0 110.484 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -119.88 13.69 10.6 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 114.004 -3.951 . . . . 0.0 110.137 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 50.09 73.55 0.97 Allowed Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 116.878 -1.929 . . . . 0.0 111.237 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -83.48 -43.6 0.07 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.128 0 N-CA-C 110.082 -0.776 . . . . 0.0 110.082 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.986 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 2.8 m -85.41 147.41 26.51 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 115.387 -2.525 . . . . 0.0 110.05 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.58 ' O ' ' C ' ' A' ' 57' ' ' ASN . 61.2 mt -95.21 179.41 5.2 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 116.839 -1.944 . . . . 0.0 109.365 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.58 ' C ' ' O ' ' A' ' 56' ' ' LEU . 12.5 m-80 28.62 60.92 0.13 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.204 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 55.06 58.3 4.85 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 115.051 -2.66 . . . . 0.0 108.682 165.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.07 171.13 51.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 113.921 -3.99 . . . . 0.0 109.812 171.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -89.15 93.5 9.6 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 115.449 -2.5 . . . . 0.0 108.798 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.6 p -95.55 109.0 21.29 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 115.436 -2.506 . . . . 0.0 108.644 -171.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 tttp . . . . . 0 C--O 1.242 0.689 0 C-N-CA 115.917 -2.313 . . . . 0.0 107.879 176.756 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.475 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.6 mt -92.71 79.33 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 114.922 -2.711 . . . . 0.0 108.915 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 114.807 -3.568 . . . . 0.0 109.713 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.54 164.37 26.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 114.598 -2.841 . . . . 0.0 110.539 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -137.48 161.38 36.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.196 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -120.43 136.17 54.82 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 115.665 -2.414 . . . . 0.0 110.274 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.986 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 52.4 m -104.85 124.11 48.87 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 115.394 -2.523 . . . . 0.0 109.003 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 119.64 35.62 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 115.886 -2.326 . . . . 0.0 108.754 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 9.9 m -71.74 149.9 44.96 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 116.265 -2.174 . . . . 0.0 109.584 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.14 164.17 26.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 116.017 -2.273 . . . . 0.0 109.172 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.64 97.84 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 114.466 -2.893 . . . . 0.0 108.602 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.25 -33.32 0.65 Allowed Glycine 0 C--O 1.247 0.917 0 C-N-CA 115.357 -3.306 . . . . 0.0 110.227 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 96.2 m-85 -116.94 159.99 21.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 117.053 -1.859 . . . . 0.0 109.114 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.759 ' H ' ' HD1' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -159.7 -126.73 0.02 OUTLIER 'General case' 0 C--N 1.363 1.176 0 C-N-CA 114.212 -2.995 . . . . 0.0 109.653 166.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.411 ' N ' ' CZ ' ' A' ' 83' ' ' PHE . . . 68.58 -176.44 28.18 Favored Glycine 0 CA--C 1.554 2.509 1 C-N-CA 113.073 -4.394 . . . . 0.0 110.143 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -48.3 -61.17 2.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.901 -1.92 . . . . 0.0 113.616 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 81.8 m-20 -106.29 19.57 20.3 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 115.913 -2.315 . . . . 0.0 108.74 -171.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 10.3 m 73.1 46.6 0.23 Allowed 'General case' 0 C--O 1.252 1.195 0 C-N-CA 116.438 -2.105 . . . . 0.0 107.956 -167.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 77' ' ' GLU . 42.6 tt0 -90.24 -30.14 17.73 Favored 'General case' 0 C--O 1.261 1.672 0 C-N-CA 116.818 -1.953 . . . . 0.0 109.155 -170.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.759 ' HD1' ' H ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.379 -3.988 0 C-N-CA 112.298 -3.761 . . . . 0.0 108.758 -162.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.415 -2.202 0 CA-C-O 121.643 0.735 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 86.7 mm-40 -89.02 -19.35 25.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.294 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.4 t -95.53 11.9 31.43 Favored 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 115.302 -2.559 . . . . 0.0 108.652 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.98 26.61 0.07 Allowed 'General case' 0 C--O 1.258 1.533 0 C-N-CA 115.876 -2.33 . . . . 0.0 109.87 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -150.15 30.02 1.09 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 114.016 -3.945 . . . . 0.0 110.136 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 52' ' ' GLY . 21.8 t-160 40.31 83.87 0.19 Allowed Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 115.977 -2.289 . . . . 0.0 110.424 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -89.34 -27.12 0.38 Allowed 'Trans proline' 0 N--CA 1.426 -2.484 0 O-C-N 123.182 1.096 . . . . 0.0 111.547 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.937 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 m -94.16 166.64 12.02 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 114.314 -2.955 . . . . 0.0 110.415 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.1 mt -113.6 175.02 5.63 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 115.898 -2.321 . . . . 0.0 109.56 -177.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 56' ' ' LEU . 42.7 m-80 27.47 62.4 0.1 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.055 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 45.5 mt-30 58.9 47.33 12.56 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 125.248 1.593 . . . . 0.0 109.034 171.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.98 157.08 35.01 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 113.939 -3.981 . . . . 0.0 109.534 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -86.04 155.13 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 114.351 -2.94 . . . . 0.0 107.765 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.0 p -135.38 105.14 6.12 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.456 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp . . . . . 0 N--CA 1.486 1.37 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.338 177.739 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.363 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.26 94.0 2.07 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.477 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 80.11 -71.68 2.73 Favored Glycine 0 C--O 1.259 1.666 0 C-N-CA 115.889 -3.053 . . . . 0.0 112.297 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -77.83 174.53 10.92 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 114.288 -2.965 . . . . 0.0 109.697 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.95 160.96 37.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 116.383 -2.127 . . . . 0.0 108.718 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.1 p -131.3 140.82 49.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 114.479 -2.888 . . . . 0.0 108.592 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.937 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 55.8 m -100.44 128.91 46.37 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.463 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.32 119.71 40.3 Favored 'General case' 0 C--O 1.255 1.387 0 C-N-CA 116.018 -2.273 . . . . 0.0 108.481 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.2 m -72.46 155.93 39.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 114.854 -2.738 . . . . 0.0 109.169 -174.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 163.65 26.36 Favored 'General case' 0 C--O 1.25 1.104 0 C-N-CA 114.683 -2.807 . . . . 0.0 108.947 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.54 100.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 114.782 -2.767 . . . . 0.0 108.99 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.27 -42.27 0.65 Allowed Glycine 0 CA--C 1.546 2.031 0 C-N-CA 115.414 -3.279 . . . . 0.0 108.309 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.22 161.33 16.7 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 115.49 -2.484 . . . . 0.0 110.154 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -147.75 142.49 26.71 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 115.477 -2.489 . . . . 0.0 108.639 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.555 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 142.87 158.63 7.61 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 115.914 -3.041 . . . . 0.0 110.478 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 78' ' ' GLY . 38.7 ttmt -39.27 -50.55 1.99 Allowed 'General case' 0 C--O 1.187 -2.232 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.183 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.715 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 59.5 m-20 -107.83 -3.1 19.31 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 116.842 -1.943 . . . . 0.0 109.146 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.5 m 83.27 31.81 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 114.874 -2.73 . . . . 0.0 109.154 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.78 -30.29 63.99 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 116.511 -2.076 . . . . 0.0 109.896 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 115.079 -2.649 . . . . 0.0 108.87 -173.145 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.9 0.381 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -96.37 -34.17 11.65 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 116.393 -2.123 . . . . 0.0 110.219 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.05 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.8 t -93.78 20.59 7.4 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 116.43 -2.108 . . . . 0.0 109.516 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.18 23.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 114.879 -2.728 . . . . 0.0 110.969 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -147.2 23.38 1.57 Allowed Glycine 0 N--CA 1.472 1.079 0 C-N-CA 114.412 -3.756 . . . . 0.0 111.328 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 43.77 80.42 0.29 Allowed Pre-proline 0 CA--C 1.581 2.146 0 C-N-CA 116.84 -1.944 . . . . 0.0 111.123 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.19 -32.42 0.3 Allowed 'Trans proline' 0 N--CA 1.412 -3.272 0 C-N-CA 121.707 1.604 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 13.3 m -85.48 140.44 30.68 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 115.796 -2.362 . . . . 0.0 109.264 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.7 mt -101.63 168.7 9.31 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.777 -1.569 . . . . 0.0 110.719 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER 43.55 60.72 2.51 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 116.559 -2.056 . . . . 0.0 110.26 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 46.85 45.56 15.1 Favored 'General case' 1 C--N 1.441 4.571 0 C-N-CA 113.397 -3.321 . . . . 0.0 115.592 174.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 60' ' ' HIS . . . -77.46 -156.62 8.12 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 114.655 -3.641 . . . . 0.0 111.231 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 1.389 ' CB ' ' N ' ' A' ' 71' ' ' THR 0.428 0.0 OUTLIER -79.61 155.32 28.17 Favored 'General case' 1 N--CA 1.367 -4.62 0 CA-C-N 109.742 -3.229 . . . . 0.0 114.009 176.685 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.05 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.2 t -147.26 120.08 8.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 114.632 -2.827 . . . . 0.0 109.151 158.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 115.623 -2.431 . . . . 0.0 106.768 174.629 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.559 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 mt -104.49 98.14 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 114.781 -2.768 . . . . 0.0 109.812 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.27 -69.15 3.05 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 114.843 -3.551 . . . . 0.0 111.298 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.48 166.41 20.36 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 115.316 -2.553 . . . . 0.0 108.882 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -123.46 150.18 44.18 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 115.351 -2.54 . . . . 0.0 109.503 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -120.93 124.27 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 115.158 -2.617 . . . . 0.0 108.888 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.8 m -109.69 146.56 34.65 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 116.337 -2.145 . . . . 0.0 108.02 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 1.389 ' N ' ' CB ' ' A' ' 60' ' ' HIS . 4.3 m -109.52 103.22 12.07 Favored 'General case' 1 N--CA 1.558 4.963 0 C-N-CA 116.788 -1.965 . . . . 0.0 112.071 175.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 90.2 m -60.83 143.38 54.84 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 115.913 -2.315 . . . . 0.0 107.86 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.2 166.95 15.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.548 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.45 96.57 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 115.711 -2.396 . . . . 0.0 108.822 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.38 -39.71 0.61 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 114.898 -3.525 . . . . 0.0 108.384 -168.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.22 166.81 11.27 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 115.441 -2.503 . . . . 0.0 108.305 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 37.7 tt0 -157.64 112.78 2.73 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 115.091 -2.644 . . . . 0.0 109.229 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.58 174.78 35.5 Favored Glycine 0 C--O 1.212 -1.276 0 C-N-CA 114.472 -3.728 . . . . 0.0 111.223 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -45.32 -58.02 3.6 Favored 'General case' 0 N--CA 1.398 -3.027 0 C-N-CA 115.994 -2.282 . . . . 0.0 111.458 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.663 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 39.2 m-20 -106.28 18.09 22.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 114.924 -2.71 . . . . 0.0 109.121 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.9 m 76.34 18.56 1.82 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 115.662 -2.415 . . . . 0.0 108.708 -174.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.93 -32.59 73.91 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 116.865 -1.934 . . . . 0.0 110.273 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 77' ' ' GLU . 87.0 m-85 . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 115.216 -2.594 . . . . 0.0 110.387 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 119.575 -0.25 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 3.3 mp0 -96.51 0.06 49.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 114.709 -2.796 . . . . 0.0 110.073 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.155 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.9 t -126.8 18.15 7.32 Favored 'General case' 0 N--CA 1.508 2.437 0 C-N-CA 115.629 -2.429 . . . . 0.0 108.943 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -74.99 33.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 116.318 -2.153 . . . . 0.0 111.068 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.42 29.26 0.96 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 114.098 -3.906 . . . . 0.0 110.347 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 49.72 80.81 0.28 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.144 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -85.92 -35.53 0.14 Allowed 'Trans proline' 0 N--CA 1.404 -3.778 0 C-N-CA 121.334 1.356 . . . . 0.0 110.994 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.1 m -79.52 143.48 34.82 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 115.115 -2.634 . . . . 0.0 111.213 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.599 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.3 mt -102.44 175.02 5.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.512 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 30.02 62.95 0.17 Allowed 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 116.859 -1.936 . . . . 0.0 111.979 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 56.92 83.37 0.1 Allowed 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 117.089 -1.844 . . . . 0.0 109.272 170.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.72 161.44 20.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 115.75 -3.119 . . . . 0.0 109.536 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.554 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 43.4 t-80 -91.01 155.41 18.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 116.395 -2.122 . . . . 0.0 108.317 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.155 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 50.7 t -131.6 126.73 35.48 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 114.77 -2.772 . . . . 0.0 110.927 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 114.578 -2.849 . . . . 0.0 108.196 176.319 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.107 0 CA-C-O 122.107 0.837 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.2 mt -109.26 58.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 114.658 -2.817 . . . . 0.0 108.524 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.424 ' CA ' ' HG2' ' A' ' 49' ' ' GLN . . . 89.64 -55.02 3.81 Favored Glycine 0 N--CA 1.478 1.469 0 C-N-CA 114.673 -3.632 . . . . 0.0 112.269 173.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.711 ' C ' ' CD1' ' A' ' 68' ' ' TYR . 5.9 p-10 -80.55 -19.46 45.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 115.845 -2.342 . . . . 0.0 112.059 -174.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.711 ' CD1' ' C ' ' A' ' 67' ' ' ASP . 38.7 p90 51.36 166.5 0.01 OUTLIER 'General case' 1 C--N 1.218 -5.113 0 CA-C-N 111.478 -2.601 . . . . 0.0 112.727 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -141.43 129.33 21.84 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 116.13 -2.228 . . . . 0.0 108.905 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -100.74 127.25 47.23 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.569 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -94.97 149.95 20.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.91 -2.316 . . . . 0.0 109.49 176.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.898 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 84.4 m -99.27 156.35 17.03 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 115.132 -2.627 . . . . 0.0 109.299 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.47 164.57 26.48 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 115.371 -2.532 . . . . 0.0 109.455 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.82 102.98 0.39 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 115.014 -2.675 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.0 -33.3 1.38 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 114.502 -3.713 . . . . 0.0 110.201 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.69 164.41 12.77 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 116.082 -2.247 . . . . 0.0 109.162 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -159.38 118.49 2.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 115.618 -2.433 . . . . 0.0 109.225 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 169.79 170.11 33.84 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 114.29 -3.814 . . . . 0.0 110.288 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 85.1 tttt -41.0 -54.67 2.72 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 115.648 -2.421 . . . . 0.0 110.711 176.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.641 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 61.4 m-20 -110.83 15.81 21.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 115.731 -2.388 . . . . 0.0 109.862 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.898 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.1 m 74.01 28.34 1.5 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 115.092 -2.643 . . . . 0.0 109.338 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -70.08 -31.51 69.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 116.245 -2.182 . . . . 0.0 110.523 -177.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 114.708 -2.797 . . . . 0.0 109.954 -175.616 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 CA--C 1.574 1.903 0 CA-C-O 117.483 -1.246 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 3.4 mp0 -104.53 7.13 35.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 115.985 -2.286 . . . . 0.0 111.173 -177.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.6 t -128.33 8.48 6.01 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 116.201 -2.2 . . . . 0.0 110.226 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.76 24.32 0.06 Allowed 'General case' 0 C--O 1.249 1.075 0 C-N-CA 115.49 -2.484 . . . . 0.0 112.044 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -144.72 23.74 1.98 Allowed Glycine 0 C--N 1.341 0.836 0 C-N-CA 114.559 -3.686 . . . . 0.0 111.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 45.78 78.63 0.38 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 115.98 -2.288 . . . . 0.0 110.223 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.68 -33.77 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 N-CA-C 110.071 -0.781 . . . . 0.0 110.071 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.031 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.2 m -76.35 152.52 36.32 Favored 'General case' 0 C--O 1.261 1.667 0 C-N-CA 116.159 -2.216 . . . . 0.0 109.568 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.2 mt -105.3 171.6 7.24 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 116.782 -1.967 . . . . 0.0 109.958 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 56' ' ' LEU . 27.8 m-80 36.17 61.45 0.77 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 117.566 -1.653 . . . . 0.0 111.734 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.432 ' NE2' ' N ' ' A' ' 58' ' ' GLN . 2.8 mp0 48.68 51.21 16.03 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 115.664 -2.414 . . . . 0.0 110.109 172.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.6 171.6 45.57 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 114.702 -3.618 . . . . 0.0 109.737 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -88.67 145.95 25.36 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.212 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 51.9 t -134.03 124.64 26.57 Favored 'General case' 0 N--CA 1.417 -2.081 0 C-N-CA 115.449 -2.5 . . . . 0.0 109.126 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.1 tptt . . . . . 0 C--O 1.252 1.205 0 C-N-CA 115.578 -2.449 . . . . 0.0 109.454 -179.881 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.631 0 CA-C-O 122.544 1.08 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 57.2 mt -87.86 90.48 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 113.724 -3.19 . . . . 0.0 108.038 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 78.77 -72.31 2.44 Favored Glycine 0 N--CA 1.496 2.679 1 C-N-CA 113.859 -4.019 . . . . 0.0 109.257 -178.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -72.23 166.25 22.79 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 115.746 -2.382 . . . . 0.0 109.706 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -115.91 163.72 15.47 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 116.303 -2.159 . . . . 0.0 109.568 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 p -128.99 135.25 48.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 115.108 -2.637 . . . . 0.0 109.333 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.031 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 94.9 m -113.43 124.24 51.95 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.382 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.75 122.2 46.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 116.163 -2.215 . . . . 0.0 110.072 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.813 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.3 m -72.91 150.2 42.78 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 114.904 -2.718 . . . . 0.0 110.178 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 169.18 15.55 Favored 'General case' 0 C--O 1.254 1.338 0 C-N-CA 115.622 -2.431 . . . . 0.0 109.984 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.07 105.89 0.76 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 114.859 -2.736 . . . . 0.0 109.952 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.78 -40.56 1.08 Allowed Glycine 0 C--O 1.213 -1.194 0 C-N-CA 115.32 -3.324 . . . . 0.0 110.325 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.19 163.07 15.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 115.475 -2.49 . . . . 0.0 110.099 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -155.49 125.37 6.53 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 115.234 -2.586 . . . . 0.0 109.374 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 160.74 166.86 20.34 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.372 -4.251 . . . . 0.0 111.164 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 22.8 tptm -39.59 -53.72 2.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 116.403 -2.119 . . . . 0.0 109.449 175.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.663 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 41.8 m-20 -113.44 11.91 18.58 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 116.355 -2.138 . . . . 0.0 109.649 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.813 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.4 m 74.39 31.75 1.01 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.094 -2.642 . . . . 0.0 109.571 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.92 -36.25 79.84 Favored 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 116.474 -2.09 . . . . 0.0 110.243 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 C--N 1.305 -1.352 0 C-N-CA 114.941 -2.704 . . . . 0.0 109.53 -171.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm . . . . . 0 C--O 1.173 -2.939 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -106.47 72.05 0.9 Allowed 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 115.81 -2.356 . . . . 0.0 108.875 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.36 -82.31 0.26 Allowed Glycine 0 C--N 1.385 3.285 1 C-N-CA 113.731 -4.08 . . . . 0.0 109.217 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -107.85 129.2 55.09 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 115.797 -2.361 . . . . 0.0 110.237 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.458 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 2.8 mp0 -98.01 -10.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 116.09 -2.244 . . . . 0.0 109.516 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 45.6 t -113.06 10.93 18.82 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 114.92 -2.712 . . . . 0.0 109.611 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -75.24 19.18 0.17 Allowed 'General case' 0 N--CA 1.509 2.504 0 C-N-CA 115.107 -2.637 . . . . 0.0 111.418 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.68 27.8 3.65 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 114.67 -3.633 . . . . 0.0 111.337 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 48.86 73.94 0.91 Allowed Pre-proline 0 N--CA 1.498 1.943 0 C-N-CA 117.256 -1.778 . . . . 0.0 111.043 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.53 -35.35 1.16 Allowed 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 121.108 1.206 . . . . 0.0 110.686 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.2 m -89.11 148.72 23.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.735 -2.386 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.504 ' O ' ' C ' ' A' ' 57' ' ' ASN . 79.4 mt -100.91 174.5 5.99 Favored 'General case' 0 C--O 1.268 2.049 0 C-N-CA 116.191 -2.203 . . . . 0.0 108.814 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 56' ' ' LEU . 7.0 m-80 34.27 68.57 0.18 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 118.167 -1.413 . . . . 0.0 111.477 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.485 ' C ' ' O ' ' A' ' 57' ' ' ASN . 11.3 pt20 36.51 54.09 1.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.669 174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.21 178.09 41.68 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 115.623 -3.18 . . . . 0.0 109.573 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.511 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 45.4 t60 -89.8 136.96 32.73 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 115.436 -2.505 . . . . 0.0 108.437 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.68 129.02 30.02 Favored 'General case' 0 C--O 1.251 1.164 0 C-N-CA 115.287 -2.565 . . . . 0.0 109.237 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 115.661 -2.416 . . . . 0.0 108.121 174.678 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.31 -92.12 0.09 OUTLIER Glycine 0 N--CA 1.477 1.396 0 C-N-CA 113.936 -3.983 . . . . 0.0 111.964 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 65' ' ' ILE . 28.2 mt -114.3 55.65 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 114.612 -2.835 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.7 -61.34 2.04 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 114.177 -3.868 . . . . 0.0 111.225 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.571 ' O ' ' O ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -78.92 3.74 16.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 115.721 -2.392 . . . . 0.0 110.07 -174.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.571 ' O ' ' O ' ' A' ' 67' ' ' ASP . 53.1 p90 39.68 179.04 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.191 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 p -139.74 145.8 38.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 115.946 -2.302 . . . . 0.0 107.694 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 25.2 m -131.56 119.12 21.04 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 114.955 -2.698 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -108.23 153.31 23.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 116.199 -2.2 . . . . 0.0 108.876 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 85.8 m -98.02 148.51 23.43 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 115.943 -2.303 . . . . 0.0 109.846 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.61 27.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 115.26 -2.576 . . . . 0.0 109.793 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.64 102.28 0.71 Allowed 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 114.902 -2.719 . . . . 0.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.22 -43.91 0.65 Allowed Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 115.411 -3.28 . . . . 0.0 108.902 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.91 155.96 18.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 116.308 -2.157 . . . . 0.0 109.502 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -146.74 142.82 28.19 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 115.855 -2.338 . . . . 0.0 108.936 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 140.68 166.82 10.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 114.174 -3.869 . . . . 0.0 109.605 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 78' ' ' GLY . 53.0 tptt -42.4 -54.36 3.85 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 116.132 -2.227 . . . . 0.0 110.664 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.607 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 21.7 m-20 -109.26 14.34 23.84 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.942 -1.903 . . . . 0.0 109.492 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 4.0 m 72.24 25.17 2.93 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 115.262 -2.575 . . . . 0.0 108.839 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -71.64 -30.38 65.69 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.928 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -88.44 144.23 26.5 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 115.918 -2.313 . . . . 0.0 109.021 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.9 p -111.32 150.05 30.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 115.683 -2.407 . . . . 0.0 108.094 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.6 p -86.9 38.23 0.79 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 114.462 -2.895 . . . . 0.0 110.946 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 C--O 1.19 -2.064 0 C-N-CA 117.037 -1.865 . . . . 0.0 109.846 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 89.2 mttt . . . . . 0 C--O 1.161 -3.571 0 CA-C-O 125.067 2.365 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.71 142.18 27.64 Favored 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 115.057 -2.657 . . . . 0.0 107.882 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.61 -157.48 7.77 Favored Glycine 0 CA--C 1.555 2.58 1 C-N-CA 112.625 -4.607 . . . . 0.0 114.037 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -110.04 121.0 44.23 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 115.674 -2.41 . . . . 0.0 109.58 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 15.7 mp0 -94.67 -23.84 17.42 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 116.634 -2.026 . . . . 0.0 108.466 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 41.9 t -90.62 20.98 4.24 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 115.702 -2.399 . . . . 0.0 110.422 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -71.97 26.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.758 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -139.27 19.9 3.02 Favored Glycine 0 C--N 1.319 -0.375 0 C-N-CA 114.782 -3.58 . . . . 0.0 110.289 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.496 ' C ' ' O ' ' A' ' 52' ' ' GLY . 51.5 t60 40.66 72.97 0.93 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 116.797 -1.961 . . . . 0.0 109.809 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 5.1 Cg_exo -81.21 -37.02 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.607 0 N-CA-C 108.763 -1.284 . . . . 0.0 108.763 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.9 m -77.68 143.92 37.75 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 114.797 -2.761 . . . . 0.0 111.499 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.653 ' O ' ' C ' ' A' ' 57' ' ' ASN . 83.9 mt -103.43 178.15 4.64 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 116.296 -2.161 . . . . 0.0 110.426 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 56' ' ' LEU . 37.1 m-80 27.81 60.73 0.11 Allowed 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 118.188 -1.405 . . . . 0.0 111.539 175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 57' ' ' ASN . 48.3 tt0 66.87 73.05 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 116.681 -2.007 . . . . 0.0 111.771 168.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.03 160.16 17.57 Favored Glycine 0 C--N 1.363 2.031 1 C-N-CA 112.592 -4.623 . . . . 0.0 110.377 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -88.51 108.94 19.66 Favored 'General case' 0 C--O 1.254 1.29 0 C-N-CA 114.497 -2.881 . . . . 0.0 108.121 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 23.6 p -88.79 112.14 22.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.08 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.8 tptt . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 115.26 -2.576 . . . . 0.0 107.963 177.61 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.28 -135.93 3.33 Favored Glycine 0 CA--C 1.549 2.205 0 C-N-CA 114.133 -3.889 . . . . 0.0 110.127 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -92.39 87.22 2.4 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.882 0 C-N-CA 117.036 -1.866 . . . . 0.0 108.568 178.502 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.37 -67.18 3.12 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 114.285 -3.817 . . . . 0.0 111.062 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -74.72 164.5 26.51 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 116.04 -2.264 . . . . 0.0 110.096 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -129.37 162.14 28.7 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 116.367 -2.133 . . . . 0.0 108.87 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.3 p -132.79 142.52 49.04 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.199 -2.6 . . . . 0.0 109.636 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.0 m -106.1 119.73 39.97 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 115.134 -2.626 . . . . 0.0 109.201 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.29 126.09 41.25 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 115.832 -2.347 . . . . 0.0 109.233 173.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 35.7 m -82.27 158.39 23.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 114.529 -2.868 . . . . 0.0 110.208 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.33 166.9 22.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 115.181 -2.607 . . . . 0.0 108.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.13 112.24 1.83 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 114.585 -2.846 . . . . 0.0 109.202 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.96 -47.49 0.8 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 114.431 -3.747 . . . . 0.0 110.452 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 97.7 m-85 -104.95 167.5 9.67 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 115.805 -2.358 . . . . 0.0 109.903 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -158.18 -0.69 0.1 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 115.398 -2.521 . . . . 0.0 111.865 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . -63.8 168.51 23.1 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 115.696 -3.145 . . . . 0.0 110.649 175.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -47.71 -52.61 17.78 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.721 -1.992 . . . . 0.0 108.667 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.702 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 50.5 m-20 -93.7 16.84 12.98 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 115.017 -2.673 . . . . 0.0 107.39 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 14.6 m 76.21 23.57 1.21 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 116.079 -2.248 . . . . 0.0 108.443 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.12 -32.51 67.02 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 115.025 -2.67 . . . . 0.0 110.411 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -87.98 151.62 22.65 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 115.836 -2.345 . . . . 0.0 109.041 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -111.11 141.6 44.4 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 115.145 -2.622 . . . . 0.0 109.013 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.0 p -92.71 35.93 1.03 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 115.767 -2.373 . . . . 0.0 109.836 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 . . . . . 0 N--CA 1.509 2.525 0 C-N-CA 115.026 -2.67 . . . . 0.0 109.436 -178.574 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 122.623 1.201 . . . . 0.0 108.739 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -82.2 162.91 22.23 Favored 'General case' 0 C--O 1.263 1.769 0 O-C-N 119.218 -2.176 . . . . 0.0 110.68 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.72 -125.87 1.27 Allowed Glycine 0 N--CA 1.507 3.395 1 C-N-CA 112.498 -4.668 . . . . 0.0 109.785 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -89.49 103.12 15.78 Favored 'General case' 0 C--O 1.203 -1.359 0 C-N-CA 115.87 -2.332 . . . . 0.0 110.678 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 91.3 mm-40 -79.17 -15.82 57.53 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 116.563 -2.055 . . . . 0.0 109.025 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 30.5 p -98.78 18.25 17.45 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 115.539 -2.464 . . . . 0.0 109.25 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -74.25 30.37 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 116.661 -2.016 . . . . 0.0 111.121 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -141.66 28.1 2.31 Favored Glycine 0 C--N 1.344 1.017 0 C-N-CA 114.478 -3.725 . . . . 0.0 110.462 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 52' ' ' GLY . 72.5 m80 43.62 76.37 0.54 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 115.263 -2.575 . . . . 0.0 110.643 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -89.14 -32.99 0.11 Allowed 'Trans proline' 0 N--CA 1.427 -2.414 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 3.7 m -83.2 156.32 23.26 Favored 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 115.088 -2.645 . . . . 0.0 110.894 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.546 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.3 mt -98.6 173.16 7.06 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 117.009 -1.877 . . . . 0.0 108.703 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.653 ' ND2' HG21 ' A' ' 85' ' ' THR . 21.1 m-80 36.99 60.04 1.02 Allowed 'General case' 0 N--CA 1.406 -2.644 0 C-N-CA 116.148 -2.221 . . . . 0.0 112.66 173.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 55.55 31.37 17.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 117.469 -1.693 . . . . 0.0 113.296 166.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.92 158.31 53.11 Favored Glycine 0 N--CA 1.504 3.185 1 C-N-CA 113.353 -4.261 . . . . 0.0 110.405 172.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.448 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 7.6 t-160 -88.38 172.01 9.71 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 115.204 -2.599 . . . . 0.0 109.48 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 30.9 p -139.95 122.76 16.49 Favored 'General case' 0 N--CA 1.504 2.225 0 C-N-CA 114.592 -2.843 . . . . 0.0 109.31 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 63' ' ' LAA . 5.3 tmtt? . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 115.171 -2.611 . . . . 0.0 108.972 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . 0.696 ' O ' ' O ' ' A' ' 62' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.3 -153.04 7.56 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 114.038 -3.934 . . . . 0.0 111.025 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.17 93.28 2.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 C-N-CA 114.86 -2.736 . . . . 0.0 107.741 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 89.36 -69.16 2.59 Favored Glycine 0 CA--C 1.548 2.133 0 C-N-CA 114.437 -3.744 . . . . 0.0 110.076 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -77.76 170.02 17.29 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 115.433 -2.507 . . . . 0.0 109.527 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 63' ' ' LAA . 29.1 p90 -132.11 158.24 42.15 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.166 -2.214 . . . . 0.0 109.572 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.2 p -127.36 133.84 50.01 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 116.39 -2.124 . . . . 0.0 108.364 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.3 m -104.97 132.7 50.88 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.742 -2.783 . . . . 0.0 109.909 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -104.72 148.72 26.28 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 115.83 -2.348 . . . . 0.0 109.701 175.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.905 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 64.7 m -110.91 143.41 41.59 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 116.298 -2.161 . . . . 0.0 108.8 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.499 ' HB3' ' CD2' ' A' ' 76' ' ' PHE . . . -76.34 170.27 16.67 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 115.392 -2.523 . . . . 0.0 110.173 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.82 140.04 58.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 116.163 -2.215 . . . . 0.0 108.987 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.71 -21.19 43.27 Favored Glycine 0 N--CA 1.427 -1.957 1 C-N-CA 113.474 -4.203 . . . . 0.0 109.904 -174.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 1.005 ' CD1' HG22 ' A' ' 85' ' ' THR . 65.7 m-85 -133.22 143.32 49.06 Favored 'General case' 0 CA--C 1.471 -2.065 0 C-N-CA 114.725 -2.79 . . . . 0.0 110.051 -170.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.736 ' N ' ' OG ' ' A' ' 84' ' ' SER . 2.0 pt-20 -164.99 173.36 11.66 Favored 'General case' 1 N--CA 1.367 -4.619 0 C-N-CA 113.843 -3.143 . . . . 0.0 112.775 165.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 139.33 178.2 16.29 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 114.698 -3.62 . . . . 0.0 110.158 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 78' ' ' GLY . 29.1 ttpp -41.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 116.433 -2.107 . . . . 0.0 108.871 175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.648 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 57.2 m-20 -118.28 24.49 10.92 Favored 'General case' 0 C--O 1.207 -1.167 0 C-N-CA 115.556 -2.458 . . . . 0.0 109.466 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.905 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.7 m 76.87 39.25 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 115.299 -2.56 . . . . 0.0 106.99 -170.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -88.25 -28.96 20.78 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 116.358 -2.137 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.64 ' C ' ' OG ' ' A' ' 84' ' ' SER . 65.4 m-85 -89.53 101.62 14.3 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 114.984 -2.687 . . . . 0.0 108.994 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 1.403 ' CB ' HG23 ' A' ' 85' ' ' THR 0.292 24.6 m 164.36 174.33 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 113.01 -3.476 . . . . 0.0 109.972 -143.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 1.403 HG23 ' CB ' ' A' ' 84' ' ' SER . 2.5 p 54.55 45.73 26.33 Favored 'General case' 0 C--N 1.279 -2.497 0 C-N-CA 114.362 -2.935 . . . . 0.0 111.905 148.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 . . . . . 0 C--O 1.188 -2.133 0 C-N-CA 116.887 -1.925 . . . . 0.0 109.568 -175.584 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.2 pttp . . . . . 0 N--CA 1.431 -1.406 0 CA-C-O 121.886 0.851 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -142.02 125.15 16.32 Favored 'General case' 0 C--O 1.261 1.68 0 C-N-CA 117.316 -1.754 . . . . 0.0 106.278 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.26 -53.0 0.01 OUTLIER Glycine 0 N--CA 1.502 3.081 1 C-N-CA 113.62 -4.133 . . . . 0.0 111.613 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 49' ' ' GLN . 31.2 t70 -136.67 10.64 3.15 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 116.43 -2.108 . . . . 0.0 108.97 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 2.9 mp0 31.79 33.92 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 117.499 -1.681 . . . . 0.0 113.493 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.2 t -166.87 27.0 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 115.94 -2.304 . . . . 0.0 108.715 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -76.18 24.23 0.14 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 115.682 -2.407 . . . . 0.0 111.24 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -146.06 24.31 1.75 Allowed Glycine 0 N--CA 1.484 1.897 0 C-N-CA 114.062 -3.923 . . . . 0.0 110.56 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 22.2 t-160 42.79 78.37 0.39 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.299 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.51 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 5.0 Cg_exo -82.12 -33.83 0.53 Allowed 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 121.035 1.157 . . . . 0.0 110.961 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.072 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.6 m -75.85 149.27 37.87 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 115.39 -2.524 . . . . 0.0 110.464 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' O ' ' C ' ' A' ' 57' ' ' ASN . 70.7 mt -97.91 174.03 6.78 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 116.114 -2.234 . . . . 0.0 109.746 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.64 ' HB2' HG21 ' A' ' 85' ' ' THR . 21.5 m-80 33.76 57.29 0.57 Allowed 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 115.845 -2.342 . . . . 0.0 114.118 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 56.62 41.99 27.69 Favored 'General case' 0 N--CA 1.515 2.811 0 C-N-CA 116.047 -2.261 . . . . 0.0 111.749 168.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.47 54.87 Favored Glycine 0 N--CA 1.444 -0.771 1 C-N-CA 113.653 -4.118 . . . . 0.0 110.125 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -93.36 133.12 36.94 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 114.65 -2.82 . . . . 0.0 109.438 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 88.4 m -98.43 105.49 17.64 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 114.742 -2.783 . . . . 0.0 107.338 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp . . . . . 0 N--CA 1.48 1.058 0 C-N-CA 115.513 -2.475 . . . . 0.0 107.696 176.425 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.67 -131.8 2.07 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 114.9 -3.524 . . . . 0.0 110.26 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.74 85.02 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 C-N-CA 114.767 -2.773 . . . . 0.0 109.034 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.1 -60.56 4.58 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 115.803 -3.094 . . . . 0.0 110.932 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.98 167.52 21.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.554 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -149.53 159.1 44.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 114.748 -2.781 . . . . 0.0 108.923 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -137.04 132.25 33.94 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 115.146 -2.622 . . . . 0.0 108.395 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.072 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.8 m -91.46 129.09 37.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 116.059 -2.256 . . . . 0.0 109.761 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.3 m -107.46 106.07 16.29 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 114.827 -2.749 . . . . 0.0 109.677 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 77' ' ' GLU . 34.3 m -68.81 142.45 54.87 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 115.473 -2.491 . . . . 0.0 109.95 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.54 169.2 18.7 Favored 'General case' 0 C--O 1.26 1.649 0 C-N-CA 115.503 -2.479 . . . . 0.0 111.69 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -55.71 143.25 31.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 115.691 -2.404 . . . . 0.0 109.783 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.16 -23.73 34.84 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 115.11 -3.424 . . . . 0.0 110.292 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 1.067 ' CD1' HG22 ' A' ' 85' ' ' THR . 73.7 m-85 -131.48 143.87 50.73 Favored 'General case' 0 N--CA 1.407 -2.578 0 C-N-CA 114.484 -2.887 . . . . 0.0 110.243 -169.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' ' OG ' ' A' ' 84' ' ' SER . 2.0 pt-20 -164.85 178.07 7.45 Favored 'General case' 1 N--CA 1.37 -4.461 0 C-N-CA 112.766 -3.574 . . . . 0.0 112.747 164.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 133.25 175.51 13.99 Favored Glycine 0 N--CA 1.484 1.864 0 C-N-CA 115.308 -3.33 . . . . 0.0 109.745 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.8 tttp -38.66 -52.21 1.66 Allowed 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 116.147 -2.221 . . . . 0.0 110.622 176.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 61.9 m-20 -119.55 20.39 12.41 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 116.412 -2.115 . . . . 0.0 108.471 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 4.5 m 79.57 43.66 0.06 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 115.884 -2.326 . . . . 0.0 107.816 -171.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -92.0 -30.5 16.03 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 116.549 -2.06 . . . . 0.0 109.468 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.547 ' C ' ' OG ' ' A' ' 84' ' ' SER . 59.1 m-85 -88.82 99.51 12.43 Favored 'General case' 0 CA--C 1.465 -2.299 0 C-N-CA 115.55 -2.46 . . . . 0.0 107.179 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 1.46 ' CB ' HG23 ' A' ' 85' ' ' THR 0.263 20.6 m 166.47 175.82 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 113.959 -3.096 . . . . 0.0 109.118 -146.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 1.46 HG23 ' CB ' ' A' ' 84' ' ' SER . 1.5 p 51.48 44.39 29.05 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 116.064 -2.255 . . . . 0.0 111.276 148.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 . . . . . 0 C--N 1.372 1.553 0 CA-C-O 115.228 -2.32 . . . . 0.0 107.702 -179.382 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . 0.265 17.6 ptpt . . . . . 0 C--O 1.203 -1.378 0 CA-C-O 122.937 1.351 . . . . 0.0 107.965 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -102.67 151.07 22.8 Favored 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 113.866 -3.134 . . . . 0.0 110.066 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.95 -173.57 38.56 Favored Glycine 0 C--N 1.289 -2.079 0 C-N-CA 114.575 -3.679 . . . . 0.0 112.356 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -88.04 134.84 33.65 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 115.518 -2.473 . . . . 0.0 108.079 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 94.6 mm-40 -83.0 13.83 3.74 Favored 'General case' 0 C--O 1.257 1.47 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.775 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 25.6 t -140.37 22.8 2.37 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 115.407 -2.517 . . . . 0.0 109.892 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.79 30.2 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 115.318 -2.553 . . . . 0.0 112.071 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.97 27.84 0.58 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 114.037 -3.935 . . . . 0.0 110.218 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.1 m80 48.44 71.39 1.61 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 115.6 -2.44 . . . . 0.0 112.086 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -76.97 -31.15 3.98 Favored 'Trans proline' 0 N--CA 1.413 -3.258 0 C-N-CA 122.224 1.949 . . . . 0.0 109.091 -177.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 14.5 m -83.92 158.65 21.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.998 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.524 ' O ' ' C ' ' A' ' 57' ' ' ASN . 62.9 mt -104.43 165.48 11.03 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 117.773 -1.571 . . . . 0.0 108.896 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.875 HD22 HG22 ' A' ' 85' ' ' THR . 15.9 m-80 34.28 63.73 0.41 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 118.181 -1.407 . . . . 0.0 111.552 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 53.88 59.03 4.54 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 115.4 -2.52 . . . . 0.0 111.553 169.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.23 170.69 52.81 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 114.223 -3.846 . . . . 0.0 110.91 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -97.09 104.96 17.03 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 115.383 -2.527 . . . . 0.0 108.124 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 53.5 t -95.25 118.57 32.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 114.372 -2.931 . . . . 0.0 109.676 -175.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? . . . . . 0 C--O 1.215 -0.732 0 C-N-CA 116.356 -2.137 . . . . 0.0 108.032 174.559 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.7 -133.76 6.49 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 114.531 -3.7 . . . . 0.0 110.984 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.71 100.1 9.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 115.305 -2.558 . . . . 0.0 108.762 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 86.07 -72.81 2.63 Favored Glycine 0 N--CA 1.477 1.386 0 C-N-CA 114.04 -3.933 . . . . 0.0 110.187 -177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.72 166.52 22.87 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.436 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -128.82 159.63 35.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 115.929 -2.308 . . . . 0.0 108.724 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.3 p -130.54 130.43 44.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 116.068 -2.253 . . . . 0.0 109.394 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 69.3 m -107.35 139.27 42.1 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 115.475 -2.49 . . . . 0.0 109.961 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.08 121.96 36.58 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 116.293 -2.163 . . . . 0.0 109.072 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 33.7 m -73.79 148.05 42.85 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 115.659 -2.416 . . . . 0.0 110.881 -176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.9 166.24 11.38 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 115.873 -2.331 . . . . 0.0 109.146 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -53.78 115.42 1.98 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.513 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 1.033 ' C ' ' HB2' ' A' ' 84' ' ' SER . . . 136.27 -34.67 2.22 Favored Glycine 0 C--O 1.262 1.862 0 C-N-CA 115.007 -3.473 . . . . 0.0 110.363 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 1.146 ' HA ' ' C ' ' A' ' 84' ' ' SER 0.266 28.9 m-85 -133.84 162.84 30.92 Favored 'General case' 0 CA--C 1.568 1.669 0 C-N-CA 118.145 -1.422 . . . . 0.0 107.686 -172.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.063 ' N ' ' O ' ' A' ' 83' ' ' PHE . 3.7 tm-20 -161.25 136.86 7.86 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 113.726 -3.19 . . . . 0.0 112.126 175.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 142.16 178.39 18.17 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 114.52 -3.705 . . . . 0.0 110.604 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 78' ' ' GLY . 62.9 tttm -46.84 -61.33 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 C-N-CA 115.339 -2.544 . . . . 0.0 111.342 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.701 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 68.7 m-20 -93.09 5.35 51.79 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.943 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.1 m 79.91 72.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 115.927 -2.309 . . . . 0.0 106.972 -164.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.967 ' C ' HG21 ' A' ' 85' ' ' THR . 40.1 tt0 -107.25 -29.82 9.1 Favored 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 116.982 -1.887 . . . . 0.0 109.002 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 1.063 ' O ' ' N ' ' A' ' 77' ' ' GLU . 80.8 m-85 -90.52 151.33 21.4 Favored 'General case' 0 C--O 1.19 -2.063 0 C-N-CA 116.904 -1.919 . . . . 0.0 108.049 164.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 1.297 ' O ' HG23 ' A' ' 85' ' ' THR 0.3 2.2 p 41.38 116.23 0.0 OUTLIER 'General case' 1 CA--C 1.421 -4.015 0 C-N-CA 113.724 -3.19 . . . . 0.0 108.963 -160.192 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 1.297 HG23 ' O ' ' A' ' 84' ' ' SER . 2.7 p 163.82 39.74 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 1 CA-C-N 108.002 -4.181 . . . . 0.0 108.764 -148.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.743 ' H ' ' HE1' ' A' ' 76' ' ' PHE . 1.7 mpp_? . . . . . 0 CA--C 1.561 1.367 0 C-N-CA 114.509 -2.877 . . . . 0.0 109.133 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp . . . . . 0 N--CA 1.441 -0.89 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -128.2 137.73 52.17 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 116.651 -2.02 . . . . 0.0 111.429 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.46 -169.76 30.03 Favored Glycine 0 N--CA 1.481 1.684 1 C-N-CA 112.23 -4.795 . . . . 0.0 109.754 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -100.3 118.5 36.69 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 116.34 -2.144 . . . . 0.0 108.539 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -96.09 -8.56 33.03 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 116.207 -2.197 . . . . 0.0 108.49 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.198 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 18.3 t -102.25 -19.73 14.93 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.212 -2.595 . . . . 0.0 110.97 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -74.77 13.99 0.56 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 114.633 -2.827 . . . . 0.0 109.458 178.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -97.58 12.58 64.62 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 114.503 -3.713 . . . . 0.0 110.095 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.418 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 89.4 m-70 45.43 71.06 1.66 Allowed Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 115.468 -2.493 . . . . 0.0 110.551 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.0 OUTLIER -84.47 -34.72 0.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.36 0 O-C-N 122.401 0.685 . . . . 0.0 110.674 178.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.9 m -92.63 156.26 17.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 116.219 -2.192 . . . . 0.0 109.945 -173.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 57' ' ' ASN . 89.5 mt -103.04 176.29 5.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 116.645 -2.022 . . . . 0.0 109.308 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 56' ' ' LEU . 16.4 m-80 29.81 63.42 0.15 Allowed 'General case' 0 N--CA 1.4 -2.968 0 C-N-CA 116.801 -1.96 . . . . 0.0 113.11 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 51.51 55.75 8.93 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 115.734 -2.387 . . . . 0.0 110.721 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.93 172.24 55.17 Favored Glycine 0 CA--C 1.536 1.349 1 C-N-CA 113.463 -4.208 . . . . 0.0 109.346 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -90.83 87.7 6.76 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 115.276 -2.569 . . . . 0.0 108.795 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.198 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.6 t -89.0 125.12 34.85 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 115.852 -2.339 . . . . 0.0 109.558 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.9 tptt . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 115.863 -2.335 . . . . 0.0 107.985 176.366 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.6 -123.19 1.64 Allowed Glycine 0 N--CA 1.478 1.459 0 C-N-CA 114.348 -3.787 . . . . 0.0 110.495 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 67.2 mt -88.63 76.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 116.315 -2.154 . . . . 0.0 108.075 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.27 -68.74 3.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 115.16 -3.4 . . . . 0.0 109.982 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -73.59 165.5 24.98 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 115.914 -2.315 . . . . 0.0 110.407 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -114.85 157.42 23.32 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 115.312 -2.555 . . . . 0.0 109.186 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.4 p -124.88 134.27 52.76 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.099 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 90.6 m -108.56 132.33 53.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.728 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 123.41 40.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 115.887 -2.325 . . . . 0.0 109.226 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.8 m -75.08 143.99 43.15 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 115.373 -2.531 . . . . 0.0 109.724 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 170.06 15.36 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.612 -2.435 . . . . 0.0 110.292 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -59.12 132.38 53.86 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 115.931 -2.307 . . . . 0.0 109.075 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.41 -20.62 36.97 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 115.453 -3.26 . . . . 0.0 110.007 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.36 152.41 39.02 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 115.742 -2.383 . . . . 0.0 109.067 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -161.68 121.15 2.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.368 -2.533 . . . . 0.0 110.331 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.517 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 163.51 173.96 32.81 Favored Glycine 0 CA--C 1.55 2.259 1 C-N-CA 113.278 -4.296 . . . . 0.0 110.293 176.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 78' ' ' GLY . 14.6 tppt? -41.92 -55.69 3.02 Favored 'General case' 0 N--CA 1.417 -2.107 0 C-N-CA 115.881 -2.327 . . . . 0.0 110.896 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.699 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 47.8 m-20 -113.59 17.07 18.53 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 115.699 -2.401 . . . . 0.0 109.321 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.9 m 76.73 32.51 0.52 Allowed 'General case' 0 C--O 1.25 1.117 0 C-N-CA 114.699 -2.8 . . . . 0.0 109.446 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.98 -30.15 62.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 115.165 -2.614 . . . . 0.0 109.735 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -90.0 160.38 16.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 116.022 -2.271 . . . . 0.0 110.387 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' ' C ' ' A' ' 85' ' ' THR . 11.0 p -120.89 70.57 0.91 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 115.899 -2.32 . . . . 0.0 109.368 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.596 ' C ' ' O ' ' A' ' 84' ' ' SER . 27.5 p 32.58 53.9 0.34 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 115.782 -2.367 . . . . 0.0 110.083 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 . . . . . 0 N--CA 1.5 2.029 0 C-N-CA 113.977 -3.089 . . . . 0.0 108.553 -178.892 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.7 mttm . . . . . 1 N--CA 1.541 4.123 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -90.62 132.45 35.74 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-N 110.121 -3.218 . . . . 0.0 107.711 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.73 -87.17 0.43 Allowed Glycine 1 CA--C 1.596 5.121 0 C-N-CA 116.707 -2.663 . . . . 0.0 109.599 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -128.16 124.98 38.18 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 116.129 -2.228 . . . . 0.0 109.593 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 12.2 mp0 -94.11 -7.51 42.27 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 114.95 -2.7 . . . . 0.0 111.124 -171.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.7 t -125.08 12.25 8.31 Favored 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 115.31 -2.556 . . . . 0.0 110.452 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -75.41 17.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 113.909 -3.116 . . . . 0.0 110.444 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -117.38 17.82 12.29 Favored Glycine 0 CA--C 1.494 -1.263 0 C-N-CA 115.554 -3.213 . . . . 0.0 109.537 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 44.07 74.7 0.74 Allowed Pre-proline 0 CA--C 1.568 1.66 0 C-N-CA 115.297 -2.561 . . . . 0.0 111.136 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.06 -40.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.974 0 C-N-CA 121.595 1.53 . . . . 0.0 110.051 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 5.4 m -74.97 152.96 38.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 115.175 -2.61 . . . . 0.0 108.842 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' ASN . 75.1 mt -103.9 170.8 7.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 116.464 -2.094 . . . . 0.0 108.877 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' LEU . 8.8 m-80 33.81 62.41 0.43 Allowed 'General case' 0 N--CA 1.422 -1.827 0 C-N-CA 116.101 -2.24 . . . . 0.0 113.748 177.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 49.93 62.35 2.7 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 117.228 -1.789 . . . . 0.0 113.689 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.97 168.66 32.87 Favored Glycine 0 C--O 1.251 1.158 1 C-N-CA 113.511 -4.185 . . . . 0.0 110.088 172.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.402 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 8.0 t-80 -89.31 164.39 14.94 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.028 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 91.0 m -131.44 119.24 21.34 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 114.96 -2.696 . . . . 0.0 110.031 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.8 tptt . . . . . 0 C--O 1.25 1.09 0 C-N-CA 115.992 -2.283 . . . . 0.0 107.015 175.625 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.45 -145.48 4.19 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 115.517 -3.23 . . . . 0.0 110.041 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.33 81.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 115.788 -2.365 . . . . 0.0 108.162 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.63 -59.19 3.7 Favored Glycine 0 C--N 1.343 0.944 1 C-N-CA 113.53 -4.176 . . . . 0.0 110.838 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.98 168.16 20.57 Favored 'General case' 0 C--O 1.259 1.597 0 C-N-CA 116.587 -2.045 . . . . 0.0 108.744 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -151.77 161.97 41.79 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 115.942 -2.303 . . . . 0.0 108.591 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.0 p -139.71 129.41 24.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 116.121 -2.232 . . . . 0.0 109.617 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 65.5 m -88.92 136.41 33.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 114.947 -2.701 . . . . 0.0 109.778 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -109.33 124.38 50.86 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 115.924 -2.31 . . . . 0.0 108.982 175.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 66.2 m -77.04 152.95 34.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.994 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.15 171.61 13.85 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 115.521 -2.471 . . . . 0.0 110.848 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.48 94.19 0.54 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 116.612 -2.035 . . . . 0.0 108.471 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.68 -30.06 0.93 Allowed Glycine 0 CA--C 1.486 -1.77 0 C-N-CA 114.98 -3.486 . . . . 0.0 109.204 -174.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -116.6 163.5 16.01 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 115.493 -2.483 . . . . 0.0 108.825 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -156.11 139.79 16.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 114.903 -2.719 . . . . 0.0 110.065 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 144.75 168.22 12.58 Favored Glycine 0 C--N 1.294 -1.766 1 C-N-CA 113.807 -4.044 . . . . 0.0 111.434 -178.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 78' ' ' GLY . 39.1 ttpt -50.92 -54.71 21.78 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 115.556 -2.457 . . . . 0.0 109.957 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.724 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 70.7 m-20 -104.17 8.68 36.34 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.085 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.306 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.4 m 81.47 43.04 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 115.185 -2.606 . . . . 0.0 108.497 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.34 -18.23 42.88 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 115.455 -2.498 . . . . 0.0 109.854 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -104.28 170.84 7.67 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 114.95 -2.7 . . . . 0.0 110.072 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.498 ' O ' ' C ' ' A' ' 85' ' ' THR . 41.1 p -121.05 82.69 1.96 Allowed 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 114.92 -2.712 . . . . 0.0 109.725 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.498 ' C ' ' O ' ' A' ' 84' ' ' SER . 24.7 p 27.78 51.9 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 117.133 -1.827 . . . . 0.0 111.002 -175.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 115.25 -2.58 . . . . 0.0 109.31 -178.721 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . 0.262 59.5 tttp . . . . . 0 CA--C 1.604 3.024 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -100.36 159.79 14.85 Favored 'General case' 0 CA--C 1.586 2.342 0 C-N-CA 113.826 -3.15 . . . . 0.0 108.432 174.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.77 175.39 3.77 Favored Glycine 0 C--O 1.197 -2.186 0 C-N-CA 115.363 -3.303 . . . . 0.0 111.071 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -90.44 133.53 34.96 Favored 'General case' 0 N--CA 1.514 2.765 0 C-N-CA 115.876 -2.329 . . . . 0.0 109.831 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.665 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 10.2 mp0 -97.99 -8.16 28.51 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 117.8 -1.56 . . . . 0.0 108.38 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.114 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.4 t -115.01 -10.76 12.21 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 115.238 -2.585 . . . . 0.0 111.288 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.99 20.17 0.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 116.003 -2.279 . . . . 0.0 111.26 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -132.31 24.9 3.91 Favored Glycine 0 C--N 1.311 -0.837 0 C-N-CA 114.344 -3.788 . . . . 0.0 111.294 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 49.62 84.13 0.21 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 117.142 -1.823 . . . . 0.0 110.96 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -95.47 -32.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.932 0 O-C-N 123.67 1.352 . . . . 0.0 109.115 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 34.1 m -81.56 163.01 22.94 Favored 'General case' 0 C--O 1.255 1.342 0 C-N-CA 114.007 -3.077 . . . . 0.0 110.937 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.523 ' O ' ' C ' ' A' ' 57' ' ' ASN . 94.5 mt -113.93 172.91 6.71 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 115.717 -2.393 . . . . 0.0 109.481 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.621 HD21 ' HA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 43.05 49.58 5.38 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 116.881 -1.928 . . . . 0.0 110.334 172.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.462 ' NE2' ' N ' ' A' ' 58' ' ' GLN . 9.6 mp0 57.62 48.22 14.57 Favored 'General case' 0 C--O 1.272 2.284 0 C-N-CA 116.502 -2.079 . . . . 0.0 112.2 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.78 160.56 34.15 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 114.917 -3.516 . . . . 0.0 111.01 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -87.5 158.29 18.97 Favored 'General case' 0 C--N 1.275 -2.647 0 C-N-CA 115.219 -2.592 . . . . 0.0 109.02 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.114 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 38.9 t -144.84 128.33 17.0 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 114.14 -3.024 . . . . 0.0 111.305 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.7 tptp . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 115.666 -2.414 . . . . 0.0 108.149 175.169 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.46 -124.23 1.98 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 114.385 -3.769 . . . . 0.0 110.536 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.39 89.51 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 114.643 -2.823 . . . . 0.0 109.829 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.665 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 80.79 -68.68 3.35 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 115.232 -3.366 . . . . 0.0 110.156 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.83 -174.47 3.06 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 114.243 -2.983 . . . . 0.0 109.569 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -139.19 166.87 23.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 116.184 -2.206 . . . . 0.0 110.737 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 p -133.18 143.52 49.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.5 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 87.9 m -117.53 141.49 48.3 Favored 'General case' 0 C--O 1.213 -0.843 0 C-N-CA 113.595 -3.242 . . . . 0.0 110.143 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.59 162.27 13.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 115.525 -2.47 . . . . 0.0 108.139 172.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.824 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 74.0 m -111.08 154.81 23.73 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 114.293 -2.963 . . . . 0.0 108.366 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.13 165.45 20.34 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 113.783 -3.167 . . . . 0.0 110.704 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.22 97.64 0.19 Allowed 'General case' 0 C--N 1.349 0.572 0 C-N-CA 115.31 -2.556 . . . . 0.0 109.604 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.68 -42.98 0.59 Allowed Glycine 0 N--CA 1.428 -1.858 0 C-N-CA 114.667 -3.635 . . . . 0.0 109.435 -172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -105.09 166.6 10.28 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 115.181 -2.608 . . . . 0.0 108.7 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -159.04 123.24 3.95 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 114.941 -2.703 . . . . 0.0 109.46 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 162.68 167.21 22.77 Favored Glycine 0 CA--C 1.543 1.838 0 C-N-CA 116.345 -2.836 . . . . 0.0 111.338 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 78' ' ' GLY . 10.8 tmtt? -44.27 -55.53 4.82 Favored 'General case' 0 N--CA 1.403 -2.778 0 C-N-CA 116.3 -2.16 . . . . 0.0 110.125 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.779 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 26.3 m-20 -102.13 5.36 40.31 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 115.095 -2.642 . . . . 0.0 109.428 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.824 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 25.0 m 79.21 14.82 1.05 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 115.46 -2.496 . . . . 0.0 109.569 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.621 ' HA ' HD21 ' A' ' 57' ' ' ASN . 29.2 tt0 -55.68 -27.01 47.79 Favored 'General case' 0 CA--C 1.571 1.755 0 C-N-CA 115.434 -2.506 . . . . 0.0 111.693 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.42 151.89 19.03 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 115.404 -2.518 . . . . 0.0 110.3 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.4 p -114.99 148.75 38.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 114.787 -2.765 . . . . 0.0 109.126 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.8 p -102.05 35.8 2.28 Favored 'General case' 0 C--O 1.247 0.926 0 C-N-CA 115.505 -2.478 . . . . 0.0 108.934 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 . . . . . 0 CA--C 1.578 2.031 0 C-N-CA 115.697 -2.401 . . . . 0.0 109.529 176.112 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 pttt . . . . . 0 N--CA 1.42 -1.948 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -137.55 29.88 2.64 Favored 'General case' 0 N--CA 1.527 3.409 0 C-N-CA 116.659 -2.016 . . . . 0.0 108.921 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.02 -173.22 54.98 Favored Glycine 0 C--N 1.351 1.385 0 C-N-CA 114.2 -3.857 . . . . 0.0 110.582 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.39 117.84 26.11 Favored 'General case' 0 C--O 1.214 -0.781 0 C-N-CA 115.209 -2.596 . . . . 0.0 109.654 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -98.68 -17.81 18.38 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 114.514 -2.875 . . . . 0.0 109.751 -174.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.445 ' C ' ' H ' ' A' ' 52' ' ' GLY . 36.8 t -82.65 -15.67 51.15 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 115.363 -2.535 . . . . 0.0 109.247 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.94 20.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 115.748 -2.381 . . . . 0.0 110.745 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -111.55 9.85 28.23 Favored Glycine 0 N--CA 1.481 1.664 0 C-N-CA 114.362 -3.78 . . . . 0.0 110.715 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.489 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 13.4 t-160 50.98 67.3 4.43 Favored Pre-proline 0 C--N 1.366 1.287 0 C-N-CA 116.41 -2.116 . . . . 0.0 109.067 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 53' ' ' HIS . 1.2 Cg_endo -83.77 -30.46 0.77 Allowed 'Trans proline' 0 N--CA 1.419 -2.871 0 C-N-CA 121.071 1.181 . . . . 0.0 110.431 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.952 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 4.3 m -87.66 147.86 25.06 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 116.314 -2.154 . . . . 0.0 110.727 -175.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 57' ' ' ASN . 76.9 mt -94.85 172.7 8.0 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.472 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.618 ' HB2' HG21 ' A' ' 85' ' ' THR . 16.8 m-80 32.68 61.83 0.36 Allowed 'General case' 0 N--CA 1.399 -3.011 0 C-N-CA 117.337 -1.745 . . . . 0.0 114.245 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 52.55 41.9 31.23 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.956 -1.498 . . . . 0.0 110.786 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.59 174.03 52.81 Favored Glycine 0 C--N 1.373 2.638 0 C-N-CA 113.946 -3.978 . . . . 0.0 109.008 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -88.76 147.95 24.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 115.123 -2.631 . . . . 0.0 108.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.9 t -140.18 123.99 17.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 115.699 -2.401 . . . . 0.0 110.599 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm . . . . . 0 CA--C 1.541 0.607 0 C-N-CA 115.374 -2.53 . . . . 0.0 108.791 176.244 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.0 -138.88 3.28 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 114.942 -3.504 . . . . 0.0 109.271 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.5 mm -80.88 86.28 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 116.358 -2.137 . . . . 0.0 108.684 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.63 -72.32 2.0 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 114.323 -3.799 . . . . 0.0 110.158 -176.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.25 167.89 19.45 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 115.214 -2.594 . . . . 0.0 109.493 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -113.3 152.72 29.52 Favored 'General case' 0 C--O 1.206 -1.228 0 C-N-CA 115.757 -2.377 . . . . 0.0 109.075 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -118.16 131.03 56.43 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 114.897 -2.721 . . . . 0.0 109.469 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.952 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 63.0 m -105.14 137.22 43.25 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 115.933 -2.307 . . . . 0.0 109.854 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.96 114.01 20.38 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 116.89 -1.924 . . . . 0.0 108.532 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 32.4 m -71.97 145.15 48.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 116.505 -2.078 . . . . 0.0 108.996 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.41 169.04 14.05 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 116.264 -2.174 . . . . 0.0 110.063 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.73 145.81 6.49 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 115.92 -2.312 . . . . 0.0 110.214 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.72 -22.56 39.71 Favored Glycine 0 CA--C 1.509 -0.338 0 C-N-CA 114.795 -3.574 . . . . 0.0 109.751 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 1.185 ' CD1' HG22 ' A' ' 85' ' ' THR . 69.4 m-85 -131.53 145.24 51.64 Favored 'General case' 0 CA--C 1.476 -1.899 0 C-N-CA 115.916 -2.314 . . . . 0.0 112.055 -173.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.701 ' N ' ' OG ' ' A' ' 84' ' ' SER . 0.8 OUTLIER -165.56 174.53 9.8 Favored 'General case' 0 N--CA 1.399 -2.996 0 C-N-CA 114.066 -3.054 . . . . 0.0 112.632 164.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 81' ' ' CYS . . . 137.76 171.74 12.29 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 116.507 -2.759 . . . . 0.0 110.642 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 78' ' ' GLY . 63.9 tttm -39.39 -52.81 2.05 Favored 'General case' 0 C--O 1.251 1.172 0 C-N-CA 116.976 -1.89 . . . . 0.0 110.179 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 67.6 m-20 -115.16 20.95 14.6 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 116.376 -2.129 . . . . 0.0 108.746 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.0 m 76.53 40.8 0.21 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 115.309 -2.556 . . . . 0.0 108.825 -171.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -88.87 -28.85 20.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 116.213 -2.195 . . . . 0.0 109.003 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.717 ' C ' ' OG ' ' A' ' 84' ' ' SER . 62.9 m-85 -88.72 100.32 13.04 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 116.432 -2.107 . . . . 0.0 107.324 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 1.469 ' CB ' HG23 ' A' ' 85' ' ' THR . 11.1 m 164.77 173.63 0.02 OUTLIER 'General case' 0 C--O 1.272 2.288 0 C-N-CA 114.036 -3.066 . . . . 0.0 110.494 -145.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 1.469 HG23 ' CB ' ' A' ' 84' ' ' SER . 1.5 p 53.01 42.65 32.26 Favored 'General case' 0 C--N 1.268 -2.973 0 C-N-CA 115.887 -2.325 . . . . 0.0 110.166 147.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 86' ' ' ARG . 77.9 mtt-85 . . . . . 0 N--CA 1.422 -1.846 0 C-N-CA 113.545 -3.262 . . . . 0.0 109.519 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.96 119.14 37.77 Favored 'General case' 0 CA--C 1.476 -1.89 0 C-N-CA 112.745 -3.582 . . . . 0.0 113.717 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.89 -65.9 0.51 Allowed Glycine 0 CA--C 1.557 2.708 0 C-N-CA 114.142 -3.885 . . . . 0.0 110.795 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -121.82 133.29 54.9 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 114.496 -2.882 . . . . 0.0 108.898 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 7.4 mp0 -96.14 -15.24 22.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 114.481 -2.887 . . . . 0.0 110.862 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.4 t -121.79 20.3 10.93 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 115.581 -2.447 . . . . 0.0 110.264 -175.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -74.98 33.21 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 116.567 -2.053 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -153.91 23.6 0.71 Allowed Glycine 0 N--CA 1.47 0.961 0 C-N-CA 114.411 -3.757 . . . . 0.0 110.997 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.8 t-160 47.15 75.17 0.69 Allowed Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 115.931 -2.308 . . . . 0.0 109.123 178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.4 Cg_endo -82.49 -34.11 0.44 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 120.566 0.844 . . . . 0.0 111.123 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 10.6 m -71.57 164.1 26.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 115.636 -2.425 . . . . 0.0 109.403 -175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.7 mt -114.8 170.81 8.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 116.473 -2.091 . . . . 0.0 110.094 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.492 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 35.32 57.28 0.84 Allowed 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 115.811 -2.355 . . . . 0.0 114.732 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 56.7 mt-30 60.5 39.6 18.01 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.113 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 161.52 50.32 Favored Glycine 1 N--CA 1.521 4.352 1 C-N-CA 113.739 -4.077 . . . . 0.0 110.847 175.905 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -89.34 167.05 13.35 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 114.987 -2.685 . . . . 0.0 107.75 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 48.5 t -136.45 133.28 36.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 113.249 -3.38 . . . . 0.0 110.126 -172.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm . . . . . 0 N--CA 1.48 1.031 0 C-N-CA 115.702 -2.399 . . . . 0.0 107.635 175.645 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.39 -138.99 2.9 Favored Glycine 1 N--CA 1.516 4.01 0 C-N-CA 116.067 -2.968 . . . . 0.0 110.317 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.16 88.59 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 115.544 -2.462 . . . . 0.0 107.234 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.75 -64.02 4.0 Favored Glycine 0 CA--C 1.545 1.966 0 C-N-CA 115.222 -3.37 . . . . 0.0 110.252 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -76.58 164.72 25.66 Favored 'General case' 0 C--O 1.26 1.629 0 C-N-CA 115.542 -2.463 . . . . 0.0 110.096 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -134.76 163.0 30.78 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 115.65 -2.42 . . . . 0.0 108.624 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.6 p -137.18 132.28 33.69 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.372 -2.531 . . . . 0.0 108.293 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 41.4 m -97.53 141.29 30.76 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 114.851 -2.74 . . . . 0.0 110.149 -177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 111.71 24.31 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 115.764 -2.375 . . . . 0.0 109.057 173.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.941 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.1 m -71.49 148.75 46.48 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 115.979 -2.288 . . . . 0.0 111.232 -176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.11 168.79 19.48 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 115.114 -2.635 . . . . 0.0 110.248 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.12 140.06 56.24 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 115.216 -2.594 . . . . 0.0 108.888 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.48 -14.91 61.75 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 116.317 -2.849 . . . . 0.0 110.425 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.17 150.18 49.63 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 116.268 -2.173 . . . . 0.0 110.334 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.73 130.87 11.11 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 115.72 -2.392 . . . . 0.0 108.755 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 154.15 163.36 11.84 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 114.314 -3.803 . . . . 0.0 110.993 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 78' ' ' GLY . 56.9 tttm -43.83 -50.26 7.93 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.57 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 42.1 m-20 -110.62 10.98 22.9 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 116.001 -2.28 . . . . 0.0 110.33 175.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.941 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 21.9 m 78.01 30.58 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 116.067 -2.253 . . . . 0.0 108.237 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.44 -32.21 68.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.518 -2.073 . . . . 0.0 109.449 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.13 154.27 20.3 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 114.926 -2.71 . . . . 0.0 109.525 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 85' ' ' THR . 39.8 p -113.79 70.77 0.73 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 114.866 -2.734 . . . . 0.0 109.151 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.507 ' C ' ' O ' ' A' ' 84' ' ' SER . 41.1 p 34.36 51.45 0.45 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 117.059 -1.856 . . . . 0.0 110.623 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 . . . . . 0 N--CA 1.489 1.509 0 C-N-CA 114.755 -2.778 . . . . 0.0 108.879 177.574 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 tttp . . . . . 0 CA--C 1.472 -2.03 0 CA-C-O 121.193 0.52 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -144.0 101.5 3.74 Favored 'General case' 0 CA--C 1.458 -2.591 0 C-N-CA 116.398 -2.121 . . . . 0.0 113.555 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.94 -111.91 0.5 Allowed Glycine 0 CA--C 1.578 3.994 0 C-N-CA 117.286 -2.387 . . . . 0.0 108.725 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -113.24 127.18 56.09 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 115.101 -2.64 . . . . 0.0 109.103 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.506 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 7.7 mp0 -89.83 -9.61 48.45 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 116.656 -2.018 . . . . 0.0 109.539 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.466 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.3 t -116.37 1.82 13.09 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 114.425 -2.91 . . . . 0.0 109.979 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -74.99 20.33 0.13 Allowed 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 115.471 -2.492 . . . . 0.0 110.484 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -119.88 13.69 10.6 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 114.004 -3.951 . . . . 0.0 110.137 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 50.09 73.55 0.97 Allowed Pre-proline 0 N--CA 1.487 1.404 0 C-N-CA 116.878 -1.929 . . . . 0.0 111.237 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -83.48 -43.6 0.07 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.128 0 N-CA-C 110.082 -0.776 . . . . 0.0 110.082 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.986 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 2.8 m -85.41 147.41 26.51 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 115.387 -2.525 . . . . 0.0 110.05 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.58 ' O ' ' C ' ' A' ' 57' ' ' ASN . 61.2 mt -95.21 179.41 5.2 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 116.839 -1.944 . . . . 0.0 109.365 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.58 ' C ' ' O ' ' A' ' 56' ' ' LEU . 12.5 m-80 28.62 60.92 0.13 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 118.238 -1.385 . . . . 0.0 110.204 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 55.06 58.3 4.85 Favored 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 115.051 -2.66 . . . . 0.0 108.682 165.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.07 171.13 51.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 113.921 -3.99 . . . . 0.0 109.812 171.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -89.15 93.5 9.6 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 115.449 -2.5 . . . . 0.0 108.798 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.6 p -95.55 109.0 21.29 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 115.436 -2.506 . . . . 0.0 108.644 -171.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 tttp . . . . . 0 C--O 1.242 0.689 0 C-N-CA 115.917 -2.313 . . . . 0.0 107.879 176.756 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.96 -127.34 1.03 Allowed Glycine 0 N--CA 1.478 1.475 1 C-N-CA 113.865 -4.017 . . . . 0.0 110.107 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.6 mt -92.71 79.33 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 114.922 -2.711 . . . . 0.0 108.915 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 114.807 -3.568 . . . . 0.0 109.713 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.54 164.37 26.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 114.598 -2.841 . . . . 0.0 110.539 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -137.48 161.38 36.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 115.613 -2.435 . . . . 0.0 109.196 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 p -120.43 136.17 54.82 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 115.665 -2.414 . . . . 0.0 110.274 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.986 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 52.4 m -104.85 124.11 48.87 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 115.394 -2.523 . . . . 0.0 109.003 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 119.64 35.62 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 115.886 -2.326 . . . . 0.0 108.754 174.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 9.9 m -71.74 149.9 44.96 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 116.265 -2.174 . . . . 0.0 109.584 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.14 164.17 26.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 116.017 -2.273 . . . . 0.0 109.172 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -63.64 97.84 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 114.466 -2.893 . . . . 0.0 108.602 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.25 -33.32 0.65 Allowed Glycine 0 C--O 1.247 0.917 0 C-N-CA 115.357 -3.306 . . . . 0.0 110.227 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 83' ' ' PHE . 96.2 m-85 -116.94 159.99 21.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 117.053 -1.859 . . . . 0.0 109.114 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.759 ' H ' ' HD1' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -159.7 -126.73 0.02 OUTLIER 'General case' 0 C--N 1.363 1.176 0 C-N-CA 114.212 -2.995 . . . . 0.0 109.653 166.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.411 ' N ' ' CZ ' ' A' ' 83' ' ' PHE . . . 68.58 -176.44 28.18 Favored Glycine 0 CA--C 1.554 2.509 1 C-N-CA 113.073 -4.394 . . . . 0.0 110.143 -179.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -48.3 -61.17 2.13 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 116.901 -1.92 . . . . 0.0 113.616 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 81.8 m-20 -106.29 19.57 20.3 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 115.913 -2.315 . . . . 0.0 108.74 -171.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 10.3 m 73.1 46.6 0.23 Allowed 'General case' 0 C--O 1.252 1.195 0 C-N-CA 116.438 -2.105 . . . . 0.0 107.956 -167.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 77' ' ' GLU . 42.6 tt0 -90.24 -30.14 17.73 Favored 'General case' 0 C--O 1.261 1.672 0 C-N-CA 116.818 -1.953 . . . . 0.0 109.155 -170.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.759 ' HD1' ' H ' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -102.31 147.44 26.68 Favored 'General case' 0 N--CA 1.379 -3.988 0 C-N-CA 112.298 -3.761 . . . . 0.0 108.758 -162.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.6 p -96.73 117.61 31.4 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 114.184 -3.006 . . . . 0.0 108.01 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.5 p -91.21 37.36 0.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 115.601 -2.44 . . . . 0.0 109.343 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 115.774 -2.371 . . . . 0.0 108.561 179.699 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.7 mttp . . . . . 0 CA--C 1.588 2.417 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -157.01 113.49 3.0 Favored 'General case' 0 N--CA 1.534 3.73 0 C-N-CA 116.115 -2.234 . . . . 0.0 108.233 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.16 -114.49 0.28 Allowed Glycine 1 N--CA 1.554 6.548 1 C-N-CA 113.426 -4.226 . . . . 0.0 109.893 -175.358 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -122.13 143.12 49.73 Favored 'General case' 0 N--CA 1.415 -2.202 0 C-N-CA 115.723 -2.391 . . . . 0.0 109.676 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 86.7 mm-40 -89.02 -19.35 25.76 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.044 -1.463 . . . . 0.0 110.294 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 52' ' ' GLY . 43.4 t -95.53 11.9 31.43 Favored 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 115.302 -2.559 . . . . 0.0 108.652 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.98 26.61 0.07 Allowed 'General case' 0 C--O 1.258 1.533 0 C-N-CA 115.876 -2.33 . . . . 0.0 109.87 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -150.15 30.02 1.09 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 114.016 -3.945 . . . . 0.0 110.136 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 52' ' ' GLY . 21.8 t-160 40.31 83.87 0.19 Allowed Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 115.977 -2.289 . . . . 0.0 110.424 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -89.34 -27.12 0.38 Allowed 'Trans proline' 0 N--CA 1.426 -2.484 0 O-C-N 123.182 1.096 . . . . 0.0 111.547 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.937 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 9.7 m -94.16 166.64 12.02 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 114.314 -2.955 . . . . 0.0 110.415 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 57' ' ' ASN . 91.1 mt -113.6 175.02 5.63 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 115.898 -2.321 . . . . 0.0 109.56 -177.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 56' ' ' LEU . 42.7 m-80 27.47 62.4 0.1 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.055 -174.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 57' ' ' ASN . 45.5 mt-30 58.9 47.33 12.56 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 125.248 1.593 . . . . 0.0 109.034 171.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.98 157.08 35.01 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 113.939 -3.981 . . . . 0.0 109.534 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -86.04 155.13 20.97 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 114.351 -2.94 . . . . 0.0 107.765 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.0 p -135.38 105.14 6.12 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.456 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp . . . . . 0 N--CA 1.486 1.37 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.338 177.739 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.6 -146.03 4.24 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 114.587 -3.673 . . . . 0.0 110.823 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.9 mm -80.26 94.0 2.07 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 C-N-CA 115.829 -2.348 . . . . 0.0 109.477 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 49' ' ' GLN . . . 80.11 -71.68 2.73 Favored Glycine 0 C--O 1.259 1.666 0 C-N-CA 115.889 -3.053 . . . . 0.0 112.297 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -77.83 174.53 10.92 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 114.288 -2.965 . . . . 0.0 109.697 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.95 160.96 37.0 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 116.383 -2.127 . . . . 0.0 108.718 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.1 p -131.3 140.82 49.85 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 114.479 -2.888 . . . . 0.0 108.592 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.937 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 55.8 m -100.44 128.91 46.37 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.463 -178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.32 119.71 40.3 Favored 'General case' 0 C--O 1.255 1.387 0 C-N-CA 116.018 -2.273 . . . . 0.0 108.481 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 80.2 m -72.46 155.93 39.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 114.854 -2.738 . . . . 0.0 109.169 -174.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.19 163.65 26.36 Favored 'General case' 0 C--O 1.25 1.104 0 C-N-CA 114.683 -2.807 . . . . 0.0 108.947 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.54 100.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 114.782 -2.767 . . . . 0.0 108.99 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.27 -42.27 0.65 Allowed Glycine 0 CA--C 1.546 2.031 0 C-N-CA 115.414 -3.279 . . . . 0.0 108.309 -172.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.22 161.33 16.7 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 115.49 -2.484 . . . . 0.0 110.154 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -147.75 142.49 26.71 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 115.477 -2.489 . . . . 0.0 108.639 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.555 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 142.87 158.63 7.61 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 115.914 -3.041 . . . . 0.0 110.478 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 78' ' ' GLY . 38.7 ttmt -39.27 -50.55 1.99 Allowed 'General case' 0 C--O 1.187 -2.232 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.183 175.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.715 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 59.5 m-20 -107.83 -3.1 19.31 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 116.842 -1.943 . . . . 0.0 109.146 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.282 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.5 m 83.27 31.81 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 114.874 -2.73 . . . . 0.0 109.154 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.78 -30.29 63.99 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 116.511 -2.076 . . . . 0.0 109.896 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -89.19 150.45 22.66 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 115.079 -2.649 . . . . 0.0 108.87 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 80.4 p -113.28 152.91 29.26 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 114.192 -3.003 . . . . 0.0 110.002 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 75.3 p -85.65 33.89 0.58 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 114.804 -2.758 . . . . 0.0 109.95 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 . . . . . 0 N--CA 1.472 0.661 0 C-N-CA 116.709 -1.996 . . . . 0.0 110.433 179.142 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt . . . . . 0 N--CA 1.507 2.402 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -79.74 145.08 33.08 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 116.945 -1.902 . . . . 0.0 109.422 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.91 -81.95 0.31 Allowed Glycine 0 C--N 1.364 2.119 0 C-N-CA 114.651 -3.642 . . . . 0.0 108.384 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -123.97 139.01 54.37 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 115.752 -2.379 . . . . 0.0 110.089 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -96.37 -34.17 11.65 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 116.393 -2.123 . . . . 0.0 110.219 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.05 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 48.8 t -93.78 20.59 7.4 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 116.43 -2.108 . . . . 0.0 109.516 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.18 23.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 114.879 -2.728 . . . . 0.0 110.969 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -147.2 23.38 1.57 Allowed Glycine 0 N--CA 1.472 1.079 0 C-N-CA 114.412 -3.756 . . . . 0.0 111.328 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 43.77 80.42 0.29 Allowed Pre-proline 0 CA--C 1.581 2.146 0 C-N-CA 116.84 -1.944 . . . . 0.0 111.123 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.19 -32.42 0.3 Allowed 'Trans proline' 0 N--CA 1.412 -3.272 0 C-N-CA 121.707 1.604 . . . . 0.0 110.614 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 13.3 m -85.48 140.44 30.68 Favored 'General case' 0 C--O 1.249 1.035 0 C-N-CA 115.796 -2.362 . . . . 0.0 109.264 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.7 mt -101.63 168.7 9.31 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 117.777 -1.569 . . . . 0.0 110.719 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER 43.55 60.72 2.51 Favored 'General case' 0 N--CA 1.42 -1.964 0 C-N-CA 116.559 -2.056 . . . . 0.0 110.26 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 46.85 45.56 15.1 Favored 'General case' 1 C--N 1.441 4.571 0 C-N-CA 113.397 -3.321 . . . . 0.0 115.592 174.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 60' ' ' HIS . . . -77.46 -156.62 8.12 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 114.655 -3.641 . . . . 0.0 111.231 -175.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 1.389 ' CB ' ' N ' ' A' ' 71' ' ' THR 0.428 0.0 OUTLIER -79.61 155.32 28.17 Favored 'General case' 1 N--CA 1.367 -4.62 0 CA-C-N 109.742 -3.229 . . . . 0.0 114.009 176.685 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.05 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 44.2 t -147.26 120.08 8.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 114.632 -2.827 . . . . 0.0 109.151 158.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 115.623 -2.431 . . . . 0.0 106.768 174.629 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.09 -124.44 2.77 Favored Glycine 0 CA--C 1.555 2.559 0 C-N-CA 114.449 -3.739 . . . . 0.0 110.513 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.5 mt -104.49 98.14 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 114.781 -2.768 . . . . 0.0 109.812 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.27 -69.15 3.05 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 114.843 -3.551 . . . . 0.0 111.298 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.48 166.41 20.36 Favored 'General case' 0 C--O 1.254 1.317 0 C-N-CA 115.316 -2.553 . . . . 0.0 108.882 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -123.46 150.18 44.18 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 115.351 -2.54 . . . . 0.0 109.503 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -120.93 124.27 44.52 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 115.158 -2.617 . . . . 0.0 108.888 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.281 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.8 m -109.69 146.56 34.65 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 116.337 -2.145 . . . . 0.0 108.02 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 1.389 ' N ' ' CB ' ' A' ' 60' ' ' HIS . 4.3 m -109.52 103.22 12.07 Favored 'General case' 1 N--CA 1.558 4.963 0 C-N-CA 116.788 -1.965 . . . . 0.0 112.071 175.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 90.2 m -60.83 143.38 54.84 Favored 'General case' 0 N--CA 1.51 2.567 0 C-N-CA 115.913 -2.315 . . . . 0.0 107.86 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.2 166.95 15.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.548 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.45 96.57 0.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 115.711 -2.396 . . . . 0.0 108.822 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.38 -39.71 0.61 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 114.898 -3.525 . . . . 0.0 108.384 -168.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.22 166.81 11.27 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 115.441 -2.503 . . . . 0.0 108.305 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 83' ' ' PHE . 37.7 tt0 -157.64 112.78 2.73 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 115.091 -2.644 . . . . 0.0 109.229 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.58 174.78 35.5 Favored Glycine 0 C--O 1.212 -1.276 0 C-N-CA 114.472 -3.728 . . . . 0.0 111.223 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -45.32 -58.02 3.6 Favored 'General case' 0 N--CA 1.398 -3.027 0 C-N-CA 115.994 -2.282 . . . . 0.0 111.458 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.663 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 39.2 m-20 -106.28 18.09 22.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 114.924 -2.71 . . . . 0.0 109.121 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.9 m 76.34 18.56 1.82 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 115.662 -2.415 . . . . 0.0 108.708 -174.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.93 -32.59 73.91 Favored 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 116.865 -1.934 . . . . 0.0 110.273 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 77' ' ' GLU . 87.0 m-85 -91.32 168.02 11.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 115.216 -2.594 . . . . 0.0 110.387 -176.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 89.9 p -117.64 154.76 31.04 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 115.616 -2.434 . . . . 0.0 108.816 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.2 p -91.38 33.96 0.97 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 114.547 -2.861 . . . . 0.0 110.475 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 116.226 -2.189 . . . . 0.0 108.55 179.238 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -139.72 161.68 36.96 Favored 'General case' 0 C--O 1.257 1.49 0 C-N-CA 115.626 -2.43 . . . . 0.0 108.824 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.34 -74.66 0.03 OUTLIER Glycine 0 N--CA 1.417 -2.604 0 C-N-CA 116.158 -2.925 . . . . 0.0 109.718 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -127.09 111.86 14.51 Favored 'General case' 0 C--N 1.381 1.974 0 O-C-N 120.158 -1.789 . . . . 0.0 110.369 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 49' ' ' GLN . 3.3 mp0 -96.51 0.06 49.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 114.709 -2.796 . . . . 0.0 110.073 -174.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.155 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 42.9 t -126.8 18.15 7.32 Favored 'General case' 0 N--CA 1.508 2.437 0 C-N-CA 115.629 -2.429 . . . . 0.0 108.943 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -74.99 33.81 0.1 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 116.318 -2.153 . . . . 0.0 111.068 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.42 29.26 0.96 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 114.098 -3.906 . . . . 0.0 110.347 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 49.72 80.81 0.28 Allowed Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.144 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD2' ' SG ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -85.92 -35.53 0.14 Allowed 'Trans proline' 0 N--CA 1.404 -3.778 0 C-N-CA 121.334 1.356 . . . . 0.0 110.994 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.1 m -79.52 143.48 34.82 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 115.115 -2.634 . . . . 0.0 111.213 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.599 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.3 mt -102.44 175.02 5.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.512 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.599 ' C ' ' O ' ' A' ' 56' ' ' LEU . 9.2 m-80 30.02 62.95 0.17 Allowed 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 116.859 -1.936 . . . . 0.0 111.979 174.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 56.92 83.37 0.1 Allowed 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 117.089 -1.844 . . . . 0.0 109.272 170.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.72 161.44 20.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 115.75 -3.119 . . . . 0.0 109.536 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.554 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 43.4 t-80 -91.01 155.41 18.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 116.395 -2.122 . . . . 0.0 108.317 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.155 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 50.7 t -131.6 126.73 35.48 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 114.77 -2.772 . . . . 0.0 110.927 -173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? . . . . . 0 C--O 1.25 1.131 0 C-N-CA 114.578 -2.849 . . . . 0.0 108.196 176.319 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.48 -94.69 0.1 Allowed Glycine 0 N--CA 1.473 1.107 0 C-N-CA 114.431 -3.747 . . . . 0.0 111.377 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.2 mt -109.26 58.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 114.658 -2.817 . . . . 0.0 108.524 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.424 ' CA ' ' HG2' ' A' ' 49' ' ' GLN . . . 89.64 -55.02 3.81 Favored Glycine 0 N--CA 1.478 1.469 0 C-N-CA 114.673 -3.632 . . . . 0.0 112.269 173.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.711 ' C ' ' CD1' ' A' ' 68' ' ' TYR . 5.9 p-10 -80.55 -19.46 45.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 115.845 -2.342 . . . . 0.0 112.059 -174.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.711 ' CD1' ' C ' ' A' ' 67' ' ' ASP . 38.7 p90 51.36 166.5 0.01 OUTLIER 'General case' 1 C--N 1.218 -5.113 0 CA-C-N 111.478 -2.601 . . . . 0.0 112.727 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 p -141.43 129.33 21.84 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 116.13 -2.228 . . . . 0.0 108.905 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.979 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -100.74 127.25 47.23 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.569 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -94.97 149.95 20.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.91 -2.316 . . . . 0.0 109.49 176.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.898 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 84.4 m -99.27 156.35 17.03 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 115.132 -2.627 . . . . 0.0 109.299 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.47 164.57 26.48 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 115.371 -2.532 . . . . 0.0 109.455 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -62.82 102.98 0.39 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 115.014 -2.675 . . . . 0.0 109.766 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.0 -33.3 1.38 Allowed Glycine 0 CA--C 1.545 1.934 0 C-N-CA 114.502 -3.713 . . . . 0.0 110.201 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -110.69 164.41 12.77 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 116.082 -2.247 . . . . 0.0 109.162 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -159.38 118.49 2.92 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 115.618 -2.433 . . . . 0.0 109.225 175.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 169.79 170.11 33.84 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 114.29 -3.814 . . . . 0.0 110.288 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 85.1 tttt -41.0 -54.67 2.72 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 115.648 -2.421 . . . . 0.0 110.711 176.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.641 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 61.4 m-20 -110.83 15.81 21.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 115.731 -2.388 . . . . 0.0 109.862 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.898 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 11.1 m 74.01 28.34 1.5 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 115.092 -2.643 . . . . 0.0 109.338 -173.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -70.08 -31.51 69.13 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 116.245 -2.182 . . . . 0.0 110.523 -177.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.81 147.45 23.79 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 114.708 -2.797 . . . . 0.0 109.954 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -110.4 115.71 30.13 Favored 'General case' 0 C--O 1.256 1.425 0 C-N-CA 115.95 -2.3 . . . . 0.0 107.88 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 85' ' ' THR . 6.7 t -97.13 33.39 1.95 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 115.175 -2.61 . . . . 0.0 111.937 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 . . . . . 0 CA--C 1.469 -2.142 0 C-N-CA 115.685 -2.406 . . . . 0.0 111.045 -177.857 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 pttm . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -122.31 91.53 3.52 Favored 'General case' 0 C--O 1.3 3.729 1 C-N-CA 110.684 -4.407 . . . . 0.0 108.511 -175.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.62 174.4 48.1 Favored Glycine 0 C--N 1.374 2.664 0 C-N-CA 115.234 -3.365 . . . . 0.0 111.493 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -119.54 119.59 34.26 Favored 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 114.586 -2.846 . . . . 0.0 111.173 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 66' ' ' GLY . 3.4 mp0 -104.53 7.13 35.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 115.985 -2.286 . . . . 0.0 111.173 -177.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 46.6 t -128.33 8.48 6.01 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 116.201 -2.2 . . . . 0.0 110.226 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.76 24.32 0.06 Allowed 'General case' 0 C--O 1.249 1.075 0 C-N-CA 115.49 -2.484 . . . . 0.0 112.044 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 50' ' ' CYS . . . -144.72 23.74 1.98 Allowed Glycine 0 C--N 1.341 0.836 0 C-N-CA 114.559 -3.686 . . . . 0.0 111.017 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 45.78 78.63 0.38 Allowed Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 115.98 -2.288 . . . . 0.0 110.223 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.68 -33.77 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 N-CA-C 110.071 -0.781 . . . . 0.0 110.071 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.031 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 6.2 m -76.35 152.52 36.32 Favored 'General case' 0 C--O 1.261 1.667 0 C-N-CA 116.159 -2.216 . . . . 0.0 109.568 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 57' ' ' ASN . 72.2 mt -105.3 171.6 7.24 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 116.782 -1.967 . . . . 0.0 109.958 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 56' ' ' LEU . 27.8 m-80 36.17 61.45 0.77 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 117.566 -1.653 . . . . 0.0 111.734 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.432 ' NE2' ' N ' ' A' ' 58' ' ' GLN . 2.8 mp0 48.68 51.21 16.03 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 115.664 -2.414 . . . . 0.0 110.109 172.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.6 171.6 45.57 Favored Glycine 0 N--CA 1.479 1.549 0 C-N-CA 114.702 -3.618 . . . . 0.0 109.737 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -88.67 145.95 25.36 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.212 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 51.9 t -134.03 124.64 26.57 Favored 'General case' 0 N--CA 1.417 -2.081 0 C-N-CA 115.449 -2.5 . . . . 0.0 109.126 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.1 tptt . . . . . 0 C--O 1.252 1.205 0 C-N-CA 115.578 -2.449 . . . . 0.0 109.454 -179.881 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LAA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.13 -131.09 3.45 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 115.613 -3.184 . . . . 0.0 111.183 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 57.2 mt -87.86 90.48 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 113.724 -3.19 . . . . 0.0 108.038 -174.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . 78.77 -72.31 2.44 Favored Glycine 0 N--CA 1.496 2.679 1 C-N-CA 113.859 -4.019 . . . . 0.0 109.257 -178.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -72.23 166.25 22.79 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 115.746 -2.382 . . . . 0.0 109.706 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -115.91 163.72 15.47 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 116.303 -2.159 . . . . 0.0 109.568 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 p -128.99 135.25 48.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 115.108 -2.637 . . . . 0.0 109.333 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.031 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 94.9 m -113.43 124.24 51.95 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 116.827 -1.949 . . . . 0.0 110.382 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.75 122.2 46.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 116.163 -2.215 . . . . 0.0 110.072 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.813 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 67.3 m -72.91 150.2 42.78 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 114.904 -2.718 . . . . 0.0 110.178 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 169.18 15.55 Favored 'General case' 0 C--O 1.254 1.338 0 C-N-CA 115.622 -2.431 . . . . 0.0 109.984 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.07 105.89 0.76 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 114.859 -2.736 . . . . 0.0 109.952 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 145.78 -40.56 1.08 Allowed Glycine 0 C--O 1.213 -1.194 0 C-N-CA 115.32 -3.324 . . . . 0.0 110.325 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -113.19 163.07 15.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 115.475 -2.49 . . . . 0.0 110.099 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -155.49 125.37 6.53 Favored 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 115.234 -2.586 . . . . 0.0 109.374 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 79' ' ' LYS . . . 160.74 166.86 20.34 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.372 -4.251 . . . . 0.0 111.164 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 78' ' ' GLY . 22.8 tptm -39.59 -53.72 2.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 116.403 -2.119 . . . . 0.0 109.449 175.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.663 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 41.8 m-20 -113.44 11.91 18.58 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 116.355 -2.138 . . . . 0.0 109.649 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.813 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 7.4 m 74.39 31.75 1.01 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 115.094 -2.642 . . . . 0.0 109.571 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.92 -36.25 79.84 Favored 'General case' 0 CA--C 1.579 2.086 0 C-N-CA 116.474 -2.09 . . . . 0.0 110.243 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -89.45 145.85 25.04 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 114.941 -2.704 . . . . 0.0 109.53 -171.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.6 p -113.41 133.26 55.28 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 115.874 -2.33 . . . . 0.0 107.914 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.1 p -95.0 36.84 1.17 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 115.994 -2.282 . . . . 0.0 110.104 -173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.1 mtm-85 . . . . . 0 CA--C 1.556 1.18 0 C-N-CA 115.373 -2.531 . . . . 0.0 108.639 179.856 . . . . . . . . 0 0 . 1 stop_ save_